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Abstract 
Heart failure is a complex clinical syndrome where the heart is unable to 
maintain adequate cardiac output to meet the metabolic demands of tissues. 
This leads to a cascade of events that act to impair the oxygen transport 
system, giving rise to symptoms of fatigue and/or dyspnoea on exertion and, 
in more severe cases, at rest. Accordingly, exercise intolerance is a cardinal 
symptom of heart failure, and is a strong predictor of prognosis and 
mortality. As such, an individual’s tolerance to exercise is inextricably linked 
to diagnosis in heart failure. The mechanisms for this exercise intolerance 
are still not fully understood and currently there is a debate surrounding 
whether exercise tolerance is governed primarily by impairments in cardiac 
function (i.e. oxygen delivery), or impairments at the skeletal muscle level 
(i.e. oxygen utilisation), or both. Resolving this issue has implications for 
improving and tailoring effective treatment in heart failure.  
The work presented in this thesis fulfils two major aims: (i) the development 
and validation of a computational model of circulatory and oxygen uptake 
dynamics, that is able to predict oxygen uptake measurements that are 
experimentally measured at the lungs, and at the skeletal muscle, for ramp 
incremental exercise and; (ii) the assessment of the clinical utility of using 
near infrared spectroscopy as a non-invasive tool to determine the locus of 
exercise intolerance in heart failure patients. 
The computational model of circulatory and oxygen uptake dynamics 
demonstrated that cardiopulmonary breath-by-breath gas exchange 
measurements alone are not sufficient to identify the locus of exercise 
intolerance in heart failure patients. However, with the addition of a model 
output that gives specific information on the skeletal muscle oxygenation 
dynamics, insights into the mechanisms governing exercise tolerance can be 
gained.  
Near infrared spectroscopy was utilised under two different experimental 
conditions. During ramp incremental exercise, it was shown that near 
infrared spectroscopy can provide specific information regarding the locus of 
exercise intolerance in heart failure, particularly, those with oxygen delivery 
limitations. In addition, using a novel technique to assess oxidative capacity, 
it was established that near infrared spectroscopy can be used to produce 
reliable assessment of skeletal muscle function and, thereby, proves a 
promising technique to identify those with skeletal muscle dysfunction.  
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Overview 
 
Heart failure (HF) is considered a global pandemic, affecting approximately 
26 million people worldwide and rising in prevalence with an increasing 
aging population (Ponikowski et al., 2014). Despite the significant advances 
in therapies and prevention, mortality and morbidity rates are still high and 
quality of life poor (Savarese and Lund, 2017).  
 
HF is a complex clinical syndrome, where the heart is unable to maintain 
adequate cardiac output to meet the metabolic demands of tissues (Kemp 
and Conte, 2012). The clinical sequelae of this results in symptoms of 
fatigue or dyspnoea on exertion and, in more severe cases, at rest. 
Accordingly, exercise intolerance is one of the main symptoms experienced 
by heart failure patients, and is often a principal reason for seeking medical 
care (Piña et al., 2003; Kitzman and Groban, 2008). Lower exercise capacity 
is also associated with mortality in both health and heart failure (Mancini et 
al., 1991; Myers et al., 2002). Furthermore, heart failure is often classified 
based upon the functional capacity of the patient (Weber et al., 1982; Kemp 
and Conte, 2012; Bredy et al., 2018). Therefore, exercise intolerance is 
inextricably linked to the diagnosis of heart failure (Kitzman and Groban, 
2008).  
 
Exercise intolerance occurs when an individual is unable to sustain a rate of 
external work for a duration sufficient to complete the required task 
(Rossiter, 2011). It is logical to think that indices of cardiac function would be 
strongly related to exercise tolerance in heart failure. However, evidence 
shows this is not the case (Franciosa et al., 1981; Weber et al., 1984; Lipkin 
and Poole-Wilson, 1986; Witte et al., 2004). As such, many studies have 
sought mechanisms to explain the source of exercise intolerance present in 
heart failure patients.    
 
There is evidence to suggest impairments at the skeletal muscle level are 
related to a reduced exercise capacity in heart failure (Hepple et al., 1999; 
Bowen et al., 2012). However, the exact mechanisms of this are still not 
completely understood. In addition, identifying the primary source (i.e. 
whether a patient is primarily limited by cardiac related issues or by skeletal 
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muscle related issues) of the exercise intolerance in a given patient poses 
an even bigger challenge.  
  
Detailed knowledge of the pathophysiological mechanisms underlying 
exercise intolerance has implications for tailoring and optimising treatments 
on an individual patient level, as well as for the development of new 
therapeutic interventions, and evaluation of the effectiveness of current 
interventional strategies. In turn, a thorough understanding of the 
mechanisms determining exercise intolerance may help to reduce the 
burden that heart failure places on NHS resources, and improve the quality 
of life in patients suffering with heart failure.   
 
This thesis aims to explore these issues, with a particular attention paid to 
impairments at the skeletal muscle level as the primary source of exercise 
intolerance. This will be achieved using a combined computational and 
experimental approach. There are two major aims of this thesis: (i) 
computational approaches to develop and validate a previously published 
computational model of circulatory and oxygen uptake dynamics for 
constant-intensity work rate exercise, that is able to predict oxygen uptake 
measurements that are experimentally measured at the lungs (i.e. 
pulmonary oxygen uptake), and at the skeletal muscle (i.e. muscle oxygen 
uptake) for changing-intensity work rate exercise and; (ii) experimental 
approaches to test the clinical utility of using near infrared spectroscopy as a 
non-invasive tool to identify individuals with skeletal muscle oxygen delivery 
limitations, and/or skeletal muscle oxygen utilisation impairment, in order 
determine the primary locus of exercise intolerance in heart failure 
patients.The major aim of chapter 1 is to provide an overview of the key 
physiological concepts that underpin this thesis and are important in 
understanding model development. This will include a detailed overview of 
oxygen uptake kinetics, as well as one the key relationships governing them: 
the oxygen delivery-to-oxygen utilisation relationship. Chapter 1 will also 
describe the physiology of the oxygen uptake response to exercise, defining 
key physiological markers of exercise intensity, how oxygen uptake is 
measured, how its kinetics are determined, and their clinical importance. The 
concepts described in Chapter 1 are central to this thesis and will be referred 
to throughout subsequent chapters. Chapter 2 contains the experimental 
methodology for each study including data collection, exercise protocols, 
measurements and equipment used and data analysis. 
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The major aim of chapter 3 is to validate a computational model of 
circulatory and oxygen uptake dynamics for ramp incremental exercise. In 
Chapter 4 this model is developed further to include an assessment of 
muscle oxygenation dynamics. One of the key concepts presented in 
Chapter 1 is the use of near infrared spectroscopy, a measurement 
technique that is key to this thesis and will feature throughout subsequent 
chapters. Chapter 2 will describe the key studies that have utilised near 
infrared spectroscopy, and that are relevant to this thesis. The chapter will 
then go on to describe the model development and model validation 
process, before describing the results from a sensitivity analysis of the 
model.  
The following chapters will focus on model application and experimental 
approaches. This includes utilising three different approaches to measuring, 
non-invasively, impairments at a skeletal muscle level.  
Chapter 5 will focus on ‘whole body’ approaches, where separating 
circulatory, pulmonary and muscle factors can prove challenging. Chapter 5 
will utilise a combination of the models presented in chapters 3 and 4, and 
experimental data collected in healthy and heart failure participants. Its 
major aim is to quantify what the pulmonary oxygen uptake measurements 
in heart failure patients truly represent.  
Chapters 6 and 7 will present two further different methods of non-invasively 
investigating skeletal muscle function. Chapter 6 will focus on the dynamic 
relationship between oxygen delivery and oxygen utilisation, while Chapter 7 
aims to investigate, solely, muscle oxygen utilisation (i.e. in isolation from 
oxygen delivery). In Chapter 6, the main aim is to characterise and quantify 
muscle oxygenation dynamics in response to ramp incremental in heart 
failure patients.  
The major aim of Chapter 7 is to test the reproducibility of a non-invasive 
method of assessing skeletal muscle function, without the confounding 
influences of oxygen delivery. Chapter 7 will begin by providing an overview 
of the oxidative capacity technique, as well as the current evidence behind it. 
Chapters 4-7 explore non-invasive methods of determining the locus of 
exercise intolerance in heart failure, with increasing specificity with each 
chapter. Chapter 5 utilises a whole-body approach, whilst Chapter 6 looks at 
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oxygen delivery in relation to oxygen utilisation and Chapter 7 looks solely at 
oxygen utilisation.  
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Chapter 1 General Introduction 
 
 
1.1 Oxygen uptake kinetics  
At the onset of exercise there is an increased demand on the body to deliver 
and utilise oxygen to provide the required energy to support the activity. This 
requires the effective co-ordination of the pulmonary, cardiovascular, and 
neuromuscular systems. The rate at which the body can adapt from one 
metabolic state to another (its kinetics) determines, in part, how well an 
individual copes with the increased work load (Rossiter, 2011). The uptake 
of oxygen by biological tissue can be described by the Fick principle: 
V̇O2 = Q̇(CaO2 - CvO2), (1) 
where V̇O2 is oxygen uptake (with units of L/min), Q̇ is blood flow (L/min), 
and CaO2 and CvO2 are arterial and venous oxygen concentrations, 
respectively (L O2 per L blood), with CaO2 typically remaining constant during 
exercise (Grassi et al., 1998). By rearranging the Fick equation: 
and noting that CaO2 is typically constant, such that: 
muscle oxygenation (as reflected in CvO2) is proportional to the ratio of O2 
delivery (i.e. Q̇) to O2 utilisation (i.e. V̇O2). A drop in the Q̇/V̇O2 ratio (i.e. a 
decrease in O2 delivery, an increase in O2 utilisation, or both) can reduce 
muscle oxygenation and inhibit peripheral O2 exchange. However, both Q̇ 
and V̇O2 change during exercise, and so it is the kinetics of the changes in Q̇ 
CvO2 = CaO2  – (V̇O2 / Q̇) , (2)                                                                  
CvO2  ∝   V̇O2 / Q̇ , (3)                                                                   
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and V̇O2 that determine muscle oxygenation during exercise: as such, the 
transient dynamics of the Q̇/V̇O2 relationship (reflected in the CvO2 profile) 
are key determinants for maintaining oxidative phosphorylation during 
exercise (Whipp and Ward, 1992; Koga et al., 2014). Understanding the 
complicated dynamics of the Q̇/V̇O2 relationship during exercise (which are 
determined by their steady state relationship, and their kinetics) can 
therefore provide a window into understanding metabolic control (O2 delivery 
and utilisation, and muscle oxygenation) at the working muscle at the onset 
of, during and after exercise (Poole et al., 2008). Before exploring V̇O2 
kinetics in relation to their influence upon exercise tolerance, it is important 
to first understand this V̇O2/Q̇ relationship, one of the key relationships 
governing oxygen uptake. 
 
1.2 The V̇O2/Q̇ relationship 
The steady state relationship between V̇O2 and Q̇ is linear and is 
approximately 5-6 (Saltin et al., 1968; Faulkner et al., 1977; Richardson et 
al., 1993). Figure 1 shows this steady state linear relationship between V̇O2 
and Q̇ at the exercising muscle (i.e. V̇O2m and Q̇m respectively). The figure 
shows the theoretical V̇O2m/Q̇m relationship of an individual during steady 
state exercise. In this case (i.e. under the steady state condition), the way an 
individual “travels”’ from their starting point (Point A) to their end point (Point 
B) is linear (blue line).  
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Figure 1: Top panel (left) The V̇O2m/Q̇m relationship during steady state 
conditions. The dashed line shows this steady state relationship, with an 
increase in Q̇m of 5 L/min for every 1 L/min increase in V̇O2m. The red 
squares represent start and end points. Blue solid line represents how an 
individual “travel” from point A to point B with time constants of 30s for both 
V̇O2m and Q̇m. Middle: V̇O2m-Q̇m relationship with time constants of 30s for 
Q̇m and 45s for V̇O2m (i.e. V̇O2m kinetics are slow relative to Q̇m kinetics). 
(Right) V̇O2m/Q̇m relationship with time constants of 45s for Q̇m and 30s for 
V̇O2m (i.e. V̇O2m kinetics are fast relative to Q̇m kinetics).In both conditions 
the V̇O2m/Q̇m relationship no longer follows a linear profile but rather 
overshoots (when Q̇m kinetics fast relative to V̇O2m kinetics; top middle) or 
undershoots (when Q̇m kinetics slow relative to V̇O2m kinetics; top right) the 
steady state increase, to get from point A to point B. Bottom panel: Muscle 
CvO2 profile during the steady state with time constants for V̇O2m and Q̇m of 
30 s (left), and during exercise transition in which Q̇m kinetics are fast 
relative to V̇O2m kinetics, where time constant of Q̇m is 30 s and V̇O2m 45 s 
(middle), and where Q̇m kinetics are slow relative to V̇O2m kinetics, with time 
constants of 45 s for Q̇m and 30 s for V̇O2m (right). During steady state 
conditions muscle CvO2 decreases hyperbolically, however in conditions 
where Q̇m kinetics are slowed muscle CvO2 undershoots its steady state 
values. NB: it is recognized that CvO2 = 0 mL/O2/mL blood is a theoretical 
artefact of the model not possible under physiological conditions but is used 
here to demonstrate the influence of V̇O2 and Q̇ kinetics on oxygen 
extraction. 
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This relationship only holds true however, in the steady state. Therefore, 
during exercise transitions (i.e. when an individual is no longer in a steady 
state), how an individual “travels” to and from point A to point B can change. 
For example, Figure 1 also shows the V̇O2m/Q̇m relationship under conditions 
where Q̇m kinetics are faster than V̇O2m kinetics (left). As shown, The V̇O2m-
Q̇m relationship is no longer linear, but rather overshoots the steady state 
line to get from point A to point B (blue line). Conversely, if V̇O2m kinetics are 
faster than Q̇m kinetics (right), the V̇O2m-Q̇m relationship undershoots its 
steady state line to get from point A to point B. 
This is important to consider as how an individual “travels” from point A to 
point B determines the muscle oxygenation profile (i.e. how much oxygen is 
extracted from the muscle). As such, the extent to which V̇O2m and Q̇m 
kinetics are speeded or slowed relative to each other influences muscle 
oxygenation also. This is shown in Figure 1: a linear increase in the 
V̇O2m/Q̇m relationship (i.e. top panel, left) necessitates a hyperbolic decrease 
in CvO2 (bottom panel, left), whereas faster Q̇m kinetics in relation to V̇O2m 
kinetics reduces the extent to which the muscle is drained of O2 during the 
transient (middle). Finally, in situations where V̇O2m kinetics are fast relative 
to Q̇m kinetics, there is an undershoot in muscle CVO2 before returning to its 
steady state, causing the muscle to be completely drained of O2 in this 
simulation (right). This is pertinent in diseases which act to slow Q̇m kinetics, 
such as heart failure. 
 
1.3 V̇O2 kinetics in relation to exercise tolerance 
Directly measuring exercising V̇O2m and Q̇m kinetics is technically 
challenging. For example, Grassi et al. (1996) used constant-infusion 
thermodilution techniques in combination with arterial and femoral venous 
blood sampling to measure leg blood flow and arteriovenous difference to 
calculate muscle V̇O2 using the Fick principle (Equation 1) during moderate 
intensity cycling in healthy young individuals. However, this method is 
extremely invasive and complex. Nevertheless, the study by Grassi et al. 
(1996) demonstrated that the kinetics of skeletal muscle V̇O2 and pulmonary 
V̇O2 (i.e. O2 uptake measured non-invasively at the mouth, and O2 uptake 
measured simultaneously at the skeletal muscle level) closely matched, to 
9 
 
within 2-3 seconds; these empirical findings confirmed previous modelling 
predictions that pulmonary V̇O2 kinetics are a close approximation of muscle 
oxygen consumption following exercise onset (Barstow et al., 1990). 
Therefore, a more commonly used and non-invasive method is to infer 
muscle V̇O2 (V̇O2m) and its kinetics indirectly from breath-by-breath 
measurements of pulmonary V̇O2 (V̇O2p). This non-invasive method of 
inferring V̇O2m kinetics from V̇O2p kinetics has led to a large focus on V̇O2p 
kinetics, and their relation to exercise tolerance (Rossiter, 2011).  
Faster V̇O2p kinetics reflect a rapidly functioning (and therefore effective) 
physiological system; trained (versus untrained) individuals typically have 
faster V̇O2p kinetics. Conversely, V̇O2p kinetics are typically slowed in 
disease states such as heart failure (Belardinelli et al., 1997; Sperandio et 
al., 2009; Kemps et al., 2010; Bowen et al., 2012; Mezzani et al., 2013), 
suggesting that these patients have impairments at some point along the O2 
transport pathway that inhibits the body’s ability to adjust to the new 
requirements for O2 delivery and utilisation. Slowed V̇O2p kinetics are 
strongly correlated to exercise intolerance (Sperandio et al., 2009) and, as 
such, are a highly prognostic indicator of morbidity and mortality in in 
diseases such as heart failure (Schalcher et al., 2003). The consequence of 
a slower V̇O2p response is a greater reliance on anaerobic energy 
generating pathways, which are limited in their capacity. An increased 
reliance on anaerobic energy generating pathways results in reductions in 
phosphocreatine (PCr), adenosine triphosphate (ATP) and glycogen, as well 
as the formation of lactate. In addition, there is a build-up of metabolites 
detrimental to muscle function, such as adenosine diphosphate (ADP), 
inorganic phosphate (Pi), and hydrogen ions (Allen et al., 2008), all of which 
contribute to increased muscle fatigue and, consequently, exercise 
intolerance. 
The mechanisms contributing to the slowed V̇O2p kinetics in heart failure are 
still not completely understood, but have been suggested to be as a result 
of: (i) a reduced O2 delivery (Hughson and Morrissey, 1982; Hughson, 1984) 
due to a reduction in cardiac output (Cerretelli et al., 1988) and/or 
impairments in blood flow distribution to the exercising skeletal muscle 
(Richardson et al., 2003); and (ii) O2 utilisation limitations in the exercising 
skeletal muscle (Grassi et al., 1997, 1998; Bowen et al., 2012; Richardson et 
al., 2015) due to mitochondrial dysfunction, and/or a reduction in the number 
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of mitochondria due to muscle atrophy, or a shift in muscle fibre type 
distribution away from type I and towards type II (less oxidative) fibres 
(Drexler et al., 1992; Kemps et al., 2010). Resolution of this issue is 
essential for understanding the mechanistic bases for the impaired V̇O2p 
kinetics found in patient populations (Poole et al., 2008) which, in turn, may 
help to target future therapeutic interventions to improve exercise tolerance, 
and explain the variance often seen in treatment effectiveness. 
Understanding the characteristics and different components of the V̇O2p 
response is therefore a necessary first step in understanding V̇O2p kinetics 
and its role in exercise, health and disease.  
 
1.4 Exercise intensity domains 
In addition to its kinetics, the V̇O2p profile during constant work rate exercise 
has been utilised to define the ‘exercise intensity’ at which an individual is 
working. Exercise intensity is a key concept in exercise physiology, as it 
allows appropriate normalisation for exercise stressors between individuals 
(Rossiter, 2011). Exercise performed at the same intensity should have a 
common stress response profile between individuals. However, defining 
exercise intensity based on single physiological parameters (such as 
percentage of maximal oxygen uptake; %V̇O2,max) could result in markedly 
different physiological responses amongst different individuals. This was 
demonstrated by Rossiter (2011), who assigned two individuals the same 
absolute work rate and percentage V̇O2,max (85%) during constant work rate 
cycle-ergometry exercise. Despite this normalisation, one of the individuals 
was only able to sustain the work rate for around ten minutes (where they 
reached the limit of tolerance), whereas the other individual was able to 
attain a steady state and maintain the exercise for 30 minutes, resulting in 
markedly different physiological responses. An alternative method of 
assigning exercise intensity is by using other physiological markers such as 
lactate threshold, critical power and V̇O2,max (Figure 2). The lactate threshold 
can be described as the level of work or O2 uptake just below that at which 
metabolic acidosis and associated changes in gas exchange occur, and 
exercise performed below lactate threshold can be sustained for long 
periods of time (Wasserman et al., 1973). Critical power can be defined as 
the highest work rate at which a steady state in V̇O2, blood lactate, 
phosphocreatine, and inorganic phosphates can be achieved, representing 
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the asymptote of the hyperbolic relationship between work rate and time to 
intolerance for a given individual (Rossiter, 2011). Within a given ‘intensity 
domain’ different  components of the V̇O2p response to constant load 
exercise can be identified; that is, V̇O2p profiles show different characteristics 
depending on the intensity domain the individual is exercising in (Whipp, 
1994) as shown in Figure 2. 
 
Figure 2: Intensity domains of muscular exercise and their associated V̇O2 
responses. The horizontal dashed lines represent the physiological 
boundaries demarcating the moderate, heavy, very heavy and severe 
exercise intensity domains. The solid black curves show the V̇O2p response 
in each exercise intensity domain. The grey dashed lines represent the V̇O2 
slow component, causing V̇O2 to rise above that predicted by the sub LT 
V̇O2 work-rate relationship. CP, critical power; LT, lactate threshold. Adapted 
from Rossiter (2011).  
Exercise performed below the lactate threshold has been termed ‘moderate’ 
intensity exercise (Whipp et al., 1982). In the moderate intensity domain 
there is no sustained metabolic acidosis, and an early steady state in V̇O2p is 
attained (usually within three minutes in healthy adults). For all work rates in 
the moderate intensity domain, once a steady state has been attained,  
100% of ATP resynthesis requirements can be met by oxidative metabolism 
(Özyener et al., 2001). Exercise performed above the lactate threshold, but 
below critical power can be defined as ‘heavy’ intensity exercise. Exercise in 
this domain becomes more complex (Whipp and Wasserman, 1972; Whipp, 
1994; Gerbino et al., 1996) with the development of a delayed increase in 
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V̇O2, known as the “slow component”. The slow component is generated 
principally in the exercising muscles (Poole et al., 1991), and is thought to 
represent reduced work efficiency by mechanisms related to; increased ATP 
requirement, and/or reduced power contribution from fatiguing muscle fibers, 
necessitating an increased power production from already recruited fibers or 
recruitment of additional fibers (Jones et al., 2011). Nevertheless, a 
(delayed) steady state is still achieved in the heavy intensity exercise 
domain, as such exercise in this domain is still sustainable. ‘Very heavy’ 
intensity exercise (between critical power and V̇O2,max) is characterised by a 
V̇O2p response with a slow component that continues to increase throughout 
the test towards V̇O2,max. A steady state in V̇O2p is not achieved in this 
domain (Özyener et al., 2001); instead, there is a progressive rise until 
V̇O2,max is reached. During ‘severe’ intensity exercise, the limit of tolerance is 
reached before a V̇O2p slow component can develop, or be clearly 
distinguishable (Özyener et al., 2001). Work rates in this domain can usually 
only be sustained for a few minutes.  
Despite the usefulness of the V̇O2p response in characterising exercise 
intensity, exercise capacity, and health status, it is important to note that the 
V̇O2p response is a ‘whole body’ measure. As such, when it comes to its 
kinetics, inferring V̇O2m kinetics from V̇O2p kinetics needs to be done 
carefully. V̇O2p kinetics not only reflect V̇O2m kinetics, but are influenced by 
muscle-to-lung transit time delays, and changes in vascular O2 
concentrations which can complicate estimation of V̇O2m from 
cardiopulmonary measurements (Barstow et al., 1990). According to 
equation 2 and, as CaO2 is typically constant in healthy humans throughout 
exercise (Grassi et al., 1996), the O2 content in the venous effluent of the 
contracting muscle is determined by the ratio between V̇O2m and Q̇m through 
the exercise transient (as described earlier). Any value of muscle CvO2, 
therefore, is dependent on the ratio of muscle V̇O2m to muscle Q̇m. However, 
the muscle CvO2 profile (and therefore the muscle V̇O2 profile) is distorted as 
it travels to the lungs. The muscle venous effluent from the exercising 
muscle is at some point mixed with venous effluent from other, non-
exercising, tissues in a flow-weighted manner. These venous effluents (both 
before and after mixing) must also travel through a series of venous volumes 
(Vv) to the lungs, that results in a transit delay between the CvO2 profile 
appearing at the muscle and appearing at the lungs. However, the muscle-
to-lung transit delay is not constant during the exercise transient, but varies 
with blood flow, and the size of the venous volumes (Bangsbo et al., 2000). 
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V̇O2p transients are, therefore, non-linear distorted variants of V̇O2m (Benson 
et al., 2013; Hoffmann et al., 2013). The muscle-to-lung transit delay is 
typically thought to be around 20s at rest and can fall to about 10s during 
exercise (Krustrup et al., 2009). The greater the increment in blood flow to 
the exercising tissue at the onset of exercise, the larger the reduction in the 
transit delay (Rossiter, 2011). This is demonstrated in Figure 3 (left), which 
shows muscle-to-lung transit time during a step increase in work rate from 0 
W to 50 W (red line), 0 W to 100 W (black line) and 0 W to 150 W (blue line). 
When the increment in blood flow to the exercising muscle is increased 
(achieved by increasing the work rate by a greater amount), the transit time 
is shorter, and vice versa. The baseline blood flow will also affect the 
muscle-to-lung transit delay, as shown in Figure 3 (Right). When baseline 
blood flow is decreased (red line) compared to control (black line), the initial 
(steady state) transit delay, plus the subsequent exercise time delays, 
become longer, and when baseline blood flow is increased (blue line) the 
transit delays are shorter.  
 
Figure 3: Left: The muscle-to-lung transit delay during simulations of a work 
rate step from: 0 to 50W (red line); 0 to 100W (black line); and 0 to 150W 
(blue line). The higher the step in work rate, the larger the increment in blood 
flow to the exercising tissues, resulting in a smaller muscle-to-lung transit 
delay during the exercise bout. Right: The muscle-to-lung transit delay 
during simulations of a work rate step from 0 to 100 W, for three different 
baseline blood flows: 8.01 L/min (red line), 8.89 L/min (black line) and 9.77 
L/min (blue line). When baseline blood flow is increased (causing an 
increased blood flow throughout subsequent exercise), the transit delay is 
smaller. 
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Note, in this simulation the increment in blood flow stays the same, and only 
the baseline blood flow is altered. Furthermore, the rate of the mixing of the 
muscle and non-exercising effluents is also dependent on blood flow and the 
size of the venous volumes. The effluent which has a higher fraction of blood 
will have a bigger influence on the mixing and, moreover, the effluent which 
reaches the mixing point first will have a bigger influence on the mixing. As 
both these factors are not constant, flow weighted mixing also varies with 
time. As a consequence of this, the CvO2 profile at the lungs during the 
exercise bout may markedly differ from the CvO2 profile generated at the 
muscle (Hoffmann et al., 2013). This highlights the importance of taking due 
care and consideration when estimating V̇O2 kinetics from breath-by-breath 
pulmonary exchange measurements. 
 
1.5 Characteristics of the pulmonary oxygen uptake response 
The dynamics of the V̇O2p response at the onset of exercise have been well 
characterised (Whipp and Wasserman, 1972; Whipp et al., 1982). Figure 4 
shows that, at the onset of constant work-rate exercise, there is an initial 
abrupt increase of V̇O2p, termed “phase I.” This is due to an increase in 
pulmonary blood flow along with a constant venous O2 content (as the 
venous effluent from the exercising muscle, with reduced O2 content, has yet 
to reach the lungs). The duration of this phase therefore reflects the initial 
muscle-to-lung transit time (Poole and Jones, 2012), and lasts approximately 
20 seconds in young and healthy individuals (De Cort et al., 1991; Benson et 
al., 2017). The ensuing component of the response (phase II) is an 
exponential increase (Grassi et al., 1996) which closely reflects the increase 
in muscle oxygen consumption (i.e. the increased O2 extraction in the 
contracting muscle). An exponential function has an amplitude, and a time 
constant (𝜏) on which the duration of phase II depends. This is 
approximately 20-45 seconds in young and healthy humans (Richardson et 
al., 2015), and this time constant represents the time taken to reach ~63% of 
the steady state response. Phase II can therefore be described with the 
equation: 
V̇O2(t) = V̇O2,b + A(1 − 𝑒−(𝑡−TD) 𝜏⁄ ) (4) 
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where V̇O2(t) is the V̇O2 at any time point, V̇O2,b is the baseline V̇O2 before 
the onset of the transition to a higher work rate, A is the amplitude of the 
V̇O2 response, and ( 1- e-(t-TD) 𝜏⁄ )  is the exponential function that describes 
the rate at which V̇O2 is rising towards the steady state, where t is time, TD 
is the time delay before the start of the exponential term and 𝜏 is the time 
constant. 
 
 
Figure 4: Breath-by-breath V̇O2 response following the onset of constant 
work rate exercise. Adapted from Manns et al. (2010). 
 
A smaller time constant (i.e. faster kinetics) reflects the ability to respond 
rapidly to a stressor, such as exercise, and is a major feature of an 
effectively functioning physiological system (Rossiter, 2011). When both 
phases are complete a ‘steady state’ is attained where all the energy 
required by the body is met by aerobic metabolism. This is termed phase III 
(Whipp and Ward, 1992). Note that exponential processes never technically 
reach a steady state but approach the asymptote i.e. (V̇O2,b + A) as t →∞ (as 
time approaches infinity). However, in reality, because of the noise on 
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experimentally-measured V̇O2 it can be  assumed that the process  reaches 
a steady state after ~4 time constants (Jones and Poole, 2005). The faster 
phase III is achieved, the smaller the “O2 deficit”, which is the sum of energy 
derived from anaerobic sources (i.e. phosphocreatine breakdown and 
glycolysis), will be. Hence, the time constant of the V̇O2p response (𝜏V̇O2p) is 
a fundamental parameter of aerobic performance, and may provide an 
insight into the broad range of exercise capabilities across populations 
(Poole and Jones, 2012). 
 
1.6 The pulmonary oxygen uptake response to incremental exercise 
So far, the V̇O2p response to constant work rate exercise has been 
described. However, normal day-to-day activity and exercise is seldom of 
the “step” protocol type, where a constant work load is added at a single 
time point. Instead, day-to-day exercise tends to involve a constantly 
changing work load, and the physiological response to a given activity 
therefore tends to span multiple exercise intensity domains. Because of this, 
cardiopulmonary exercise testing using step exercise protocols tends to be 
limited to specialised research studies, and instead an incremental exercise 
protocol to the limit of tolerance, where work rate is gradually increased until 
the individual can no longer exercise, is the most widely used test of the 
efficiency of the integrated functioning of the cardiopulmonary and 
neuromuscular systems (Rossiter, 2011). Unlike a constant work rate test, 
incremental exercise spans the range of exercise intensity domains; as 
such, a steady state in V̇O2p is not attained, requiring the body to 
continuously adapt to changing metabolic demands. The incremental 
exercise protocol can vary, increasing either (i) in small progressive work 
rate increases (e.g., 20 W) for a fixed period (e.g., every minute) in a 
staircase fashion, termed “step incremental”, or (ii) in a smooth linear fashion 
where work rate is constantly and smoothly increased at a given rate (e.g., 
20 W per minute), termed “ramp incremental”. The V̇O2p response to ramp 
incremental exercise of optimum duration (Buchfuhrer et al., 1983) is, 
following an early exponential phase, typically linear with increasing work 
rate and can be described by the equation: 
V̇O2 (t) = ∆V̇O2 (ss) ∙ [t  −  𝜏 ∙  (1 −  e  -t τ⁄ )] (5) 
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where V̇O2 (t) is the V̇O2 at any given time, ∆V̇O2(ss) is the steady state 
increase in V̇O2 above the baseline value required for the work rate at time t, 
and τ is the time constant of the response (Whipp et al., 1981). During ramp 
exercise however, it is not possible to distinguish between phase I and 
phase II. As such, 𝜏 represents both phase I and II of the response and is 
commonly referred to as the mean response time (MRT). The ramp 
incremental test allows determination of other important parameters of 
aerobic function, such as the V̇O2,peak, lactate threshold, and V̇O2 gain (the 
‘cost’ of O2 per Watt of exercise). The linearity of the V̇O2 response to 
incremental exercise is somewhat unexpected, considering that during 
constant-load/ power exercise at exercise intensities above lactate threshold 
the V̇O2 slow component drives V̇O2 above the expect value. This is typically 
not the case during incremental exercise (i.e. the emergence of a slow 
component above lactate threshold is not seen), and this is suggested to be 
the result of a slowly developing inefficiency (rise in V̇O2 gain) coupled with a 
progressive slowing of V̇O2 kinetics (Rossiter, 2011). However, during ramp 
incremental tests in which the duration is prolonged (i.e. if the work rate 
increments are relatively slow) nonlinearities in the V̇O2p response have 
been reported (Davis et al., 1982; Hansen et al., 1988) possibly allowing 
time for a V̇O2 slow component to emerge.   
1.7 Exercise tolerance and heart failure 
Heart failure (HF) is a multifaceted syndrome in which one of the main 
symptoms is exercise intolerance, often due to muscular fatigue and 
dyspnoea, linked to structural and functional aberrations in the O2 transport 
pathway (Nilsson et al., 2008; Poole et al., 2011). As a result of this, patients 
with HF in many cases have a reduced quality of life. Heart failure has a 
poor prognosis with 30-40% of patients diagnosed with HF dying within one 
year. Furthermore, the prevalence of HF is on the rise with an increasingly 
ageing population. It is a current and growing health concern that accounts 
for 2% of inpatient bed days, and 5% of emergency hospital admissions 
(Cowie, 2000; Owan et al., 2006; Hobbs et al., 2007).  
Exercise tolerance is a principal predictor of hospital readmissions in HF 
(Hirai et al., 2015). However, the exact mechanisms leading to impaired 
exercise tolerance in this patient population are still not completely 
understood (Nilsson et al., 2008). Whilst an impaired cardiac function (which 
acts to impair cardiac output and consequently O2 delivery) certainly plays 
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an important role in determining exercise tolerance (Hughson et al., 2001; 
MacDonald et al., 2001), there is no strong correlation between indices of 
cardiac function [i.e. left ventricular ejection fraction (Figure 5) and resting 
cardiac output] and exercise capacity (Franciosa et al., 1981; Weber et al., 
1984; Lipkin and Poole-Wilson, 1986; Witte et al., 2004). There is, however, 
convincing evidence that skeletal muscle O2 utilisation (i.e. a dysfunction at 
the skeletal muscle level) may also contribute to poor exercise tolerance in 
heart failure patients (Grassi et al., 2003; Bowen et al., 2012). 
 
 
Figure 5: Relationship between V̇O2,peak (pV̇O2; a measure of exercise 
capacity) and left ventricular ejection fraction (LVEF; a measure of cardiac 
function) in heart failure patients. Taken from Witte et al. (2004).  
 
What is unclear, is whether one or both of these impairments (i.e. O2 
delivery or O2 utilisation), is the primary cause of exercise intolerance in a 
given heart failure patient. For example, interventions aimed solely at 
improving cardiac output (such as cardiac resynchronisation therapy; CRT) 
may not be effective in improving symptoms associated with exercise 
intolerance (such as breathlessness and fatigue) in a patient who is also 
limited at the skeletal muscle level. Resolution of this issue is essential in 
understanding the patient-specific mechanisms of exercise intolerance in 
heart failure, to allow for better targeting of therapeutic interventions.  
1.8 Oxygen delivery and exercise capacity 
Cells rely on a continuous supply of oxygen to maintain aerobic respiration 
(Treacher and Leach, 1998). Within the mitochondrial inner membrane, 
oxygen acts as the terminal acceptor at the end of the electron transport 
chain whereby oxidative phosphorylation results in the synthesis of 
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adenosine triphosphate (ATP), the co-enzyme that supplies energy to all 
active metabolic processes. Delivery of oxygen around the body occurs 
though convective (i.e. the movement of oxygen within the circulation) and 
diffusive (the passive movement of oxygen down a concentration gradient) 
transport (Dunn et al., 2016). Convective delivery can be described by the 
Fick principle: V̇O2 = Q̇ x (CaO2 – CvO2), and diffusive delivery by Ficks law 
of diffusion: V̇O2 = DO2m x (PmV̇O2-PiO2), where DO2m is the muscle O2 
diffusing capacity, PmV̇O2 is the microvascular partial pressure and PiO2 is 
the intracellular partial pressure. The integration of these two equations 
determines an individual’s maximal oxygen capacity (V̇O2,max), which 
measures the upper ceiling of the O2 transport/utilisation system and thus a 
person’s capacity for exercise (Wagner, 1996). As such, in a clinical setting 
V̇O2,max can be utilised as a physiological marker to evaluate exercise 
capacity and the severity of diseases that affect components of the O2 
transport chain (e.g. pulmonary, cardiovascular, neural and skeletal muscle 
systems), such as HF (Weber et al., 1982). Any impairments in the 
convective and/or diffusive O2 transport system may reduce an individual’s 
exercise tolerance.  
 
1.9 Convective oxygen delivery 
At the onset of, and during exercise the increased demand for oxygen is 
facilitated by an increase in cardiac output (CO), at least in healthy 
individuals (De Cort et al., 1991). Cardiac output is the product of stroke 
volume (SV) and heart rate (HR) such that: CO = SV * HR. At exercise onset 
the increase in cardiac output is achieved by an immediate increase in 
stroke volume and heart rate. Stroke volume increases during low levels of 
exercise via the Frank-Starling mechanism and during higher levels of 
exercise, stroke volume increases predominantly due to increased 
contractility, and may even decline slightly due to tachycardia and limited 
filling time (Kitzman and Groban, 2008). Heart rate increases in a linear 
fashion due to a decreased vagal tone and an increase in sympathetic 
nervous system stimulation. As exercise continues, stroke volume plateaus 
and remains relatively constant and further increases in cardiac output are 
primarily achieved by an increase in heart rate (Higginbotham et al., 1986). 
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In heart failure, there is a plethora of structural, mechanical and functional 
impairments that act to constrain blood flow to the exercising muscle during 
exercise in heart failure (Poole et al., 2011; Kemp and Conte, 2012). 
Impairments in ejection fraction (the proportion of blood ejected from the 
ventricles during ventricular contraction), stroke volume (the amount of blood 
ejected by the ventricle per heartbeat), and the heart rate response 
contribute to a reduced cardiac output (Sullivan et al., 1989). Additionally, 
the initial rapid increase in cardiac output seen in healthy individuals may be 
attenuated in HF; the result is a lower and slower cardiac output response 
(Zelis et al., 1968, 1974, 1988). When cardiac output cannot be maintained 
to meet the demands of the body, compensatory mechanisms are employed 
to maintain systemic arterial pressure; while initially beneficial, the long-term 
effects of these mechanisms serve to worsen heart failure in a vicious cycle 
(Poole et al., 2011). In HF elevated sympathetic nervous system activation 
and increased levels of circulating humoral mediators (i.e. norepinephrine, 
and angiotensin II), combined with a reduction in endothelial nitric oxide 
(Kubo et al., 1991; Ferreira, Hageman, et al., 2006; Chaggar et al., 2009) 
contribute to global vasoconstriction which, when maintained over time, 
leads to impairments in the ability of the body to distribute cardiac output to 
and within the skeletal muscle (Zelis et al., 1981).  
 
1.10 Diffusive oxygen delivery 
At the onset of exercise in healthy humans, red blood cell (RBC)-muscle 
mitochondrial O2 flux increases rapidly (Hirai et al., 2015). As demonstrated 
by Fick’s law of diffusion, that flux is determined by the O2 pressure 
differential between the capillary (i.e. microvascular PO2; PmV̇O2) and the 
intramyocyte milieu (intracellular PO2; PiO2) operating against a finite O2 
diffusing capacity (Hirai et al., 2015). PmV̇O2 is determined by the O2 
delivery-to-O2 utilisation ratio (i.e. V̇O2m/Q̇m; Figure 6) 
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Figure 6: (A) Skeletal muscle fibre with adjacent capillaries and flowing red 
blood cells. (B). Schematic illustration showing O2 flux from blood to 
mitochondria. Taken from Hirai et al. (2015).   
 
In heart failure, diffusive O2 delivery may be compromised consequent to 
structural and functional impairments. At the muscle capillary level there is a 
reduced capillarity and an increase in the proportion of capillaries that do not 
support red blood cell flux (Kindig et al., 1999; Richardson et al., 2003), 
resulting in fewer oxygenated red blood cells in the capillary bed at any 
given moment that are available to contribute to blood-to-myocyte O2 flux, 
thereby placing a low limit on DO2m (Poole et al., 2011). In addition, within 
the skeletal muscle there is muscle wasting (Mancini et al., 1992) and 
reduced mitochondrial volume density, in addition to a generalised shift 
away from type I (highly oxidative) fibres and towards type II and type IIb 
(less oxidative) fibres (Lipkin et al., 1988; Mancini et al., 1989; Sullivan et al., 
1990; Drexler et al., 1992). These impairments to the O2 transport system in 
heart failure give way to alterations in the V̇O2m/Q̇m ratio and as PmV̇O2 is a 
direct consequence of the V̇O2m/Q̇m ratio, PmV̇O2 is typically lower than 
normal at rest and during contractions in heart failure (Diederich et al., 2002; 
Behnke et al., 2004). The dynamics of this decrease in PmV̇O2 vary 
according to disease severity (Diederich et al., 2002). As (according to the 
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Fick’s law of diffusion) PmV̇O2 is a key determinant of the blood-muscle O2 
flux, alterations in PmV̇O2 will have a direct impact on muscle metabolism 
(Heinonen et al., 2015). Specifically, a lower microvascular PO2 will impair 
blood–myocyte O2 flux, compromising mitochondrial control and increasing 
reliance of non-oxidative metabolism. This increase in the reliance on non-
oxidative metabolism contributes to exercise intolerance in HF (Wilson et al., 
1984) and, therefore, understanding the mechanisms that contribute to the 
reduced PmV̇O2 (i.e. alterations in the V̇O2m/Q̇m ratio) is crucial to 
understanding exercise intolerance in HF.  
 
1.11 Principles of near infrared spectroscopy 
Near infrared (NIR) spectroscopy (NIRS) is an imaging technique used 
clinically and in research laboratories to measure and quantify the 
oxygenation status of human tissue. The basis of NIRS relies on two 
principles; (i) that tissue is relatively transparent to NIR light and, (ii) that 
there are compounds in the tissue in which absorption of light is dependent 
on the oxygenation status of the tissue. The propagation of light though 
tissue is dependent on the absorption, scattering and reflection properties of 
photons. The primary light absorbing compounds in the tissue within the NIR 
range are called chromophores. The absorption of these chromophores by 
NIR light, occurs at specific wavelengths determined by the molecular 
properties of the materials in the NIR light path (Jöbsis, 1977). The 
attenuation of light through a tissue can be related to the concentration of 
chromophores in the tissue by the Beer-Lambert Law: 
A = log ( I
I0
) =  ε∙C∙d, (6) 
where, A (attenuation) is the logarithmic ratio of two intensities, I: the 
incident light (i.e. the light inputted), and I0: the transmitted light (i.e. the light 
outputted), which is equal to 𝜀: the molar extinction coefficient (which 
describes how strongly a substance absorbs light at a particular 
wavelength), C: is the concentration of the chromophore, and d: is the path 
length of the photon from the emitting to receiving light source (i.e. how far 
light has to travel through a substance).   
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According to the Beer-Lambert Law, a more concentrated solution absorbs 
more light than a more dilute solution, and therefore the NIR absorption 
changes will predominately reflect the smaller vessels (arterioles, capillaries, 
and venules (Mancini et al., 1994)). In larger vessels (veins and arteries) the 
NIR light is almost completely absorbed due to the comparatively high haem 
concentrations (Chance et al., 1992). In the muscle tissue, the primary 
absorbing chromophores are haemoglobin (Hb), myoglobin (Mb), and 
cytochrome c oxidase. However, the contribution of cytochrome c oxidase to 
the NIRS signal is thought to be very low at around 2-5% (Boushel et al., 
2001). As such, the main chromophores of interest in monitoring skeletal 
muscle oxygenation by NIRS are haemoglobin and myoglobin. 
Haemoglobin 
A haemoglobin molecule (Figure 7) is made up of 4 amino acid chains (two α 
polypeptide globin chains and two β polypeptide globin chains). Each chain 
has a haem group containing an iron (Fe) ion at its center, which acts as the 
binding site for oxygen. Each haemoglobin molecule therefore has four 
major O2 binding sites (Thomas and Lumb, 2012).  
 
 
Figure 7: Schematic diagram showing the basic structure of a single adult 
haemoglobin molecule, including two α-globin chains (green), two β-globin 
chains (yellow), each containing a haem–iron complex (blue). Fe: iron. 
Taken from Thomas and Lumb (2012).  
Haemoglobin has several functions, a major function being transporting, 
delivering, and removing oxygen and carbon dioxide throughout the body. 
To achieve this, haemoglobin molecules have several properties that make it 
good at binding to, and dissociating from, oxygen. For example, 
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haemoglobin is allosteric; as such, the binding of oxygen to one haem group 
increases the binding affinity of oxygen to the remaining haem groups. 
Similarly, the binding of CO2 decreases its oxygen affinity and, as such, in 
the presence of high CO2, O2 becomes dissociated. This co-operative, 
reversible binding of oxygen to haemoglobin results in the sigmoidal shape 
of the oxyhaemoglobin dissociation curve (Figure 8). The oxyhaemoglobin 
dissociation curve shows that, at very low O2 partial pressures (PO2), the 
slope of the oxyhaemoglobin curve is almost flat. Each subsequent oxygen 
molecule binds to haemoglobin more easily and, therefore, the slope 
increases. As PO2 increases, the binding sites become occupied and the 
curve flattens out again (Thomas and Lumb, 2012).   
 
 
Figure 8: The oxyhaemoglobin dissociation curve (solid line). The curve can 
be shifted to the left or right (dashed lines), by factors listed in the figure. 
PO2, partial pressure oxygen. Taken from O’Driscoll et al. (2008).  
 
In acidic environments (e.g., areas in of high CO2, such as in the exercising 
muscle) the oxyhaemoglobin dissociation curve is shifted to the right (called 
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the Bohr effect) consequently favouring the dissociation of oxygen from 
haemoglobin (i.e. lower oxygen affinity) in the metabolically active tissues. 
Conversely, areas of lower CO2 (such as in the lungs), have a higher affinity 
for oxygen and thus favour the loading of oxygen to haemoglobin. This shift 
is advantageous during exercise, as it allows more O2 to be delivered to the 
tissues for energy production.  
 
Myoglobin 
Unlike haemoglobin, with its four chains carrying oxygen, myoglobin consists 
of one molecule of haem and one polypeptide chain; myoglobin therefore 
binds only one molecule of O2 per molecule of protein. Myoglobin has two 
main functions. It acts as a small O2 store that can temporarily provide O2 
when blood O2 delivery isn’t sufficient, such as during periods of intense 
muscular activity. In addition, it acts as an O2 carrier, thereby enhancing 
diffusion of O2 through the cytosol. 
  
 
Figure 9: Myoglobin consists of one polypeptide chain and a haem-binding 
domain. The polypeptide chain consists of eight α-helices (blue) that wrap 
around a central pocket containing a haem group (red), which is capable of 
binding oxygen, carbon monoxide and nitric oxide.  
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Its dissociation curve is left of that of haemoglobin and has a hyperbolic 
profile (Figure 10), thus myoglobin has a high affinity for O2, and only 
releases O2 in areas of very low PO2.   
 
 
Figure 10: Haemoglobin and myoglobin dissociation curves. The Myoglobin 
curve lies to the left of the haemoglobin curve and has a hyperbolic profile, 
with a high affinity for O2, thus O2 is only dissociated in areas of very low O2. 
Taken from Blix (2018). See equations 40 and 43 for formulations. 
 
1.12 Absorption of haemoglobin and myoglobin by NIRS 
Due to their similar absorption spectra, it is not possible to distinguish 
between haemoglobin and myoglobin by NIRS. Studies reporting the 
contribution of myoglobin to the NIRS signal have yielded inconsistent 
results, with estimates of the contribution of myoglobin to the NIRS signal 
ranging from ~10% (Chance et al., 1992; Mancini et al., 1994) to greater 
than 50% (Lai et al., 2009; Davis and Barstow, 2013). Therefore, changes in 
tissue saturation measured by NIRS are attributed to both changes in 
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haemoglobin and myoglobin (see limitations section for further details). It is 
possible to distinguish between the two major forms of haemoglobin and 
myoglobin; oxygenated haemoglobin plus oxygenated myoglobin (HbMbO2) 
and deoxygenated haemoglobin plus deoxygenated myoglobin (HHbMb) 
due to differences in their absorbance spectra of ~850 nm and 760 nm 
respectively. For example, at wavelengths of 800 nm the oxygenated and 
deoxygenated forms of haemoglobin and myoglobin exhibit similar 
absorption coefficients and, therefore, absorption of light at this wavelength 
is proportional to the total amount of haemoglobin and myoglobin in the 
muscle under examination. However, at wavelengths of 760 nm, absorption 
is predominantly by the deoxygenated forms and so changes in light 
absorption at this wavelength provide assessment in changes of 
deoxygenated haemoglobin and myoglobin (Wilson et al., 1989). The 
difference  in absorption between these wavelengths is an index of the 
balance between oxygen delivery and oxygen removal at the level of the 
small blood vessels (Pereira et al., 2007). As such, NIRS allows a non-
invasive insight into local muscle oxidation status during rest and exercise.  
 
1.13 Types of NIRS device 
There are several types of NIRS devices, the simplest being a continuous-
wave (CW) spectrometer which measures the attenuation of light through 
the tissue of interest (Boushel et al., 2001). A standard NIRS device (Figure 
11) consists of a light source, emitting two or more wavelengths of light into 
the near-infrared region of the tissue of interest, and a light detector placed 
at a known distance from the light source(s). The NIR light travels in a 
banana shaped curve through tissue and, therefore, the path length (d) is 
longer than the geometric distance between the light source and detector. In 
addition, the amount of light scattering in unknown. In a highly scattering 
medium, photons will travel a mean distance that is far greater than d, this 
have been defined as the differential path-length and represents the true 
distance between optodes. To account for this, a differential path-length 
factor (DPF) is applied to the Beer-Lambert Law for continuous wave 
spectrometry (Delpy et al., 1988) such that: 
A = log (
I
I0
) =  ε ∙ C ∙ d ∙ DPF +G (7) 
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where G is the scattering coefficients of the tissue along with the geometry 
of the optodes. G is unknown and as such, continuous wave spectroscopy 
can only provide relative changes in HbMbO2 and HHbMb (Boushel et al., 
2001). More complex NIRS devices, such as time-resolved and frequency-
resolved spectrometers, estimate the distribution of path lengths travelled in 
the tissue, and are therefore able to provide absolute measurements of 
HbMbO2 and HHbMb. Consequently, time and frequency resolved 
spectrometer are typically costlier, and as such continuous wave 
spectrometers are more widely used (Pereira et al., 2007; Ferrari et al., 
2011).  
 
 
Figure 11: Schematic of a basic NIRS device, placed over skeletal muscle. 
 
1.14 Physiological variables measured by NIRS  
1.14.1 Oxygenated haemoglobin and myoglobin 
Mancini et al. (1994) demonstrated a correlation between venous 
haemoglobin oxygen saturation measured by venous plethysmography  and 
muscle deoxygenation measured by NIRS during forearm exercise in 
humans. Further, they showed: (i) the NIRS signal was sensitive to changes 
in limb blood flow (ii) by laser flow Doppler, the NIRS signal was minimally 
affected by skin blood flow and (iii) using 1H-magnetic resonance 
spectroscopy, the contribution of myoglobin to the NIRS signal was minimal. 
However, some cycling studies have shown a dissociation between NIRS 
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muscle oxygenation and femoral O2 saturation (Costes et al., 1996; 
MacDonald et al., 1999). For example, it was observed that at exercise 
onset, NIRS muscle oxygenation decreased with a corresponding decrease 
in venous femoral O2 saturation, however, as exercise continued there 
appeared to be a muscle HbMbO2 ‘re-oxygenation’ which was not paralleled 
in venous O2 saturation. A similar pattern in HbMbO2 (but not in HHbMb) 
was observed by Grassi et al. (2003); the authors of this study suggested 
the HbMbO2 re-oxygenation was likely a consequence of increased skin 
blood flow.   
 
1.14.2 Deoxygenated haemoglobin 
It has been demonstrated that the NIRS muscle deoxygenation signal is well 
correlated to venous O2 saturation in exercising humans (Boushel et al., 
1998, 2001; Esaki et al., 2005; Vogiatzis et al., 2015). Further, whilst 
interpretation of the HbMbO2 signal appears to be dependent on changes in 
skin blood flow, the HHbMb signal appears to be less influenced by changes 
in skin blood flow, as it is primarily dependent on O2 extraction (Grassi et al., 
2003). As such, of the NIRS derived parameters, relative changes in HHbMb 
can be considered a proxy for the arterio-venous O2 difference (i.e. 
proportional to CaO2 – CvO2), and thus microvascular O2 extraction (DeLorey 
et al., 2003; Grassi et al., 2003).   
 
1.14.3 Tissue oxygenation index 
In addition to changes in HbMbO2 and HHbMb, most NIRS systems provide 
continuous monitoring of tissue O2 saturation as the tissue oxygenation 
index (TOI), which represents the ratio of oxygenated haem to total haem, 
i.e. HbMbO2/(HbMbO2+HHbMb) (Bowen et al., 2012). Characterisation of 
TOI uses spatially resolved spectroscopy, which utilises several light 
detectors within the same NIRS probe. When light is sent through a tissue 
the reflection of light is dependent on the absorption coefficient and the 
reduced scattering coefficient. In spatially resolved spectrometry, measuring 
the spatial variation of the intensity of retro-reflected light as a function of 
distance between light source detectors allows estimation of light attenuation 
(Matcher et al., 1995). The combination of the multi-distance measurements 
of optical attenuation allows calculation of the relative contributions of 
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oxygenated and deoxygenated haemoglobin in the illuminated tissue 
(Matcher et al., 1995; Suzuki et al., 1999).  
1.15 The oxygen extraction response during exercise 
As discussed in Chapter 1, there is a linear relationship between Q̇ and V̇O2 
during steady state exercise, this relationship can be described by the 
equation: 
Q̇ =  m  ∙   V̇O2 +   c, (8) 
where m is the slope and c is the y-axis (i.e. Q̇ L/min) intercept of the 
relationship (Whipp et al., 1982). The slope of the relationship is 
approximately 5-6 (Saltin et al., 1968; Faulkner et al., 1977; Richardson et 
al., 1993), and has been demonstrated to be similar during different exercise 
modalities (Faulkner et al., 1977; Knight et al., 1992; Richardson et al., 
1993). The linear relationship has a positive intercept on the y (or Q̇) axis 
and, therefore, necessitates a hyperbolic increase in the arterio-venous O2 
difference (i.e. greater oxygen extraction) as V̇O2 and Q increase. This has 
been demonstrated by (Ferreira, McDonough, et al., 2006) who modelled 
these important relationships (Figure 12). 
 
 
Figure 12: Schematic of the relationship between (A) blood flow and (B) 
arteriovenous O2 difference (a-vO2 diff) vs. oxygen uptake (V̇O2) during 
steady-state exercise. Adapted from Ferreira et al., (2006). Solid line depicts 
an illustrative Q̇ to V̇O2 relationship, where Q̇ = 10+5(V̇O2). Dashed lines 
represent isopleths of a-vO2diff.(in ml O2 (100 ml blood)−1) assuming an 
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arterial O2 content of 20 ml O2 100 ml−1. As a-vO2diff.= V̇O2/ Q̇, the lines 
pass through the origin. The slope (Q̇/V̇O2) describing each constant a-
vO2diff. decreases hyperbolically with increasing a-vO2diff. Importantly, the 
slope is the inverse of a-vO2diff. (V̇O2/Q̇); therefore, a-vO2diff. increases 
hyperbolically as a function of V̇O2. 
 
In Figure 12, the solid line shows a V̇O2/Q̇ relationship where Q̇ = 10 + 
5V̇O2. The dashed lines represent isopleths of the (a-v)O2 difference [ml O2 
(100 ml blood)-1]. For a given (a-v)O2 difference (i.e. at the top of panel A, 
from 2.0 - 20), the V̇O2/Q̇ slope decreases hyperbolically as (a-v)O2diff. 
increases. This slope is the inverse of the (a-v)O2 difference: therefore, the 
(a-v)O2 difference increases hyperbolically as a function of V̇O2. This (a-
v)O2-V̇O2 relationship (Figure 12; right) is best described by a rectangular 
hyperbola of the form:  
(a-v)O2 diff=
ax
(b+x)
 (9) 
where a is the maximal y value and b = the x value corresponding to 0.5a 
(Whipp et al., 1982; Ferreira et al., 2006).  
The notion of a linear V̇O2/Q̇ relationship during ramp incremental exercise 
(i.e. during non-steady state exercise) however, has been challenged. 
Stringer et al., (1997) observed a linear relationship between (a-v)O2 
difference and V̇O2m during ramp exercise, and later demonstrated that Q̇m 
does not increase linearly with V̇O2m; rather, Q̇m increases faster relative to 
V̇O2m but the rate of increase gets progressively slower (i.e. V̇O2m and Q̇m 
become better matched) as exercise intensity increases (Stringer et al., 
2005). This change in the relationship between V̇O2m and Q̇m during ramp 
incremental exercise should then influence O2 extraction. Accordingly, it has 
been demonstrated that the pattern of ∆HHbMb (i.e. proportional to O2 
extraction) during ramp incremental exercise does not follow a hyperbolic 
profile (as with steady state exercise). Rather, Ferreira et al., (2007) found 
that the ∆HHbMb response to ramp exercise followed a sigmoidal profile 
(Figure 13), supporting the notion of a non-linear relationship between V̇O2m 
and Q̇m during ramp incremental exercise.  
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Figure 13: Increase in deoxygenated haemoglobin+ myoglobin (HHb) during 
incremental exercise. Solid line represents best fit from sigmoidal function. 
Taken from Ferreira et al., (2007). 
 
The sigmoidal model suggests that at very low work rates Q̇m kinetics are 
faster than V̇O2m kinetics, resulting in a relatively larger increase in O2 
delivery compared to O2 extraction and, therefore, a slow increase in 
fractional O2 extraction. Following this initial slow response, HHbMb 
increases more steeply, indicating that fractional O2 extraction is much 
greater relative to the increase in O2 delivery during higher work rates, until 
in most subjects a plateau is reached, indicating that there is a tight coupling 
between V̇O2m and Q̇m.  
Muscle oxygenation dynamics (and their corresponding NIRS responses; 
namely TOI and deoxygenated haemoglobin + myoglobin) in health have 
been well characterised. However, they are still not completely understood in 
heart failure, where the implications for understanding control of O2 delivery 
and utilisation are even greater (Poole and Jones, 2012). Experimental 
studies during moderate-intensity constant work rate (step) exercise in heart 
failure patients (Sperandio et al., 2009; Bowen et al., 2012) have 
demonstrated a transient overshoot in the HHbMb signal by NIRS (or 
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corresponding undershoot in TOI), implying that estimated fractional O2 
extraction increases above the steady state level because of impaired O2 
delivery relative to O2 requirements at the onset of exercise. However, the 
step protocol is rarely used in a routine clinical setting, as information on the 
cardiopulmonary responses pertinent to disease states (i.e. lactate 
threshold, V̇O2,peak and work efficiency) is obtained using a ramp incremental 
protocol, where work rate is progressively increased until the patient can no 
longer exercise (Whipp et al., 1981). Although a ramp incremental exercise 
test is the most widely used cardiopulmonary exercise test to assess 
exercise function in the clinic, the muscle oxygenation profile during such 
exercise has been investigated much less in heart failure. Further, as 
effective adjustment to constant changes in metabolic demand (as in a ramp 
incremental test) is an important determinant of exercise tolerance (Boone et 
al., 2016), and heart failure patients rarely spend time in a ‘steady state’ as 
seen at the end of step exercise protocols, understanding control of O2 
delivery and utilisation during such exercise will give us insights into 
mechanisms underlying exercise intolerance in heart failure. 
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Chapter 2 General methods 
2.1 Experimental data collection  
2.1.1 Protocol 1 
Participants 
Six healthy male competitive or amateur cyclists (mean ± SD: age, 22.8 ± 
4.4 years; height, 181.0 ± 4.2 cm; body mass, 73.7 ± 6.1 kg) performed a 
step incremental exercise test to the limit of tolerance on a cycle ergometer. 
Note that the methods and the data used described in this protocol were 
taken (with permission) from Grassi et al. (1996). 
Equipment and measurements 
Subjects performed a 4-minute warm-up period at 100 W proceeded by an 
increase in work rate of 25 W each minute. Mean maximal V̇O2 was 4.35 ± 
0.46 L/min (absolute) or 59.1 ± 5.3 mL/kg/min (relative). Breath-by-breath 
gas exchange was measured during all tests using an OUR system 
(Consentuis Technologies, Sandy, USA), with inspired and expired flows 
measured by a pneumotach (Fleisch no. 3) and gas concentrations 
measured by a mass spectrometer (model MGA 1100, Perkin-Elmer, 
Waltham, USA). Subsequently, subjects performed a series of 5 constant 
work rate exercise tests. For the constant work rate tests, subjects 
performed 4-6 minutes of unloaded pedalling, followed by 5 minutes of 
moderate intensity constant work rate exercise for 5 minutes. Work rates 
were determined from the incremental test, mean power output was 183 ± 
20 W. Muscle blood flow, Q̇m, was determined during three of the constant 
work rate tests by a constant-infusion thermodilution technique. This 
involved the placement of two catheters, one in the radial artery (for arterial 
blood sampling), one in the femoral vein (for venous blood sampling), and a 
thermocouple in the left femoral vein (for injection of sterile cold normal 
saline and blood gas sampling). Values for Q̇m calculated during the three 
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constant work rate bouts were determined over 3s discrete time intervals 
throughout the transient. During the other two constant work rate bouts, 3-4 
ml samples of arterial and venous blood were drawn anaerobically for 
measurement of PO2, PCO2, pH, O2 saturation, and Hb concentration by a 
gas analyser and CO oximeter (model IL 1306 and IL282, Instrumentation 
Laboratories). Samples were drawn at rest and approximately every 5-8 s 
during the transient. V̇O2A in the leg was calculated using the Fick principle 
(Equation 1).  Model input parameters are shown below in Table 1. 
Table 1: Pre-optimised model input parameters (middle column) with 
sensitivity analysis model input values) 
Parameter Parameter value 
 
Minus 
10% 
Pre-
optimised 
Plus 
10% 
CaO2 (L O2/ L blood) 0.18 0.20 0.22 
 
 
 
 
Venus volumes, litres  
 
 
Muscle 0.63 0.70 0.77 
Body 0.09 0.10 0.11 
Mixed 2.07 2.30 2.53 
 
 
 
 
Baseline (unloaded pedalling) values   
V̇O2A, L/min 0.78 0.87 0.96 
Fraction from musclea 0.51 0.57 0.63 
Q̇tot, L/min 8.00 8.89 9.78 
Fraction to musclea 0.51 0.57 0.63 
 
 
 
 
Exercise V̇O2 and Q̇ parameters  
 
 
∆V̇O2m /∆WR, (L/min/W) 0.01 0.01 0.01 
∆Q̇ / ∆V̇O2m 5.40 6.00 6.60 
 
 
 
 
Muscle V̇O2 and blood flow kinetics  
 
 
𝜏Q̇m (s) 21.60 24.00 26.40 
𝜏V̇O2m (s) 19.80 22.00 24.20 
Table parameters: Q̇ denotes blood flow. The subscripts ‘tot’ and ‘m’ denote total and muscle 
components, respectively. aThe remainder of the baseline V̇O2p (and Q̇tot) comes from (and goes to) 
the body compartment. All pre-optimised parameters are experimentally collected data from Grassi et 
al. (1996).  NB: Pre-optimsed values are mean values from Grassi data, SD have been removed for 
clarity 
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Data analysis 
V̇O2A data from the incremental test was averaged over 30 s time intervals 
and plotted as a function of time. Because, for the model validation at least, 
the mechanisms causing any plateau in V̇O2A at or near the limit of tolerance 
are not of primary concern (indeed, the model does not contain the 
appropriate components to be able to predict such phenomena), and the 
primary interest is the dynamics of the V̇O2A response during the initial and 
fundamental (increasing) portions of the test, any plateau V̇O2A data that 
occurred at the end of each test were removed before comparing with model 
data. 
2.1.2 Protocol 2 
Participants and ethics 
11 young healthy participants (mean ± SD: age, 26 ± 5 years; body mass, 74 
± 14 kg; Height 1.7 ± 0.7 m) volunteered to take part in the study and 
provided informed written consent. The investigation was approved by the 
Faculty of Biological Sciences ethical review committee. Health screening 
and readiness for physical activity (PAR-Q) questionnaires were completed 
prior to any exercise. 
Equipment and measurements 
Gas exchange measurements: Pulmonary gas exchange was measured 
breath-by-breath throughout exercise for measurement of key variables 
associated with exercise tolerance. The breath-by-breath system 
(MedGraphics D-Series, MedGraphics Medical Graphics Corporation, St 
Paul, MN, USA) was calibrated before each test. The flow sensor was 
calibrated using 3-litre syringe; ten strokes passed through the pneumotach, 
at different flow rates. The calibration values were validated, and calibration 
was accepted when the standard deviation of the mean volume values was 
less than 0.02 L. O2 and CO2 analysers were calibrated using two different 
calibration gases of known concentrations (O2, 12.0% and 21%, and CO2, 
5% and 0%). 
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Muscle oxygenation dynamics: Oxygenation of the left quadriceps muscle 
was measured by a wireless, portable continuous-wave, spatially-resolved 
spectroscopy (SRS) NIRS device (PortaMon, Artinis, The Netherlands), 
which consists of three light emitting diodes at wavelengths of 760 and 850 
nm corresponding to the absorption wavelengths of oxygenated 
haemoglobin and deoxygenated haemoglobin. The distances between 
receiver and transmitter were set at 30, 35, and 40mm. NIRS data were 
collected at a sampling frequency of 10 Hz. Relative concentrations of 
oxygenated and deoxygenated haemoglobin and myoglobin were measured 
throughout. In addition, TOI was measured using the SRS approach. The 
NIRS probe was placed over the vastus lateralis muscle, and a black cloth 
was placed over the device to occlude ambient light. The NIRS probe and 
black cloth was secured with adhesive tape and an elastic bandage.  
Haemodynamic assessments: Heart rate was determined from each R-R 
interval obtained from a 12-lead electrocardiogram. Cardiac output was 
estimated non-invasively via photoplethysmography (Finometer, FinaPres 
Medical Systems BV). This method continuously measures beat-to-beat 
finger blood pressure waveforms, to construct mean brachial arterial 
pressure. Stroke volume, heart rate, and cardiac output were calculated 
using Modelflow® algorithms. The FinaPres device was fitted to the left arm, 
with the cuff positioned on the medial phalanx of the middle or index finger 
(depending on best fit). The device contains a height correction unit to 
compensate for the hand position according to the position of the heart. Prior 
to the onset of exercise, participants remained at rest for physiological 
calibration which is performed automatically using the Physiocal software in 
the device.  
Exercise protocols 
All tests were performed on a computer-controlled electromagnetically 
braked cycle ergometer (Excalibur Sport PFM, Lode, BV, Groningen, NL). 
Participants attended the Leeds integrative exercise physiology laboratory 
on three separate occasions described below.  
Visit 1: Ramp-Incremental Step Exercise test 
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On visit one participants performed a symptom limited ramp incremental 
step exercise (RISE) test (Rossiter et al., 2006). A RISE test consists of a 
standard ramp incremental exercise test to the limit of tolerance, followed by 
a constant work rate (step) exercise bout to the limit of tolerance, the work 
rate of which was set at 95% of the maximum work rate achieved during the 
ramp portion of the test. The ramp and step exercise bouts were separated 
by 6 minutes of unloaded pedalling. Each test was preceded and followed 
with at least 4 min unloaded pedalling at 20 W. Ramp rates (which ranged 
from 15-35 W/min) were individually targeted to produce a test duration of 8-
12 minutes (Buchfuhrer et al., 1983). The ramp and step portions of the test 
were terminated when the pedal cadence could no longer be maintained 
above 50 rpm despite strong verbal encouragement.  
Visit 2 and 3: Moderate-intensity constant load step tests 
Visits two and three were identical. On both visits participants performed two 
moderate intensity constant load step exercise tests (4 step tests in total) at 
a work rate determined from the ramp incremental exercise test 
corresponding to 90% of lactate threshold. Each step test was 6 minutes in 
duration and was separated by 6 minutes of unloaded pedalling at 20 W. 
Each test was preceded with and followed with at least 4 min unloaded 
pedalling at 20 W.  
Data analysis 
Breath-by-breath data: Lactate threshold was estimated using the V-slope 
method, with confirmatory analysis of end tidal O2 and CO2, ventilatory 
equivalents for O2 and CO2, and the respiratory exchange ratio (Whipp et al., 
1986). Baseline V̇O2 was taken as an average of breaths during the last 60 s 
unloaded pedalling, V̇O2,peak was taken as the highest 12-breath average 
from the final 24 breaths (~20 s) of exercise during the ramp test. V̇O2 data 
from each individual test was edited to eliminate any errant breaths that may 
have been caused by swallows or coughs etc. 99.7% prediction bands were 
fitted to the data, and any breaths that fell outside these bands (~4 SD from 
the local mean) were considered to be uncharacteristic of the underlying 
physiological response, and were therefore eliminated to improve the 
confidence of the fit (Lamarra et al., 1987; Benson et al., 2017). For healthy 
participants breath-by-breath V̇O2 responses (from the step exercise tests) 
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for each subject were time aligned at the onset of exercise for each exercise 
bout and interpolated to second-by-second values. The four exercise bouts 
were then averaged to create one mean data set that incorporated all the 
repeated step tests. This process yielded one value for time and V̇O2 
(Benson et al., 2017). Each V̇O2 response profile was fit with an exponential 
of the form:      
y0 +  A ∗  (1− exp( 
- (x−TD) / τ)) (10) 
where 𝑦0is baseline, A is the amplitude, TD is the time delay, and 𝜏 is the 
time constant. The first 20s of data was disregarded during the fitting 
procedure to isolate phase II kinetics.  
Haemodynamic measurements: Baseline cardiac output was taken as the 
final 60 s of unloaded pedalling. Data from the first and third step were time 
aligned and averaged to reduce signal-to-noise ratio, where possible (NB: in 
4 participants, FinaPres calibration was lost at exercise onset during one of 
the step exercise bouts, preventing accurate kinetic estimation; therefore, in 
these participants only one step bout was used). Each cardiac output 
response was then fitted with an exponential function [using the same 
equation used to fit the V̇O2 kinetics (Equation 10)] from time 0 (i.e. no time 
delay) for determination of cardiac output kinetics. All fitting was carried out 
in OriginLab (OriginLab Corporation, Northampton, MA, USA). 
NIRS measurements: (Chapter 4) HHbMb was normalised from baseline to 
peak HHbMb (0-100%). Baseline HHbMb was taken as an average of the 
final 60 s unloaded pedalling, peak HHbMb was taken as the final HHbMb 
value during the ramp test. HHbMb amplitude was determined by peak 
HHbMb minus baseline HHbMb. Peak HHbMb was taken as the final 
HHbMb value (rather than the peak HHbMb during the whole ramp) to 
maintain the profile of the response following normalisation procedures.  
(Chapter 6) NIRS data were averaged into one second bins. These second-
by-second responses were then normalised to the total amplitude of the 
response from baseline (0%) to peak (100%) exercise. Baseline HHbMb was 
determined as the mean of the last 60 seconds of unloaded pedalling, and 
peak HHbMb was taken as the mean of the final HHbMb data point  of the 
ramp exercise (Boone et al., 2009). The final data point was chosen as the 
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peak value (rather than taken as an average of the final data points) to 
maintain the dynamic profile of the response following normalisation 
procedures. The amplitude of ∆HHbMb was taken as peak HHbMb minus 
baseline HHbMb. Normalised ∆HHbMb (∆HHbMb %) was plotted as a 
function of increasing work rate (W). Two inflection points were identified 
from the raw signal. Point A corresponded to the work rate after exercise 
onset at which HHbMb started to systematically increase. Point B 
corresponded to the point at which there was a systematic departure from 
linearity. Linear regression was applied from point A to point B and from 
point B to point C (peak exercise). The response was then split into three 
phases. Phase 1 represented the portion of the response from onset of the 
ramp up until point A. Phase 2 corresponded to the mid-portion of the 
response (i.e. from point A to point B), and phase 3 included the data from 
point B onwards (Figure 14). Finally, the slope of the linear regression of 
phase 2 was calculated in addition to the HHbMb difference between points 
B and C. Due to probe displacement during exercise, two heart failure 
patient’s NIRS data were eliminated from data analysis.  
 
 
Figure 14: Representative deoxygenated haemoglobin-myoglobin 
(∆HHbMb) response profile plotted as a function of increasing work rate (W) 
in a healthy control. Points ‘A’ and ‘B’ correspond to the first and second 
inflection points. Point ‘C’ is the peak work rate (W).  
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Comparing sigmoidal vs double linear functions 
For a subset of 8 patients, sigmoidal and double linear function fits to the 
data were compared. For these patients NIRS data were averaged and 
normalised using the same method described above. In addition to the 
above, normalised HHbMb (∆HHbMb %) was plotted as both a function of 
absolute work rate and normalised work rate. The averaged, normalised 
data were then fit with a piecewise linear function of the form: 
 
𝑦 =
{
 
 
 
 
𝑦1(𝑥3 −  𝑥) + 𝑦3(𝑥 − 𝑥1)
𝑥3  − 𝑥1
 
, 𝑥 < 𝑥3
𝑦3(𝑥2  −  𝑥) + 𝑦2(𝑥 − 𝑥3)
𝑥2  − 𝑥3
, 𝑥 ≥ 𝑥3
 (11) 
 
where 𝑥1 and 𝑥2 are 𝑥 values of the curve endpoints; 𝑥3 is the intersection of 
the two segments (the break point), and  𝑦1, 𝑦2 and 𝑦3 are 𝑦 values at 𝑥1, 𝑥2  
and 𝑥3  respectively. This double linear analysis yields: 
 
𝑦 = {
 𝑏1𝑥 + 𝑎1, 𝑥 < 𝑥3
 
 𝑏2𝑥 + 𝑎2, 𝑥 ≥ 𝑥3
 (12) 
 
 
where b represents the slope, and 𝑎 is the 𝑦-intercept value. 
 
The data were also fit with a sigmoidal model of the form: 
𝑦 = 𝑦0 + 𝐴/ [1 + 𝑒− (− 𝑐 + 𝑑𝑥)] (13) 
 
where 𝑦0 is baseline, 𝐴 is the amplitude, 𝑐 is a constant dependant on 𝑑, the 
slope of the sigmoid, where 𝑐/𝑑 gives the 𝑥 value corresponding to 50% of 
the total amplitude. 
 
Fitting model comparisons 
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The Akaike Information Criterion (AIC) compares the quality of model (the 
function in this case) fits to data, relative to each other. The sigmoid and 
double linear function were compared by calculating the change in corrected 
Akaike Information Criterion (∆AICC) scores (Akaike, 1974; Spencer et al., 
2012). As described in detail in Spencer et al. (2012), for each model: 
 
AICC = N ln (
RSS
N
) +  2K + [
2K(K + 1)
N − K − 1
] (14) 
where N is the number of data points used in the analysis for that subject, 
RSS is the residual sum of squares from the regression analysis, and K is 
the number of parameters in the fitted model + 1.  
The AICC score was calculated by subtracting the AICC score from the 
double-linear function with the AICC score from the sigmoid function; as the 
model with the lower AICC score is most likely to describe the underlying 
data more accurately, a positive ∆AICC score favours the double-linear 
model.  
 
Statistical analyses 
Fitting was carried out in OriginLab (OriginLab Corporation, Northampton, 
MA, USA). The model parameters were estimated by least-squares 
regression (sigmoid) or linear regression (double linear). Persons product 
moment correlation was calculated to quantify the relationship between key 
variables, and a student’s t-test was used to determine significant difference 
between means. Significance was accepted when p < 0.05.  
Key experimentally measured baseline, exercise, and peak exercise values 
obtained from this protocol are shown in Table 2.  
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Table 2: Key baseline, exercise, and peak exercise values (n=11) 
Parameter Mean ± SD 
Baseline values  
V̇O2p (L/min) 0.96 ±  0.21 
Q̇ (L/min) 8.47 ±  1.51 
Exercise values  
V̇O2p𝜏  (L/min) 24.40 ± 06.80 
Q̇𝜏 (L/min) 29.60 ± 15.30 
V̇O2m𝜏(s) 26.60 ±  4.20 
ΔV̇O2/ΔWR (L/min/W) 0.01 ±  0.00 
Q̇-V̇O2 slope 5.43 ±  1.16 
Q̇ (L/min)  11.49 ±  2.93 
Total time (s) 691.80 ± 76.00 
Ramp rate (W/min) 23.30 ±  5.57 
Peak exercise values  
V̇O2p (L/min) 3.57 ±  0.97 
TOI amp (%) 14.39 ±  7.20 
Peak work rate (W) 290.00 ±75.00 
  
Parameters shaded in grey were determined from the ramp incremental exercise test. Remaining parameters were 
determined from step exercise tests (see methods section). Baseline values were determined from an average of 
the last 60s unloaded pedalling; V̇O2m𝜏(s) was back-calculated in the model from pulmonary V̇O2 measurements; 
Q̇-V̇O2 slope was determined from moderate step exercise by (ΔQ̇/ΔV̇O2); V̇O2p was taken as the highest 12 breath 
average during the last 30 seconds of ramp exercise. Table parameters: V̇O2p pulmonary oxygen uptake; Q̇ blood 
flow; V̇O2p𝜏 oxygen uptake kinetics; Q̇𝜏 blood flow kinetics; TOI amp tissue oxygenation index amplitude 
 
2.1.3 Protocol 3 
Subjects and ethics were the same as for protocol 2.  
Equipment, measures and protocols 
Subjects were placed supine on a padded table with their legs fully 
extended. The NIRS probe was placed longitudinally on the belly of the right 
medial gastrocnemius and secured with adhesive tape and an elastic 
bandage. A 13 cm x 85 cm blood pressure cuff was placed on the proximal 
thigh of same leg, attached to a rapid cuff inflator, and a cushioned pad was 
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placed under the ankle of the participant such that the lower leg was 
elevated (~50-75 mm), and the NIRS probe was suspended above the table, 
to limit potential movement artefacts from the NIRS probe touching the table 
during the assessment. The participant was first familiarised with cycles of 
plantar flexion-relaxation exercise (at roughly one per second) against a 
manually applied (hand) resistance. Participants were instructed to keep 
their knee joint straight and focus on only using the gastrocnemius to 
perform the exercise. Repeated cuff inflations from low (~50 mmHg) to high 
(~250 mmHg) were also performed during familiarisation phase, and arterial 
occlusion (AO) was determined from a tolerated cuff pressure within the 
range of 200-300 mmHg that resulted in HHbMb rise, HbMbO2 fall, and an 
approximately constant tHbMb over ~15-20 s. Following familiarisation and a 
2-3-minute resting period (to allow the NIRS signals to return to a resting 
state), the measurement protocol began. The participant was instructed to 
execute 10-12 cycles of plantar flexion exercise (this was approx. 10 – 15 s), 
which was followed immediately by sustained arterial occlusion (SAO), 
which was applied until a steady state in TOI (%) was reached. When a 
steady state in TOI was reached, the cuff was deflated, and muscle ‘re-
oxygenation’ was recorded until a steady state was reached. This procedure 
(the physiological normalization; PN) identifies the functional range of TOI 
under resting conditions, from minimum TOI at the end of the sustained 
arterial occlusion to maximum TOI at the peak of the reactive hyperaemia. 
Next, the participant performed two oxidative capacity assessments. Here, 
the participant performed cycles of plantar flection exercise to desaturate the 
muscle to a target of 50% of the physiological normalization amplitude 
(Figure 15). This was immediately followed by a series of intermittent arterial 
occlusions (5 occlusions for 5 s, and 10 occlusions for 10 s, each separated 
by 5-20 s recovery). The occlusion protocol was designed to maximise the 
ability to characterise the kinetics changes in mV̇O2 whilst minimising any 
discomfort to participants. The oxidative capacity assessment was then 
repeated for a second time once a resting steady state was re-established.  
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Figure 15: Raw tissue oxygenation index (TOI) trace from one complete visit 
in a representative subject. PN is the physiological normalisation procedure. 
“min” and “max” mark minimum [at the end of the sustained arterial 
occlusion (SAO)] and maximum (at peak reactive hyperaemia) TOI 
respectively. IOA represents periods of intermittent arterial occlusions, from 
which the kinetics of mV̇O2 recovery are calculated (see methods section for 
details).   
Data analysis 
Raw HHbMb, HbMbO2, and TOI was averaged into second-by-second data. 
HHbMb and HbMbO2 were then corrected for changes in blood volume 
using the following equations (Ryan et al., 2012).  
β(t)= 
HbMbO2(t)
[HbMbO2(t)]+[HHbMb(t)]
 (15) 
 
where β is the blood volume correction factor, and t represents time. A value 
for β was calculated for each data point. Each data point was then corrected 
using its corresponding β such that: 
HbMbO2c=HbMbO2-[tHbMb x (1- β)] 
(16) 
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and 
HHbMbc=HHbMb-(tHb- β) 
(17) 
where HbMbO2c and HHbMbc are corrected oxygenated and deoxygenated 
haemoglobin and myoglobin respectively (Figure 16). This gives a HbMbO2 
signal that is corrected by subtracting the proportion of the blood volume 
change attributed to HbMbO2, giving a corrected HbMbO2 that represents 
the HBMbO2 signal minus the oxygenated blood volume change. Similarly, 
the raw HHbMb signal is corrected by subtracting the proportion of the blood 
volume change attributed to HHbMb, giving a corrected HHbMb signal that 
represents the HHbMb signal minus the deoxygenated blood volume change 
(Ryan et al., 2012). During the repeated oxidative capacity tests, for each 
intermittent arterial occlusion the negative slope of corrected HbO2c was 
fitted with a simple linear regression to estimate relative mV̇O2. The time 
constant (𝜏, with units of seconds) and the mV̇O2 exponential recovery rate 
constant k were estimated using non-linear least-squares regression. The 
rate constant k (where k (min-1) = [1/ τ]* 60) for the recovery of mV̇O2 is 
directly related to the muscles oxidative capacity, while the time constant 𝜏 
(i.e. 𝜏 = [1/k]*60) is inversely related to muscle oxidative capacity.  
Statistical analysis 
All data are presented as mean ± SD unless otherwise stated.  A Bland-
Altman analysis was performed for repeated measurements to assess the 
agreement between the mV̇O2 recovery kinetics. Coefficient of variance (CV) 
and intra class correlation coefficient (ICC) was used to assess within 
subject test-retest variability. Where within the same day tests (i.e. bout one 
and bout two) were found to be reproducible, these tests were averaged and 
compared in the same manner described above for between day (i.e. day 1 
and day 2) test-retest reproducibility. 
 
47 
 
 
Figure 16: Raw HHbMb (red line), HbMbO2 (blue line) and tHbMb (green 
line) during physiological normalisation and two oxidative capacity tests in a 
representative subject before (top panel) and after (bottom panel) correcting 
for blood volume changes.  
2.1.4 Protocol 4 
Subjects and ethics 
8 Heart failure patients (mean ± SD: age, 59 ± 10 years; body mass, 82 ± 13 
kg; Height 1.7 ± 0.7 m; LVEF 33 ± 9 %; NYHA classes II-III) attended Leeds 
Clinical Research Facility on three occasions. 
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Equipment and measures 
Pulmonary gas exchange measurements were collected as described in 
protocol 2. 
Exercise protocols 
Visit 1: Ramp incremental exercise test 
Patients performed a symptom limited ramp incremental exercise test to the 
limit of tolerance as described above. Ramp rates ranged from 5-15 W/min 
and were individually targeted to produce a test duration of 8-12 minutes. 
The test was terminated when the pedal cadence could no longer be 
maintained above 50 rpm despite strong verbal encouragement, or at the 
discretion of the cardiac physiologist overseeing the test. Before each bout, 
the ergometer flywheel was manually accelerated to 50 rpm to eliminate 
inertial influence at exercise onset. Pedal cadence was maintained between 
50 and 60 rpm during exercise.  
Visit 2 and 3: Moderate intensity step exercise test 
Patients performed a constant load moderate intensity exercise tests at a 
work rate determined from the ramp incremental exercise test corresponding 
to 90% of lactate threshold. Patients performed at least 4 minutes of warm-
up exercise at 10 W, followed by a constant work load bout lasting 6 minutes 
in duration, and followed with at least 6 minutes of rest with the patient sat 
on the ergometer. All tests were conducted at the same time of day for each 
patient, with 7 days between visits.  
Data analysis 
Data analysis was the same as described in protocol 2 (for healthy 
participants) with the exception of hemodynamic measurements. For heart 
failure patients it was not possible to obtain baseline cardiac output from the 
exercise protocol used. As such, baseline cardiac output was estimated by 
using a scaling factor determined from previously published cardiac output 
and V̇O2 measurements in two hundred and nineteen heart failure patients 
(Williams et al., 2001). From Williams et al. (2001) the ratio of baseline 
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cardiac output to baseline V̇O2 was 4.8:0.33 (L/min) respectively. Therefore, 
a scaling factor of 14.5 was used for baseline cardiac output estimation (i.e. 
baseline cardiac output = baseline V̇O2 * 14.5). 
 
2.1.5 Protocol 5 
Subjects and ethics 
33 heart failure patients (mean ± SD: age, 65 ± 10 years; body mass, 85 ± 
16 kg; Height 1.2 ± 0.8 m; LVEF 30 ± 8 %; NYHA classes I-III) volunteered 
to take part in the study and provided informed written consent. The 
investigation was approved by the National Institute for Health Research, 
Leeds Clinical Facility research committee.  
Equipment and measures  
Pulmonary gas exchange measurements and NIRS were collected as 
described in protocol 2.  
Exercise protocols 
Patients attended Leeds Clinical Research Facility on one occasion. On 
arrival, prior to any exercise, a resting echocardiogram was performed for 
measurement of key cardiac function parameters. Participants then 
performed a symptom limited ramp incremental exercise test to the limit of 
tolerance. Each test was preceded and followed with at least 4 minutes of 
unloaded pedalling at 10 W. Ramp rates (which ranged from 5-15 W/min) 
were individually targeted to produce a test duration of 8-12 minutes. The 
test was terminated when the pedal cadence could no longer be maintained 
above 50 rpm despite strong verbal encouragement, or at the discretion of 
the cardiac physiologist overseeing the test.  
Data analysis 
Data was analysed according to the methods described in protocol 2.  
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Chapter 3 A validated model of 
muscle oxygen uptake and circulatory 
dynamics during incremental exercise 
 
3.1 Introduction 
Exercise capacity is determined, largely, by the balance between oxygen 
supply and oxygen demand, and is a reliable predictor of prognosis in 
diseases the affect the cardio-respiratory system, such as heart failure 
(Cahalin et al., 1996; Stelken et al., 1996; Francis, 2000). An in-depth 
understanding of the mechanisms governing the control of muscular blood 
flow (Q̇m) and oxygen uptake (V̇O2m) is therefore important and may provide 
useful insights into the mechanisms determining exercise capacity in heart 
failure. Computational models have been useful in this regard but have 
predominantly been utilised for constant work rate (i.e. a constant metabolic 
demand) exercise (Barstow and Molé, 1987; Barstow et al., 1990; Lai et al., 
2007; Zhou et al., 2008; Benson et al., 2013). During exercise in which the 
work-rate is continually increasing (incremental) exercise, the metabolic 
demands are constantly changing, and consequently, the relationship 
between Q̇m and V̇O2m must also adapt to meet these demands. This is 
important to consider as activities of daily living rarely occur at one metabolic 
rate and so assessing these dynamics during incremental exercise may be 
more applicable to everyday life. A computational model of oxygen transport 
and utilisation for incremental exercise may therefore be useful in aiding our 
current understanding of muscle blood flow and oxygen uptake in health 
failure patients.  
3.1.1  A model of muscle and pulmonary O2 uptake and circulatory 
dynamics during exercise 
Computational modelling is an indirect method of estimating physiological 
variables where direct measurements are not feasible. By integrating 
mechanistic models of O2 transport, circulatory dynamics, O2 uptake and 
metabolism in skeletal muscle with experimental measures, factors which 
cannot be readily measured or altered in vivo can be explored. Further, the 
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effects of variation in parameters that are difficult to measure or manipulate 
in vivo can be quantitatively assessed (Barstow et al., 1990; Lai et al., 2009; 
Benson et al., 2013; Hoffmann et al., 2013). Barstow et al. (1990) developed 
a computational model to simulate circulatory and metabolic responses to 
exercise. The model is composed of three compartments; the exercising 
muscle, a lumped compartment for the rest of the body, and the pulmonary 
system through which all the cardiac output passes. A single venous volume 
(Vv) connected the compartments on the venous side (Figure 17). 
 
Figure 17: Schematic of the model developed by Barstow et al. (1990) that 
links exercising “muscle” and non-exercising “rest of body” compartments to 
the pulmonary circulation. The subscripts ‘tot’, ‘m’ and ‘b’ denote total, 
muscle and body components, respectively. The macron denotes “mixed 
venous”. Taken from Benson et al. (2013).  
 
This purposely simple model assumes the muscle to be a single 
homogenous compartment, where V̇O2 and Q̇ were modelled to increase 
exponentially in response to a step increase in work rate. Equation 2 can be 
expanded to include the descriptions of V̇O2m and Q̇ such that: 
 CvO2  =  CaO2  −    
V̇O2b +  ∆ V̇O2∙(1− e
− tτV̇O2m)
Q̇b +  ∆Q̇ ∙ (1−  e
− tτQ̇)
 , 
      
(1
8) 
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where V̇O2m,b and Q̇b are baseline values, τV̇O2m and  τQ̇ are muscle V̇O2 
and cardiac output time constants respectively, and ∆V̇O2 and ∆Q̇ are the 
steady state increases. During cycle ergometry exercise (where external 
work rate can be controlled) ∆V̇O2 can be determined by: 
∆V̇O2  = G ∙ WR , (19) 
where G is the V̇O2 functional gain with units of L/min/W (i.e. the O2 cost of 
exercise). For cycle ergometry exercise, G is approximately 10 mL/min/W, 
and this is relatively constant  across different genders, training status, and 
health status (Demarle et al., 2001). The steady-state change in blood flow, 
∆Q̇, is defined as a function of the ∆V̇O2, based on the linear relationship 
between Q̇ and V̇O2. The Q̇/V̇O2 relationship can be described 
mathematically by the equation: 
Q̇ = m  ∙  V̇O2 +  c , (20) 
where m is the slope and c is the intercept of the linear relationship (Whipp 
et al., 1982). Therefore, ∆Q̇ during exercise is given as the product of ∆V̇O2 
and the slope of the Q̇/V̇O2 relationship, i.e. a 5 L/min increase in Q̇ for every 
1 L/min increase in V̇O2, giving a slope of 5. The kinetics of cardiac output 
and muscle V̇O2 were modelled to increase to their steady-state values in an 
exponential manner. Finally, resting cardiac output (Q̇tot) and resting alveolar 
V̇O2 (V̇O2A) was divided so that a fraction was directed to the ‘muscle’ 
compartment, and the remainder going to the ‘rest of the body’ 
compartment. Note that the model predicts alveolar, rather than pulmonary, 
V̇O2 as the experimental data against which the model was validated were 
measures of alveolar V̇O2. However, there is minimal difference between 
these two measures (Beaver et al., 1981) and so V̇O2A and V̇O2p can be 
considered synonymous, as least for the concepts discussed here. The 
fractions of total Q̇ to and V̇O2 from the exercising muscle compartment at 
rest were set to 57%, with the remainder going to/coming from the rest-of-
body compartment, and CaO2 was kept constant throughout.   
Effects of different time constants for Q̇m and V̇O2m on the CvO2 profile at 
exercise onset showed that, if τQ̇ is less than or equal to τV̇O2m muscle 
CvO2 falls to a new steady state without an overshoot. When τQ̇ is longer 
than τV̇O2m (i.e. blood flow kinetics are slower) muscle CvO2 transiently 
undershoots its steady state value, i.e. when the V̇O2m/Q̇m ratio is increased, 
muscle CvO2 reaches some ‘critical value’ or in some scenarios, all O2 is 
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extracted from the muscle. This ratio is also affected by venous O2 
capacitances [i.e. a healthy individual may store approximately 450 ml O2 in 
the venous vasculature (Rossiter, 2011)] which sets the limits for the 
allowable discrepancy between Q̇m and V̇O2m kinetics during the exercise 
transient (Barstow et al., 1990). This could be significant in cases where Q̇ 
kinetics are compromised, such as in heart failure patients. Under conditions 
where the model values were set to replicate those of healthy humans, 
however, oxygen delivery rises more rapidly than oxygen extraction, and 
hence, is not limiting to muscle V̇O2 kinetics during moderate exercise (i.e. in 
this situation CvO2 does not undershoot its steady state value. In addition, 
another key finding of the model was that, despite some “kinetic 
dissociation” due to circulatory effects, phase II V̇O2p kinetics closely 
reflected V̇O2m kinetics to within a couple of seconds, a finding later 
confirmed experimentally (Grassi et al., 1996) in healthy young adults 
[although this may not be true in disease states such as heart failure, where 
cardiac function can be impaired, acting to slow cardiac output kinetics 
(Matsumoto et al., 1999)].  
 
3.1.2 The multi-compartment model (MCM) 
This model was recently optimised by Benson et al. (2013) where further 
complexity was added to the model, including the addition of separate 
venous volumes for the muscle and rest of body compartments, in order that 
the model more closely matched experimentally-recorded measures of Q̇, 
CvO2 and V̇O2 (Figure 18; left). As the venous volumes were not directly 
measured experimentally, their values were determined by selecting, on an 
individual basis, the three venous volume values that gave the minimum 
kinetic difference of ∆phase I, phase I time delay (i.e. initial muscle-to-lung 
time transit time), and phase II V̇O2A 𝜏 between the model output and the 
experimental data.  This optimised model accounted for changes in blood 
flow and V̇O2 (and therefore the Q̇b/V̇O2,b ratio and CvO2,b) in the non-
exercising tissues, which the original model was unable to appropriately 
account for. These changes allowed phase I and phase II alveolar oxygen 
uptake (V̇O2A) kinetics to be accurately predicted from knowledge of 
circulatory and respiratory dynamic interactions at the onset of exercise 
(Figure 18, right). The model was validated against data from the only study 
to date that directly and simultaneously measured pulmonary ventilation and 
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gas exchange, leg blood flow, blood gases and lactate concentration, and 
V̇O2 at the leg during moderate intensity cycle-ergometer exercise in healthy 
young men (Grassi et al., 1996).  
Figure 18: Left: schematic of the optimised model developed by Benson et 
al. (2013) named the multi-compartment model (MCM) due to its separate 
venous volumes for muscle and rest of body compartments. See Figure 17 
for definitions. Right: the predicted V̇O2A output from the optimized MCM for 
a representative subject (solid line), superimposed on the experimental V̇O2A 
measurements from that subject (open squares). ϕIΔ, phase I amplitude; ϕI, 
phase I time delay; ϕIIτ, phase II time constant; TD, time delay. Taken from 
Benson et al. (2013). 
 
A key finding from the MCM was that the kinetics of V̇O2A during exercise 
are very sensitive to pre-exercise conditions such as resting or unloaded 
exercise blood flow distributions. Model input values (i.e. Q̇tot, fraction Q̇ to 
muscle) assumed by Barstow et al. (1990) were significantly less than the 
experimentally derived values. As such, simulations of the CvO2 profile using 
the input values from Barstow et al. (1990) in comparison to the 
experimental values, resulted in a 50% undershoot in CvO2m (Figure 19), 
which would result in all available muscle O2 being extracted, this is despite 
the only differences being the absolute values of Q̇m and V̇O2m at unloaded 
pedalling. Moreover, the CvO2 undershoot does not just shift downwards, but 
is more pronounced under conditions where the muscle is poorly perfused at 
rest or unloaded pedalling (Benson et al., 2013). This is because, where 
CaO2 is constant, the CvO2 profile is determined by the ratio of the V̇O2m/Qm 
relationship (see Equation 3), which has a positive Q̇m intercept. In this 
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context, larger discrepancies between V̇O2m/Q̇m [in the values assumed by 
Barstow (1990)], resulted in a larger V̇O2/Q̇ ratio, causing a CvO2 
undershoot whereas, closer V̇O2m/Q̇m values measured experimentally 
(Grassi et al., 1996), resulted in a lower V̇O2m/Q̇m ratio and thus reduced the 
CvO2 undershoot (Benson et al., 2013). 
    
 
Figure 19: Simulated CvO2 profiles for a 100-W step change in work rate 
from unloaded pedalling (ULP) with use of SCM parameter values or 
experimentally measured values. Taken from Benson et al. (2013). SCM, 
single compartment model: model of Barstow et al. (1990) named the single 
compartment model due to having one venous volume compartment.  
 
Experimentally, this important V̇O2/Q̇ relationship may partially explain the 
transient overshoot in muscle deoxygenation (Sperandio et al., 2009) or 
transient undershoot in tissue oxygenation (Bowen et al., 2012) measured 
by near infrared spectroscopy at exercise onset seen in heart failure patients 
(where sluggish cardiac function may act to slow Q̇m kinetics). Sperandio et 
al. (2009) observed a transient overshoot in the deoxygenated haemoglobin 
+ myoglobin signal, implying that estimated fractional O2 extraction 
increased above the steady state level because of impaired blood flow 
relative to V̇O2 causing CvO2 (or capillary PO2) to reach some critical value, 
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that likely reduces the diffusion gradient from capillary to mitochondria, 
causing impaired O2 flux and limiting the rate of increase in muscle V̇O2.  
3.2 MCM model: current state and projections 
The models of Barstow et al. (1990) and Benson et al. (2013) have shown 
that computational approaches can be beneficial in helping to understand 
the kinetics of oxygen uptake and the availability of O2 at the skeletal muscle 
during exercise. This has implications for understanding the mechanisms 
underlying the changes to V̇O2p kinetics seen in heart failure: are changes to 
measured pulmonary V̇O2 direct reflections of changes to muscle V̇O2, or 
can changes to resting blood flow, for example, influence V̇O2p kinetics?  
Computational models integrating muscle oxygen uptake and circulatory 
dynamics have demonstrated how impairments in oxygen transport (i.e. poor 
cardiac function) and/or utilisation can lead to distortions of key physiological 
relationships (e.g. slowed V̇O2 kinetics), that ultimately lead to exercise 
intolerance (Benson et al., 2013). To date, models of oxygen uptake and 
circulatory dynamics have been predominately developed for constant work 
rate (step) exercise (Barstow et al., 1990; Lai et al., 2009; Benson et al., 
2013), where valuable inferences can be made during the transition from 
rest or unloaded pedalling to the prescribed work rate. The model of Benson 
et al. (2013) has only been validated for moderate intensity exercise during 
the on-transient (i.e. at the start of sub-lactate threshold constant-load 
exercise), and not for higher intensity domains (above lactate threshold). It is 
therefore unclear whether the model can reproduce the physiological 
characteristics seen across exercise intensities and during different exercise 
protocols such as ramp incremental exercise to the limit of tolerance. This is 
pertinent in disease states such as heart failure, as activities of daily living 
are rarely performed at one exercise intensity (or metabolic steady state). 
Additionally, ramp incremental tests (requiring continuous adjustment to 
changes in metabolic demand) are the most commonly used cardio-
pulmonary exercise test in clinical settings (Weisman, 2003). As such, its 
use as a diagnostic tool is limited, at least until such a validation is carried 
out. The aim for this chapter was to develop and validate the MCM for 
incremental exercise by adding new components to the model. This chapter 
consists of the addition of these components and parameterisation to the 
data. The new components are described below (see section “developing 
the model for incremental exercise”) and can be summarised by equations 
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25-27. NB: This chapter was a collaborative piece of work with Dr Al 
Benson. Contributions as follows: Sophie Hampson; model development & 
formulation of equations, data collection, data analysis, model validation, 
and all write up. Dr Al Benson: model development & formulation of 
equations, all model coding. 
 
3.3  Methods 
Experimental methods 
The experimental data used in this chapter were taken (with permission) 
from Grassi et al. (1996). Experimental methods are described in the general 
methods section under sub-heading “Protocol 1” 
Computational methods 
3.3.1 The MCM model 
The MCM developed by Benson et al. (2013) was based on the original 
model of Barstow et al. (1990). It is composed of three compartments; 
‘muscle’ ‘rest of body’ and ‘pulmonary’, with venous volume effluents from 
the muscle and rest of body compartment, and a third venous volume which 
both effluents flow through, in a flow-weighted mixing manner. As in the 
Barstow et al. (1990) model, Q̇m and V̇O2m increased exponentially (see 
Equation 4) towards their steady state which was determined by their 
assigned work rate profile. O2 concentrations of the muscle (CvO2m) and rest 
of body (CvO2b) effluents were calculated by utilising the Fick equation: 
CvO2x (t) = CaO2  −  VO2x(t) / Q̇x(t), (21) 
where the subscript x represents either muscle or rest of body. Flow 
weighted mixing was calculated by: 
CvO2,m + b = CvO2m(
Q̇m
Q̇tot
) +  CvO2b (
Q̇b
Q̇tot
)  , (22) 
where all variable are functions of time. The blood with the now mixed 
venous O2 concentration then travels down a single venous volume to the 
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pulmonary compartment the variable flow in the venous volume is 
determined by Q̇tot. This results in a muscle-to-lung transit time delay (TD) 
that is determined by the values of Vv, Q̇tot, and t. The TD for the venous 
effluents being mixed at any given time is calculated by integrating Q̇tot from t 
until the integral is equal to Vv, conforming to the equation:  
Vv =  ∫ Q̇tot(t)dt
t+TD(t)
t  . (23) 
Integration was carried out using the trapezoid rule. Mixed CvO2 (CV̅O2) at 
the lung and at time t+TD(t) is given by CvO2m+b at time t, with CvO̅2 
remaining at its unloaded pedalling (baseline) value for when t is less than 
the initial muscle-to-lung time delay. V̇O2A at each time t is then solved using 
the Fick principle: 
V̇O2A(t) = Q̇tot(t)[CaO2− CV̅O2(t)] (24) 
  
3.3.2 Developing the MCM for incremental exercise 
To simulate incremental exercise, some important changes to the MCM 
were required. This involved (i) the inclusion of “muscle fibre recruitment” 
and (ii) changing the profile of the V̇O2 and Q̇ responses following exercise 
onset. 
During increasing work rate exercise, muscle fibres are sequentially 
recruited to meet the increasing work rate requirements of the task, in order 
to increase the metabolic rate to generate the required energy (Burnley et 
al., 2002). The MCM developed to reproduce responses to step exercise 
(Benson et al., 2013; henceforth referred to as “MCMstep”) contained a single 
homogeneous muscle compartment. In order to reproduce responses to 
incremental exercise, it was therefore necessary to develop a model that 
contained separate “muscle fibres” that could be sequentially recruited as 
work rate increased (this version of the model will be referred to as 
“MCMinc”): During an exercise simulation, the MCMinc gradually recruits these 
individual muscle fibres as the exercise protocol progresses and the work 
rate increases, with a given number of muscle fibres recruited per watt 
increase in work rate. Each muscle fibre has its own V̇O2 gain (Gfibre) that is 
determined by whole body V̇O2 gain and the number of fibres recruited per 
watt of exercise – for example, if whole body V̇O2 gain is 10 mL/min/W and 5 
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muscle fibres are recruited per watt of exercise, then the individual Gfibre = 
10/5 = 2 mL/min/W. (Note that, if required, the parameters associated with 
each individual “muscle fibre” can be set individually to produce a 
heterogeneous muscle compartment. For these studies, however, gain and 
other parameters in each fibre were set to be identical, producing a 
homogeneous muscle compartment.) The V̇O2 of each muscle fibre 
increases in an exponential manner to a steady state, as described by 
Equation 27. These muscle fibres are sequentially recruited and their V̇O2 
responses are summed. Thus, the V̇O2 response profile of individual muscle 
fibres is a mono-exponential increase (exponential decay) to steady-state, 
while the whole-muscle V̇O2 response shows a short exponential phase 
followed by a linear increase (assuming the gain of each recruited muscle 
fibre is identical) typical of whole-muscle/whole-body V̇O2 responses to ramp 
incremental exercise. 
The change in Q̇ and V̇O2 during the ramp for each individual muscle fibre 
and body compartment was therefore calculated by:  
∆V̇O2fib = (∆V̇O2 ∆Wmus)⁄ /𝑁fibres/W, (25) 
and,  
∆Q̇fib =  ∆V̇O2fib ∙( ∆Q̇ ∆V̇O2mus)⁄ , (26) 
where ∆V̇O2fib is the steady state change in muscle fibre V̇O2 (L/min), 
∆V̇O2 ∆Wmus⁄  is the change in muscle compartment V̇O2 per watt of exercise 
(i.e. the V̇O2 gain of the muscle; L/min/W), Nfibres/W is the number of muscle 
fibres recruited per watt of exercise (W), ∆Q̇fib is the steady state change in 
muscle fibre blood flow (L/min), and ∆Q̇ ∆V̇O2mus⁄  is the change in muscle 
compartment blood flow per litre change in muscle V̇O2 (L/min).  
Cardiac output to muscle fibres, and V̇O2 from muscle fibres, were modelled 
to increase monoexponentially, conforming to the equation: 
fibrex (t)= fibrex,base+ ∆fibrex ∙ (1− e-(t-𝑡recruit,x) τx⁄ ), (27) 
where the subscript x denotes Q̇ or V̇O2, fibrex,base is baseline or starting fibre 
value, ∆fibrex is the steady state change in muscle fibre required for a given 
work rate, and trecruit,x is the fibre recruitment time for fibre x.  
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Oxygen concentrations in the blood draining the muscle and rest of body 
compartments, flow weighted mixing, transit delays and pulmonary V̇O2 was 
calculated in the same manner as the MCM for step exercise (described 
above, and see Benson et al. (2013). Mean response time was calculated as 
the time delay between the end of the simulation and the time at which the 
end-simulation V̇O2p would have occurred if the V̇O2p response increased 
linearly with no kinetics according to V̇O2 = G × 𝑡 × ramp slope. Model V̇O2p 
outputs were averaged into 30s bins in the same manner as the 
experimental data and plotted as functions of increasing work rate before 
being superimposed over experimental V̇O2p data. 99% percent prediction 
bands (equal to 3 standard deviations from the mean, where 1 SD on the 
V̇O2p noise is 0.1 L/min (Lamarra et al., 1987; Rossiter et al., 2000) were 
applied to the model V̇O2p data, indicating the regions in which one would 
expect 99% of experimental breaths to fall. The accuracy of the model was 
determined by the percentage of data points that fell within these 99% 
prediction bands. Models were coded in C and were compiled to run on a 
Windows PC using Code::Blocks IDE (integrated development environment) 
software (open-source software available at http://www.codeblocks.org) The 
model was validated against V̇O2p data from the same subjects in which the 
original MCM (for moderate intensity constant work rate exercise) was 
developed against (Grassi et al., 1996). 
3.4 Results and discussion 
3.4.1 Initial model validation 
The pulmonary V̇O2 output from the MCMinc  were validated, on a subject-by-
subject basis, against the ramp data from the Grassi study (Grassi et al., 
1996) using the subject-specific parameters from the original (i.e. pre-
optimised) MCMstep (Benson et al., 2013) as inputs to the model. Table 3 
shows the level of agreement between experimental data and the MCMinc  
with pre-optimised parameters, presented as percentage of experimental 
data points that lie within the model 99% prediction bands (i.e. the model 
V̇O2p output ± 0.3 L/min, which equates to ± 3 standard deviations of the 
noise expected on V̇O2p (Lamarra et al., 1987; Rossiter et al., 2000). 
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Table 3: Level of agreement between pre-optimised model values and 
experimental data for individual subjects 
Subject Level of agreement (%) 
1 88 
2 94 
3 94 
4 63 
5 72 
6 76 
The mean overall agreement between our experimental data and the pre-
optimised model parameters was 81% (i.e. on average 81% of the 
experimental V̇O2p data lay within 3 standard deviations from the mean of 
the model V̇O2p data). Figure 20 shows the (30s) averaged experimental 
data with 3 SD error bars, and the pre-optimised model values averaged in 
the same manner as the experimental data. As shown, the model did not 
always lie in the 3 standard deviations of expected noise, this is especially 
true towards the end of the ramp where the V̇O2p starts to plateau in some 
subjects (despite obvious plateau data at or near the limit of tolerance being 
removed from the experimental dataset before comparison). Figure 21 
shows the time series pre-optimised model V̇O2p data superimposed with 
experimental data. As with the averaged data, not all the experimental data 
fell within 99% prediction bands.  
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Figure 20: Averaged pre-optimised model V̇O2p values (black triangles) with 
y-error bars marking 3 standard deviations from the mean, superimposed on 
experimental data (red circles).  
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Figure 21: Time series pre-optimised model (solid black line) with 99% 
prediction bands (dashed black lines) superimposed with 30s averaged 
experimental V̇O2p data.  
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3.4.1 Model optimisation 
Next, it was explored whether normal expected physiological variability in 
parameters could account for the discrepancy between the model and the 
experimental data. To identify model parameters that have a significant 
effect on the model output (and thus help us streamline its optimisation) a 
sensitivity analysis was performed on the MCMinc. Model parameters were 
changed by ± 10% from their pre-optimised  values (see Table 1 and Table 4 
for sensitivity analysis input and output values). Any parameter that caused 
a >1% change in the baseline V̇O2, the slope of the V̇O2 response, the peak 
V̇O2, or the kinetics of the V̇O2 response (see Table 5) was considered a 
parameter that could be modified in order to optimise the MCMinc. The 
search identified baseline cardiac output (Q̇b), baseline pulmonary V̇O2 
(V̇O2p,b), functional gain (ΔV̇O2/ΔWR), the slope of the V̇O2-Q̇ relationship 
(ΔV̇O2/ΔQ̇), and muscle V̇O2 kinetics (τV̇O2m) to be most important 
parameters in terms of modifying the model outputs under observation (see 
Table 5). Subsequently, these key parameters were modified, on a subject-
by-subject basis, to find the combination of parameter values that gave the 
best fit between the MCMinc output and the experimental data. Of the five 
key parameters identified, Q̇b, ΔV̇O2/ΔWR, ΔV̇O2/ΔQ̇, and τV̇O2m were 
changed. Baseline oxygen uptake (V̇O2p,b) was not changed, as this 
parameter value was measured directly from the experimental data, and so 
was not an unknown. As V̇O2m kinetics were modified, to avoid kinetic 
mismatch (where O2 delivery is unphysiologically slow compared to O2 
utilisation, or vice versa) Q̇ kinetics (τQ̇) were also modified to maintain the 
τQ̇/τV̇O2m ratio at a suitable level. To avoid unphysiological best-fit 
parameter values, any changed parameter values were constrained to lie in 
the range of mean ± 3 SDs of the values from Grassi et al. (1996) and 
Benson et al. (2013): 5.95 ≤ Q̇b ≤ 12.24 s; 6.92 ≤ ΔV̇O2/ΔWR ≤ 12.02 ml.min-
1.W-1; 4.44 ≤ ΔV̇O2/ΔQ̇ ≤ 7.62; 13.81 ≤ τV̇O2m ≤ 30.93 s; 0.84 ≤ τQ̇/τV̇O2m ≤ 
1.32. Because of the complexity of the model and the fact that analytical 
solutions to the equations are not possible (thus precluding the use of the 
gold-standard Levenberg-Marquardt algorithm for parameter fitting), a 
custom “alternating variable search” (Press, 2007) was employed to find the 
combination of parameter values (for parameters identified as key in the 
sensitivity analysis) that reduced the sum-of-squares between binned and 
experimental data to a minimum (where model output data were binned and 
averaged to match the experimental data). The alternating variable search 
starts by increasing then decreasing one parameter (Q̇b in this case) by 
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10%: if either change resulted in a model output with a better fit to the 
experimental data, that parameter change was kept and the parameter took 
on the new value (i.e. its previous value plus or minus 10%, depending on 
whether increasing or decreasing the parameter value resulted in the better 
fit); if neither increasing nor decreasing the parameter value resulted in a 
better fit between model output and experimental data, the old parameter 
value was kept. The algorithm then works through the remaining parameters 
in turn (ΔV̇O2/ΔWR, followed by ΔV̇O2/ΔQ̇, τV̇O2m and finally τQ̇/τV̇O2m) 
performing the same ±10% parameter value change as described above. 
Once the algorithm had changed each parameter by ±10%, the process was 
repeated, again looping through each parameter in turn and changing the 
parameter value by ±10%. When changing any parameter by ±10% no 
longer resulted in a better fit between model output and experimental data, 
the entire process described above was repeated but with ±1% parameter 
changes. Again, once changing any parameter by ±1% no longer resulted in 
a better fit between model output and experimental data, the entire process 
was repeated a final time using ±0.1% parameter changes. Note that, 
because of the large muscle-pulmonary kinetic dissociation seen with 
Subject 6 and the probability that this occurred because of complicated bi-
exponential cardiac output and muscle blood flow kinetics (Grassi et al., 
1996; Benson et al., 2013), subject 6 was omitted from the current 
optimisation procedure.  
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Table 4: Pre-optimised model output parameters (top line) and model output parameters following sensitivity analysis 
  Minus 10% Plus 10% 
 
V̇O2 V̇O2 
 
Baseline 𝝉 Slope Peak Baseline MRT Slope Peak 
 
(L/min) (s) (L/min/min) (L/min) (L/min) (s) (L/min/min) (L/min) 
         Pre-optimised: 0.87 23.40 0.20 2.79 0.87 23.40 0.20 2.79 
         CaO2 0.87 23.40 0.20 2.79 0.87 23.39 0.20 2.79 
Venus volumes, litres 
    Muscle 0.87 23.37 0.20 2.79 0.87 23.44 0.20 2.79 
Body 0.87 23.40 0.20 2.79 0.87 23.40 0.20 2.79 
Mixed 0.87 23.29 0.20 2.79 0.87 23.52 0.20 2.79 
Baseline (unloaded pedalling) values 
    V̇O2A 0.78 23.62 0.20 2.70 0.96 23.17 0.20 2.88 
Fraction from musclea 0.87 23.45 0.20 2.79 0.87 23.35 0.20 2.79 
Q̇tot 0.87 23.12 0.20 2.79 0.87 23.62 0.20 2.79 
Fraction to musclea 0.87 23.33 0.20 2.79 0.87 23.45 0.20 2.79 
Exercise V̇O2 and Q̇ parameters 
    ∆V̇O2m / ∆WR 0.87 23.60 0.18 2.60 0.87 23.23 0.22 2.98 
∆Q̇ / ∆WR 0.87 23.85 0.20 2.79 0.87 23.03 0.20 2.79 
Muscle V̇O2 and blood flow kinetics 
    Q̇m τ 0.87 21.18 0.20 2.80 0.87 25.62 0.20 2.78 
V̇O2m τ 0.87 23.42 0.20 2.79 0.87 23.38 0.20 2.79 
Table parameters: Q̇ denotes blood flow. The subscripts ‘tot’ and ‘m’ denote total and muscle components, respectively. aThe remainder of the baseline V̇O2p (and 
Q̇tot) comes from (and goes to) the body compartment. 
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Table 5: Sensitivity analysis results to identify parameters that have an influence on the ramp model 
 
Minus 10% Plus 10% 
 
V̇O2 V̇O2 
 
Baseline 𝝉 Slope Peak Baseline MRT Slope Peak 
 
(L/min) (s) (L/min/min) (L/min) (L/min) (s) (L/min/min) (L/min) 
         CaO2  0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Venus volumes 
Muscle 0.0 -0.1 0.0 0.0 0.0 0.2 0.0 0.0 
Body 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Mixed 0.0 -0.5 0.0 0.0 0.0 0.5 0.0 0.0 
Baseline (unloaded pedalling) values 
V̇O2A -10.3 0.9 0.0 -3.2 10.3 -1.0 0.0 3.2 
Fraction from musclea 0.0 0.2 0.0 0.0 0.0 -0.2 0.0 0.0 
Q̇tot 0.0 -1.2 0.0 0.0 0.0 0.9 0.0 0.0 
Fraction to musclea 0.0 -0.3 0.0 0.0 0.0 0.2 0.0 0.0 
Exercise V̇O2 and Q̇ parameters 
∆V̇O2m / ∆WR 0.0 0.9 -10.0 -6.8 0.0 -0.7 10.0 6.8 
∆Q̇ / ∆WR 0.0 1.9 0.0 0.0 0.0 -1.6 0.0 0.0 
Muscle V̇O2 and blood flow kinetics 
Q̇m τ 0.0 -9.5 0.0 0.4 0.0 9.5 0.0 -0.4 
V̇O2m τ 0.0 0.1 0.0 0.0 0.0 -0.1 0.0 0.0 
Table parameters: Q̇ denotes blood flow. The subscripts ‘tot’ and ‘m’ denote total and muscle components, respectively. aThe remainder of the baseline V̇O2p (and 
Q̇tot) comes from (and goes to) the body compartment. Values highlight in red indicate any parameters that caused changes of greater than 1% in baseline V̇O2, V̇O2 
kinetics, V̇O2/WR slope, or V̇O2,peak. 
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This process yielded post-optimisation best fit parameters (Table 6).  Figure 
22  shows model output with best fit parameters (averaged in the same 
manner as experimental data) superimposed with the experimental data, 
and Figure 13 shows second-by-second best fit model values superimposed 
with averaged experimental values post optimisation.  
Table 6: Individual subject best fit parameters following model optimisation 
Parameter  Subject 
 
1 2 3 4 5 
Q̇b (L/min) 13.04 21.98 13.57 14.37 12.50 
ΔV̇O2/ΔWR (L/min/W) 0.01 0.01 0.01 0.01 0.01 
ΔV̇O2/ΔQ̇  7.62 4.44 7.61 7.61 7.62 
τV̇O2m (s) 13.81 21.45 13.81 13.81 13.81 
τQ̇ (s) 18.23 28.28 12.35 11.70 11.99 
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Figure 22: Averaged pre-optimised model V̇O2p values (black triangles) with 
y-error bars marking 3 standard deviations from the mean, superimposed on 
experimental data (red circles) 
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Figure 23: Time series pre-optimised model (solid black line) with 99% 
prediction bands (dashed black lines) superimposed with 30s averaged 
experimental V̇O2p data. 
 
 
71 
 
The post-optimisation best fit parameters give V̇O2p values in which 100% of 
values lie within ± 3 SDs of V̇O2 noise (i.e. 99% prediction bands) for all 5 
subjects at all time points. Therefore, it can be concluded that normal 
variation in parameters provide a model that fits the experimental data, thus 
validating the MCMinc. Average best fit parameters (i.e. the post-optimsation 
MCMinc  values) for the MCMinc model are shown in Table 7.  
 
Table 7: Pre and post optimisation parameter values for the MCMinc model 
Parameter MCM values 
 Pre-optimisation Post-optimisation 
CaO2 (L O2/ L blood) 0.20 0.20 
 
 
 Venus volumes (L)  
 Muscle 0.70 0.70 
Body 0.10 0.10 
Mixed 2.30 2.30 
 
 
 Baseline (unloaded pedalling) 
values 
 
 
V̇O2A, (L/min) 0.87 2.31 
Fraction from musclea 0.57 0.57 
Q̇tot, (L/min) 8.89 15.09 
Fraction to musclea 0.57 0.57 
 
 
 Exercise V̇O2 and Q̇ parameters  
 ∆V̇O2m /∆WR, (L/min/W) 0.01 0.01 
∆Q̇ / ∆V̇O2m 6.00 6.98 
 
 
 Muscle V̇O2 and blood flow kinetics  
 𝜏Q̇m (s) 24.00 15.30 
𝜏V̇O2m (s) 22.00 16.50 
Table parameters: Q̇ denotes blood flow. The subscripts ‘tot’ and ‘m’ denote total and muscle 
components, respectively. aThe remainder of the baseline V̇O2p (and Q̇tot) comes from (and goes to) 
the body compartment. Note these are averaged values from the experimentally collected data (Grassi 
et al., 1996). Standard deviations have been removed for clarity.  
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Note the large differences in some of the parameters (baseline V̇O2, 
baseline Q̇tot, ΔV̇O2 and ΔQ̇ relationship and V̇O2 and Q̇ kinetics) following 
optimisation. One of the possible reasons for these differences is likely from 
the different unloaded pedalling work rates. For the incremental exercise 
protocol baseline pedalling in the elite amateur cyclists was 150 W. A higher 
baseline work rate will elevate baseline V̇O2 and cardiac output, thereby 
increasing the V̇O2/Q̇ slope. The difference in the kinetics is also likely a 
consequence of the higher V̇O2 and Q̇. This is because the model does not 
take into account baseline work rate (i.e. all model simulations were 
simulated from a 0 W baseline) thereby requiring faster kinetics to meet V̇O2 
demands.  
Model limitations 
Computational models are simplified versions of complex systems. The 
MCMinc presented here, is a relatively simplified model of circulatory and 
oxygen transport dynamics with a lumped “exercising muscle”, “non-
exercising muscle,” and “lung” compartment. The MCMinc assumes 
homogenous muscle compartments however, during exercise transitions 
there is substantial heterogeneity of fibre types with differing V̇O2/Q̇ ratios 
distributed within bodily tissues, between exercising and non-exercising 
muscles (Ferreira, McDonough, et al., 2006), and within different locomotor 
muscles engaged in exercise (Armstrong and Laughlin, 1985; Piiper et al., 
1985; McDonough et al., 2005; Koga et al., 2007, 2014; Laaksonen et al., 
2010). This balance between V̇O2 and Q̇ is important as it sets the 
microvascular (or capillary) PO2 and thus the upstream driving pressure for 
blood-myocyte O2 flux as well as influencing metabolic control via the impact 
on intramyocyte PO2 and V̇O2 kinetics. Consequently, the heterogeneities in 
these compartments may influence model predictions. For example, areas 
with a low Q̇/V̇O2 ratio will have a high fractional O2 extraction and 
consequently, a microvascular PO2 so low that blood-myocyte O2 flux will be 
impaired compromising mitochondrial control. Benke et al. (2003) and 
McDonough et al. (2005) showed that the kinetic profile of microvascular 
PO2 and its absolute levels during contractions vary markedly in the soleus 
muscle compared with either the peroneal or gastrocnemius. In the peroneal 
and gastrocnemius muscles, microvascular PO2 was shown to fall much 
faster and to a lower level that in the soleus muscle. As the model assumes 
homogenous muscle compartment, the variable V̇O2/Q̇ ratios within the 
exercising muscle are not represented and the muscle oxygen extraction 
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response is based on a homogenous V̇O2/Q̇ ratio such that any variance in 
the V̇O2/Q̇ ratio within the muscle compartments in the model are not 
accounted for. The overall oxygen extraction response may therefore be 
under or overestimated depending on the fibre type composition and blood 
flow distribution in the muscle of interest. Model predictions may be 
improved further by creating a model compartment in which the V̇O2/Q̇ ratio 
can be altered depending on the fibre type composition of the exercising 
muscle and its V̇O2/Q̇ ratio.  
  
The model is also simplified with the exclusion of any complex energetic 
systems, such as the breakdown of phosphocreatine, which has been 
demonstrated to influence the V̇O2p phase II (i.e. V̇O2p kinetics) response 
(Geer et al., 2002; Rossiter et al., 2002; Forbes et al., 2009). For example, 
inhibition of creatine kinase (the enzyme which catalyses the reversible 
transfer of high energy phosphates between phosphocreatine and ADP), at 
exercise onset, accelerates V̇O2 kinetics (Grassi et al., 2011). Furthermore, 
during high intensity exercise (i.e. during the later stages of the incremental 
exercise test) approximately 90% of the magnitude of the V̇O2 slow 
component is reflected within the exercising muscle by its PCr response 
(Rossiter et al., 2002).  
One of the consequences of not including more complex energetic systems 
is that the model cannot predict some of the subtleties of the V̇O2p response, 
such as the lactate threshold (one of the key parameters determined from 
incremental exercise testing). The model can, however, produce a V̇O2p 
mean response time (the sum of the kinetics of phase I and phase II), 
another important parameter determined from incremental exercise. Despite 
its importance, the V̇O2p mean response time is not typically used for kinetic 
analysis in healthy individuals due to the inability to dissociate phase I and 
phase II. Because of this, much less attention has been paid to the V̇O2p 
mean response time (relative to phase II V̇O2p kinetics), especially in health. 
The V̇O2p mean response time, however, is more commonly used in heart 
failure patients, where distinguishing between phase I and phase II is more 
complex (this will be explored in more detail in Chapter 3). The incremental 
model can be used to probe in more detail, the mean response time, and in 
particular explore its significance in heart failure.  
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Additionally, the model is not able to predict any plateaus in V̇O2p which 
were seen experimentally towards the end of the ramp in some subjects. 
The plateau in V̇O2 has been used to as criteria during an incremental test, 
to determine if the individual has achieved a true V̇O2 max. However, the 
V̇O2 plateau is inconsistent across individuals (Beltz et al., 2016). For 
example, a plateau in the V̇O2 response to incremental exercise has been 
reported in as low as 20% of some subjects (Niemelä et al., 1980; Myers et 
al., 1990) to as high as 94% in others (Taylor et al., 1955). Furthermore, this 
plateau is dependent on many factors: for example, Zuniga et al. (2012) 
compared the incidence of a V̇O2 plateau during incremental ramp exercise 
with incremental step exercise. During the ramp incremental protocol, they 
found that 64% of subjects exhibited a V̇O2 plateau compared to 36% during 
the step incremental protocol. This is interesting given that it has been 
shown that there are no significant differences in lactate threshold, V̇O2max, 
or ∆V̇O2/∆WR relationship as long as the overall increase in work rate 
remained the same (Zhang et al., 1991), and in fact, a 1-min step 
incremental test was indistinguishable from a ramp incremental test (Zhang 
et al., 1991). It has also been demonstrated that training status may affect 
the V̇O2 plateau incidence: for example, in a group of elite cyclists 47% 
exhibited V̇O2 plateau, compared to 24% untrained (Lucia et al., 2006). The 
authors of the latter study suggested that this was possibly due to trained 
cyclists having higher pain threshold than their untrained counterparts. Other 
variables effecting the V̇O2 plateau incidence are age (Astorino et al., 2000), 
testing modality i.e treadmill vs cycle ergometer exercise (Gordon et al., 
2012), and the methodology in which V̇O2p data are processed (Astorino, 
2008). Given that the (patho)physiological mechanisms underlying the V̇O2p 
plateau remain to be elucidated, adding unknown components to the model, 
so that it can predict plateaus in V̇O2p (even phenomenologically), would be 
speculation and is beyond the scope of this study. However, it needs to be 
recognised that the inability of the model to predict V̇O2p plateaus is 
potentially a limitation. Nevertheless, despite the potential influence of these 
factors, the model is still able to predict the V̇O2p response with good 
accuracy.  
3.5  Conclusion 
The data presented here provide a version of the MCMstep adapted for 
incremental exercise. The model is, to our knowledge, the first to accurately 
predict V̇O2p responses to incremental exercise, from knowledge of 
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circulatory and respiratory interactions measured directly from healthy 
individuals. This was achieved by the addition of a muscle fibre compartment 
in which separate muscle fibres, with their own V̇O2 gain, could be recruited 
sequentially according to the increase in work rate. Additionally, the profile of 
the V̇O2 and Q̇ responses were modelled to increase with a short 
exponential phase followed by a linear phase, to replicate the V̇O2 response 
to incremental exercise.  
The model can be used to explore some of the subtleties of the kinetics of 
the V̇O2p response for incremental exercise, the mean response time. This 
will be addressed in Chapter 3. In addition, the model will be further 
developed in Chapter 4, to include a ‘muscle oxygenation’ output, which will 
be used to further explore the mechanisms of exercise tolerance in heart 
failure patients, the model will be used in this context to inform experimental 
data presented in Chapter 5.  
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Chapter 4 Investigating muscle 
oxygenation dynamics by computational 
modelling and near infrared spectroscopy 
4.1 Introduction 
Whole body measurements of pulmonary oxygen uptake can be measured 
during a cardiopulmonary exercise test, with good precision at the mouth 
(V̇O2p), and have been shown to be a close representation of oxygen uptake 
at the skeletal muscle (V̇O2m) in healthy humans (Grassi et al., 1996). 
However, there are limitations associated with this measurement technique, 
including the inability to discriminate between exercising and whole-body 
measurements (i.e. there is a small but significant change in oxygen uptake 
in the non-exercising muscles, which influences whole body oxygen uptake) 
as well as between different muscles engaged in the exercise (Benson et al., 
2013). In addition, the presence of O2 stores between the site of O2 
exchange and the measurement site complicate data interpretation during 
exercise transitions (Cerretelli and Di Prampero, 1987). Another way of 
measuring V̇O2m in humans is the direct Fick method (Grassi et al., 1996; 
Bangsbo et al., 2000). However, this method is highly invasive and complex. 
Furthermore, sampling the venous effluent of the exercising muscle without 
contamination of venous blood from other muscles remains a technical 
limitation in humans (Grassi and Quaresima, 2016). Consequently, NIRS 
has been utilised as a non-invasive method of measuring muscle 
oxygenation dynamics (i.e. balance between oxygen delivery and utilisation)  
due to its ability to provide information on key physiological and 
pathophysiological mechanisms relevant in the evaluation of exercise 
tolerance in healthy and patient populations (Grassi and Quaresima, 2016).   
Modelling studies have also been utilised to investigate key relationships 
related to convective and diffusive O2 delivery, and their effects on V̇O2 
kinetics. Spires et al. (2013) showed that when O2 delivery is limited, the 
permeability surface area (a key determinant of oxygen diffusion) increases 
at a greater rate than Q̇ to enhance O2 diffusion rates between blood and 
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tissue. Additionally, Lai et al. (2009) developed a model of O2 transport and 
metabolism to determine the contribution of myoglobin to the NIRS signal 
under conditions of normoxia and hypoxia. The latter study demonstrated 
that Mb contribution to the NIRS signal was significant under normoxic 
conditions, and becomes even more substantial during hypoxia, and 
therefore may play a role in changing the muscle oxygenation signal under 
conditions of normoxia and hypoxia (Lai et al., 2009). The latter study used 
experimentally derived NIRS along with V̇O2 and hemodynamic 
measurements as inputs to the model, to determine the factors (relative 
contributions of haemoglobin and myoglobin, effects of muscle blood volume 
etc.) that may modify the NIRS signal. However, no model has used 
knowledge of O2 utilisation and transport dynamics to simulate a ‘NIRS 
output’; that is, to predict the NIRS output for any given simulated “subject” 
and exercise protocol. Such a model would be a useful research tool as it 
will allow insight into the mechanisms that cause inter- and intra-
subject/patient variability in measured NIRS signals and may provide a tool 
that can be translated to the clinic to determine the locus of any O2 
transport/utilisation limitation.  
The aim of this study was to (i) develop a computational model of oxygen 
transport and circulatory dynamics (Benson et al., 2013) to include a NIRS 
output (deoxygenated haemoglobin + myoglobin, oxygenated haemoglobin + 
myoglobin, total heme, and tissue oxygenation index) for both constant work 
rate (step) and incremental (ramp) exercise; (ii) validate the model using 
experimentally collected NIRS (deoxygenated haemoglobin and myoglobin, 
oxygenated haemoglobin and myoglobin, tissue oxygenation index, total 
heme), pulmonary gas exchange measurements (V̇O2) and directly 
measured muscle V̇O2 and Q̇ data obtained from healthy individuals; (iii) to 
explore, mechanistically, whether any of the key variables that play a role in 
determining muscle oxygenation in the model may explain the different NIRS 
responses seen in healthy individuals and those with heart failure. As with 
the model in Chapter 3 the model was developed collaboratively with Dr Al 
Benson. Contributions as follows: Sophie Hampson; model development & 
formulation of equations, data collection, data analysis, model validation, 
and all write up. Dr Al Benson: model development & formulation of 
equations, all model coding. The new components of the model are detailed 
in equations 28-52 (see below in section ‘New NIRS development’) which 
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breakdown the steps in creating an additional muscle NIRS compartment for 
the model. 
4.2  Methods 
Experimental data collection is described in the general methods section 
under sub-heading ‘Protocol 2’ 
Computational methods 
4.2.1 New NIRS model development 
The newly developed NIRS model (described below) is the only 
computational model (so far and to our knowledge) that can produce NIRS 
outputs (specifically oxygenated haemoglobin, deoxygenated haemoglobin, 
total haemoglobin and tissue oxygenation index). It takes simulated arterial 
and venous O2 concentrations from the O2 transport model (described in 
Chapter 1) as inputs and calculates the corresponding muscle NIRS signals. 
A schematic of the muscle compartment of the NIRS model is shown in 
Figure 24. It was assumed that the muscle is homogeneous, such that the 
concentrations (e.g. of oxy and deoxy haemoglobin and myoglobin) in the 
small muscle region investigated by NIRS (i.e. the “muscle compartment” in 
the NIRS model) are representative of those throughout the rest of the 
exercising muscle. 
 
Figure 24: Schematic of the muscle compartment of the NIRS model. 
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Note the following volume relationships: The muscle compartment is 
composed of a blood compartment and a tissue (or “intracellular”) 
compartment, such that: 
muscle volume (Vm)
= blood volume (Vb) + tissue volume (Vi) 
blood fraction in muscle  (𝑓b) =
Vb
Vm
 =
Vb
Vb + Vi
 
tissue fraction in muscle (𝑓i) =
Vi
Vm
 =
Vi
Vb + Vi
 
and therefore 𝑓b + 𝑓i = 1.0 
The blood compartment in the muscle is composed of arterial1, capillary and 
venous1 compartments, such that: 
blood volume (Vb)
= arterial volume (Va) + capillary volume (Vc)
+ venous volume (Vv) 
arterial fraction in muscle blood (𝑓a) =
Va
Vb
 =
Va
Va + Vc + Vv
 
capillary fraction in muscle blood (𝑓c) =
Vc
Vb
 =
Vc
Va + Vc + Vv
 
venous fraction in muscle blood (𝑓v) =
Vv
Vb
 =
Vv
Va + Vc + Vv
 
                                                          
1 Throughout this section, “arterial” refers to blood in the arterioles of the 
muscle microcirculation, and has the same O2 concentration as blood in the 
arteries of the O2 transport model. Similarly, “venous” refers to the blood in 
the venules of the muscle microcirculation, which has the same O2 
concentration as the venous effluent leaving the exercising skeletal muscle 
in the O2 transport model, i.e. before it travels along the “muscle venous 
system” and mixes with blood from “non-exercising” muscles. 
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and therefore 𝑓a + 𝑓c + 𝑓v = 1.0 
 
Initial pre-exercise volume fractions 
Initial (pre-exercise) arterial, capillary and venous fractions in muscle blood 
were set to be fa = 0.06, fc = 0.84 and fv = 0.1, according to measurements 
made in skeletal muscle (Poole et al., 1995). Note the large difference in 
these initial values, particularly the capillary and venous fractions, compared 
to those in  Lai et al. (2009) (fa = 0.1, fc = 0.15 and fv = 0.75) which are likely 
to reflect vascular volumes in the brain rather than skeletal muscle (Davis 
and Barstow, 2013). Any change in muscle blood volume during exercise is 
assumed to be proportional to the change in muscle blood flow, and takes 
place in the capillaries, with the arterial and venous volumes in the muscle 
(Va and Vv) remaining constant. After derivation of the NIRS model 
equations, the developed NIRS model was optimised to: (i) determine the 
proportionality constant linking change in capillary volume to change in 
muscle blood flow; and (ii) determine the contributions of haemoglobin and 
myoglobin to the NIRS signal, which are reflected in the blood and tissue 
fractions in the muscle (fb and fi): see “Model optimisation” below. 
 
Calculate total O2 concentration in capillary blood 
O2 concentration in the capillary is spatially-varying, i.e. changes with 
distance along the capillary. It was assumed that the drop in capillary O2 
concentration along the length of the capillary is linear. The mean capillary 
O2 concentration (over the whole muscle) is therefore given by the mean of 
the arterial and venous O2 concentrations: 
CcO2 = (CaO2 + CvO2) 2⁄  (28) 
When calculating venous O2 concentration, any blood transit times in the 
small total capillary volume in the exercising muscle of ~100 ml can initially 
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be ignored.2 That is to say, any change in mean capillary O2 concentration 
will be instantly reflected in an equal change in venous O2 concentration. 
 
Calculate oxygenated and deoxygenated haemoglobin concentrations 
in arterial, capillary and venous blood 
Haemoglobin concentration in the blood, [Hb], has a value of 150 g Hb/L 
blood in healthy adult humans. This concentration can be converted from 
units of g/L to molar units (M) by dividing by the molar mass of 
haemoglobin3, MHb, then multiplying by 1000 to give more useable units of 
mM: 
[Hb](mM)=
1000 × [Hb](g/L)
MHb
   (29) 
where MHb = 65000 g/mol. Therefore, [Hb] = 150 g/L = 2.308 mM. 
Regardless of the units used for Hb concentration, the amount of 
haemoglobin that is oxygenated was required: that is, haemoglobin O2 
saturation (SxO2; given as a fraction, and where the subscript x denotes 
arterial, capillary or venous blood) was required. In order to do this, 
equations linking total O2 concentration in the blood (CxO2; known from the 
O2 transport model) and SxO2 were needed. The ‘oxygen content equation’ 
states that total O2 concentration is the sum of the Hb-bound and free O2 
concentrations: 
CxO2 = CxO2,bound + CxO2,free (30) 
where, as before, the subscript x denotes arterial, capillary or venous blood. 
The Hb-bound O2 concentration is given by 
                                                          
2 Assume body mass of 75 kg. Then, from values given in Lai et al. (2009) 
active muscle volume is “13% of body mass” (presumably swapping units 
from kg to L), so 9.75 L; muscle blood volume is 7% of muscle volume, so 
682.5 ml; and capillary volume is 15% of muscle blood volume, so 102.375 
ml. 
3 Molar mass used to be termed “molecular weight”, and is sometimes given 
in units of daltons (Da), where 1 Da = 1 g/mol. 
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CxO2,bound = 𝐶Hb [Hb] SxO2 (31) 
where CHb = 0.00134 L O2/g Hb is Hüfner’s constant defining the maximum 
O2 binding capacity of haemoglobin, and [Hb] (in units of g Hb/L blood) and 
SxO2 have been defined above. From Henry’s law, the free O2 concentration 
is given by 
CxO2,free = 𝛼bPxO2 (32) 
where 𝛼b = 0.000031 L O2/mmHg O2/L blood is the solubility coefficient of O2 
in blood, and PxO2 is the partial pressure of O2 (mmHg). By substituting 
equations 31 and 32 into equation 30, total O2 concentration in the blood is 
given by 
CxO2 = 𝐶Hb [Hb] SxO2 + 𝛼bPxO2 (33) 
The model now has an equation linking CxO2 and SxO2. However, both SxO2 
and PxO2 in equation 33 are unknowns, precluding calculation of SxO2 from 
CxO2 using equation 33. Therefore, to get only one unknown, one unknown 
can be substituted for the other. The two unknowns, SxO2 and PxO2, are 
related through the oxygen-haemoglobin dissociation curve, which can be 
described by Severinghaus (1979): 
SxO2 =
1
[( 1
PxO2
3 + 150 PxO2
)23400] + 1
 
(34) 
Unfortunately, equation 34 cannot be rearranged to make PxO2 the subject 
of the equation, due to the cubic term. Although Severinghaus (1979) 
provided an alternative equation describing the oxygen-haemoglobin 
dissociation curve with PxO2 on the left-hand-side of the equation, as 
needed, it is accurate only for values of SxO2 lower than 0.965; therefore the 
equation above was used which is accurate over the entire oxygen-
haemoglobin dissociation curve. So, substituting equation 34 into equation 
31 gave 
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CxO2,bound =
𝐶Hb [Hb]
[( 1
PxO2
3 + 150 PxO2
)23400] + 1
 
(35) 
and , from equations 32, 35 and 37, 
CxO2 =
𝐶Hb [Hb]
[( 1
PxO2
3 + 150 PxO2
)23400] + 1
+ 𝛼bPxO2 (36) 
Equation 36 now had only one unknown, PxO2. PxO2 could therefore be 
calculated using equation 36, and the resultant values plugged into equation 
34 which gave SxO2. (This was needed to calculate PxO2 anyway, as it was 
needed for calculating myoglobin saturation below, so this was not a 
“wasted” step.) However, as with equation 34, equation 36 could not be 
directly solved for PxO2 (i.e. it is not possible to rearrange the equation to get 
PxO2 on the left-hand-side) due to the cubic term. Instead, a “brute-force 
search” was used to find the solution, by varying PxO2 until the right-hand 
side of the equation matches the value of CxO2 the O2 transport model has 
produced. Practically, this can be achieved using a “lookup table” containing 
pre-calculated solutions to the equation for different values of PxO2 at a 
suitable resolution: one finds the closest CxO2 value in the table to the O2 
transport model’s current CxO2 value and reads off the corresponding PxO2 
value, then SxO2 can be calculated by substituting this value for PxO2 into 
equation 34. The concentration of oxygenated haemoglobin in arterial, 
capillary or venous blood, [HbO2,x], is then calculated as the product of the 
haemoglobin concentration and the haemoglobin saturation: 
[HbO2,x] = [Hb] SxO2 (37) 
using units of g/L or mM for [HbO2,x] and [Hb], as seemed fit. It follows that 
the remainder of the haemoglobin is deoxygenated: deoxygenated 
haemoglobin concentration in arterial, capillary or venous blood, [HHbx], is 
therefore given by 
[HHbx] = [Hb] (1− SxO2) = [Hb] − [HbO2,x] (38) 
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Calculate oxygenated and deoxygenated myoglobin concentrations the 
tissue 
Myoglobin concentration, [Mb], in the tissue has a value of 4.08 g Mb/L 
tissue4. Again, this concentration was converted from units of g/L to molar 
units (M) by dividing by the molar mass of myoglobin, MMb, then multiplying 
by 1000 to give more useable units of mM: 
[Mb](mM)=
1000 × [Mb](g/L)
MMb
   (39) 
where MMb = 17000 g/mol. Therefore, [Mb] = 4.08 g/L = 0.24 mM. Again, 
regardless of the units used for Mb concentration, the amount of myoglobin 
that is oxygenated needed to be determined: that is, myoglobin O2 saturation 
(SiO2; given as a fraction, and where the subscript i denotes the tissue 
compartment) was needed. The oxygen-myoglobin dissociation curve can 
be described by 
SiO2 =
PiO2
P50 + PiO2
 (40) 
where PiO2 is the partial pressure of O2 (mmHg) in the tissue, and P50 = 3.2 
mmHg is the Mb half-saturation pressure (Richardson et al., 2006). 
Experimental evidence (Hirai et al., 2018) has shown that the absolute value 
of the PO2 gradient between the capillary and the tissue (ΔPO2, and where 
ΔPO2 = PcO2 – PiO2) remains relatively constant throughout a rest-
contraction protocol, with values of ΔPO2 = 19.2 ± 9.4 mmHg and ΔPO2 = 
17.3 ± 6.5 mmHg reported at rest and during steady-state contractions, 
respectively, with a brief drop to approximately ΔPO2 = 14.4 ± 7.9 mmHg 
during the initial 30 s of contractions (see Figure 3 in; Hirai et al. (2018)). It 
was therefore assumed that ΔPO2 remained constant at 17.3 mmHg (the 
mean of the data presented in Figure 3 in Hirai et al. (2018), and so PiO2 is 
given as 
PiO2 = PcO2 − 17.3 (41) 
                                                          
4 The mean Mb concentration and Mb molar mass (molecular weight) 
reported in Duteil et al. (2005) was 0.24 mM and 17 kDa, respectively. 
Concentration in units of g/L is given by multiplying concentration in mM by 
molecular weight in kDa, so 0.24 mM × 17 kDa = 4.08 g/L. 
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with PiO2 constrained to be ≥3.1 mmHg (Richardson et al., 2006), and where 
PcO2 is known from equation 36. The value for PiO2 obtained from equation 
41 can be plugged into equation 40 to give a value for SiO2. The 
concentration of oxygenated myoglobin in in the tissue, [MbO2,i], is then 
calculated as the product of the myoglobin concentration and the myoglobin 
saturation: 
[MbO2,i] = [Mb] SiO2 (42) 
using units of either g/L or mM for [MbO2,x] and [Mb], to match the units 
chosen for haemoglobin. It follows that the remainder of the myoglobin is 
deoxygenated: deoxygenated myoglobin concentration in the tissue, [HMbi], 
is therefore given by 
[HMbi] = [Mb] (1 − SiO2) = [Mb] − [MbO2,i] (43) 
 
Calculate haem group concentrations in the muscle 
The oxyhaemoglobin and deoxyhaemoglobin concentrations in arterial, 
capillary and venous blood, and the oxymyoglobin and deoxymyoglobin 
concentrations in the tissue, are given by equations 37, 38, 42 and 43. The 
oxy- and deoxyhaemoglobin concentrations in the entire muscle ([HbO2] and 
[HHb], respectively) are given by the sum of the blood compartment oxy- 
and deoxyhaemoglobin concentrations weighted by their compartment 
volume fractions in the muscle: 
[HbO2] = 𝑓b(𝑓a[HbO2,a] + 𝑓c[HbO2,c] + 𝑓v[HbO2,v]) (44) 
[HHb] = 𝑓b(𝑓a[HHba] + 𝑓c[HHbc] + 𝑓v[HHbv]) (45) 
Likewise, the oxy- and deoxymyoglobin concentrations in the entire muscle 
([MbO2] and [HMb], respectively) are given by the tissue oxy- and 
deoxymyoglobin concentrations weighted by the tissue volume fraction in the 
muscle:  
[MbO2] = 𝑓i[MbO2,i] (46) 
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[HMb] = 𝑓i[HMbi] (47) 
The total oxygenated and deoxygenated haem group concentrations in the 
muscle ([HbMbO2] and [HHbMb], respectively) are given by the sum of the 
respective muscle haemoglobin and muscle myoglobin concentrations: 
[HbMbO2] = [HbO2] + [MbO2]
= 𝑓b(𝑓a[HbO2,a] + 𝑓c[HbO2,c] + 𝑓v[HbO2,v]) + 𝑓i[MbO2,i] (48) 
[HHbMb] = [HHb] + [HMb]
= 𝑓b(𝑓a[HHba] + 𝑓c[HHbc] + 𝑓v[HHbv]) + 𝑓i[HMbi] (49) 
where the concentrations in equations 44-49 are in units of g/mol or, more 
commonly, mM. 
 
Calculate NIRS signals 
Haemoglobin molecules contain four haem units that each bind one oxygen 
molecule, whereas myoglobin contains only one haem unit that binds a 
single oxygen molecule. An oxygenated haemoglobin molecule therefore 
absorbs four times as much light as an oxygenated myoglobin molecule, and 
this affects their relative contributions to the NIRS signals (Davis and 
Barstow, 2013). Near infrared spectroscopy cannot differentiate between 
light absorption due to haemoglobin and myoglobin, and gives a lumped 
“oxygenated haem” signal (HbMbO2) and a lumped “deoxygenated haem” 
signal (HHbMb).  Therefore, a scaling factor was applied to [HbO2] in order 
to accurately reflect the contributions of the different haem groups to these 
two NIRS signals:  
HbMbO2 = [HbO2] 4⁄ + [MbO2]
= 𝑓b(𝑓a[HbO2,a] + 𝑓c[HbO2,c] + 𝑓v[HbO2,v]) 4⁄ + 𝑓i[MbO2,i] (50) 
HHbMb = [HHb] + [HMb]
= 𝑓b(𝑓a[HHba] + 𝑓c[HHbc] + 𝑓v[HHbv]) + 𝑓i[HMbi] (51) 
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Note that NIRS signals were differentiated from actual haem group 
concentrations by the absence of square brackets for the NIRS signals. 
Many experimental NIRS systems do not give absolute units for HbMbO2 
and HHbMb and instead use arbitrary units. In such cases, the NIRS signals 
are usually normalised (“norm”), as a percentage, to their starting values (“t 
= 0”) and their values at the end of the exercise protocol (“t = end”):  
HbMbO2,norm = 100 × (1 −
HbMbO2,𝑡=0 − HbMbO2
HbMbO2,𝑡=0 − HbMbO2,𝑡=end
) (52) 
HHbMbnorm = 100 ×
HHbMb − HHbMb𝑡=0
HHbMb𝑡=end − HHbMb𝑡=0
 (53) 
such that HbMbO2,norm = 100% at the start of exercise and 0% at the end of 
exercise, while HHbMbnorm = 0% at the start of exercise and 100% at the end 
of exercise. This normalises the signals to conditions at the end of the 
exercise protocol (i.e. to V̇O2,peak during a ramp protocol, or to steady-state 
V̇O2 during a step protocol) and allows any under- or overshoots in the 
HbMbO2 and HHbMb signals during the exercise protocol to be identified. 
Alternatively, the NIRS signals can be given as a change (Δ) from their 
starting values, as in Lai et al. (2009):  
∆HbMbO2 = 100×
HbMbO2 − HbMbO2,𝑡=0
HbMbO2,𝑡=0
 (54) 
∆HHbMb = 100 ×
HHbMb − HHbMb𝑡=0
HHbMb𝑡=0
 (55) 
The individual oxy- and deoxy- haemoglobin and myoglobin concentrations 
in the muscle (equations 44-47) can be normalised using the same methods. 
Finally, the tissue oxygenation index (TOI) is the ratio of the oxygenated 
haem concentration to the total (oxygenated and deoxygenated) haem 
concentration, as a percentage: 
TOI = 100×
[HbO2] 4⁄ + [MbO2]
[HbO2] 4⁄ + [MbO2] + [HHb] + [HMb]
 (56) 
where the divisor 4 is as described for equation 50. 
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4.2.2 Model optimisation 
Change to capillary blood volume during exercise 
Any change in muscle blood volume during exercise is assumed to be 
proportional to the change in muscle blood flow (Q̇m), and takes place in the 
capillaries, with the arterial and venous volumes in the muscle remaining 
constant. Thus ΔVc ∝ ΔQ̇m, and so 
Vc = 𝑘Vc,𝑡=0 Q̇m Q̇m,𝑡=0⁄  (57) 
where k is a proportionality constant scaling the change in muscle blood flow 
to the change in capillary volume, and Vc,t=0 and Q̇m,t=0 are capillary volume 
and muscle blood flow at the start of exercise (i.e. at t = 0 s), respectively. In 
the NIRS model, capillary volume is constrained to only increase, and to 
increase to a maximum of five times its pre-exercise value, such that             
Vc,t=0 ≤ Vc ≤ 5Vc,t=0. 
Contributions of haemoglobin and myoglobin to the NIRS signal 
There is debate about the contributions of haemoglobin and myoglobin to 
the NIRS signal (Davis and Barstow, 2013; Grassi and Quaresima, 2016), 
with these relative contributions likely to be due to the volumes of blood and 
tissue, respectively, that the NIRS probe interrogates. 
Model optimisation 
The likely value of the proportionality constant k and the fractions of blood 
(fb) and tissue (fi) in the muscle volume interrogated by NIRS were 
investigated, by optimising the NIRS model developed here (combined with 
the previously-validated O2 transport model; see Chapter 3) against 
experimental data of simultaneously-measured pulmonary O2 uptake (V̇O2p), 
cardiac output (Q̇) and NIRS (specifically TOI) during ramp incremental 
exercise. Values for baseline V̇O2p, baseline Q̇, muscle V̇O2 kinetics (back-
calculated from experimentally-measured V̇O2p kinetics), blood flow kinetics, 
V̇O2 gain and the slope of the Q̇/V̇O2 relationship were obtained from the 
experimental data and used as inputs to the model, on a subject-by-subject 
basis, along with details relating to the ramp exercise protocol (ramp work 
rate and total duration) – see Table 2. The NIRS model parameters k and fb 
(and therefore fi) were then modified, using a custom alternating variable 
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search (see Chapter 3 for details), until the NIRS model TOI output matched 
the experimentally recorded TOI as closely as possible. For each 
optimisation, initial parameter values were set to k = 1.0 and fb = 0.5 (and 
therefore fi = 0.5). Because altering fb (and therefore fi), changes the 
contributions made to the NIRS signals (including TOI) by haemoglobin and 
myoglobin, altering these variables also alters baseline TOI in the model. 
Therefore, to ensure that the model baseline TOI matched the experimental 
baseline TOI, fractional blood flow distribution to the muscle (fQ,mus) in the O2 
transport model was altered to ensure the balance of oxygenated and 
deoxygenated haemoglobin and myoglobin gave a model baseline TOI that 
was within ±2.5% (approximately ±4 standard deviations of the noise on TOI 
measured by NIRS) of the experimental baseline TOI. While doing this, fQ,mus 
was constrained to not drop so low as to completely drain O2 in the muscle 
venous effluent during the ramp protocol, and not increase so much that O2 
in the “body” compartment venous effluent was completely drained. This was 
successfully achieved with modelling data obtained from nine of the 10 
subjects. With data from the remaining subject, fb and fQ,mus could not be 
balanced to give a model baseline TOI within ±2.5% of the experimental 
baseline TOI: as such, baseline TOI was not constrained for this subject. 
4.3 Results and discussion 
Peak pulmonary oxygen uptake during the ramp exercise test was (mean ± 
SD) 3.57 ± 0.97 (L/min), with a peak work rate of 290 ± 75 (W).  Minimum 
and maximum tissue oxygenation during the ramp incremental exercise test 
was 60 ± 8 (%) and 75 ± 3 (%) respectively.  Figure 25 shows individual 
subject model predicted tissue oxygenation index (red line) and 
experimentally (NIRS) derived tissue oxygenation index (black circles). 
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Figure 25: Individual subject tissue oxygenation index response during ramp 
incremental exercise (black circles) overlaid on model predicted tissue 
oxygenation index response (red line).  
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There was no significant difference between model predicted, and 
experimentally derived, minimum TOI (p>0.05), maximum TOI (p>0.05), and 
TOI amplitude (p>0.05; see Table 8 and Figure 26. 
 
 
Table 8: Individual subject tissue oxygenation values determined during 
ramp incremental exercise 
Subject TOI minimum (%) TOI maximum (%) TOI Amplitude (%) 
 
Exp Model Exp Model Exp Model 
1 45.5 46.7 76.3 71.5 30.8 24.8 
2 63.6 59.3 72.9 72.4 9.30 13.1 
3 73.4 72.9 80.8 81.3 7.40 8.4 
4 64.2 58.6 71.0 73.0 6.80 14.4 
7 63.5 63.4 75.0 75.1 11.5 11.7 
8 61.1 61.6 72.0 75.0 10.9 13.4 
9 69.9 59.4 76.5 78.6 6.60 19.2 
10 60.7 60 74.5 74.3 13.8 14.3 
11 52.4 46.2 70.3 70.4 17.9 24.2 
12 61.7 61.9 72.9 71.6 11.2 9.70 
TOI tissue oxygenation index; Exp experimental data  
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Figure 26: Top panel: (left) minimum model predicted TOI and 
experimentally derived TOI, (right) maximum model predicted TOI and 
experimentally derived TOI. Bottom panel: Model predicted TOI amplitude 
and experimentally derived TOI amplitude. 
Individual differences between model predicted TOI start, TOI end and delta 
TOI shown below (Table 9). The mean overall discrepancy between model 
predicted TOI and experimentally derived TOI was 0.2-2.9%. 
Table 9: Individual subject differences between model predicted, and 
experimentally derived tissue oxygenation index at the start of exercise, the 
end of exercise, and change in TOI (delta) during the ramp incremental test. 
Subjec
t 
Starting TOI 
difference (%) 
End TOI 
difference (%) 
Delta TOI 
difference (%) 
1 1.2 4.8 6.0 
2 4.3 0.5 3.8 
3 0.5 0.5 1.0 
4 5.6 2.0 7.6 
5 0.1 0.1 0.2 
6 0.5 3.0 2.5 
7 10.5 2.1 12.6 
8 0.7 0.2 0.5 
9 6.2 0.1 6.3 
10 0.2 1.3 1.5 
Mean 2.6 0.1 2.7 
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Figure 27: Individual subject model predicted ΔHHbMb (red line) and 
experimentally measured ΔHHbMb (blue circles).  
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Figures 25 and 27 show individual model predicted TOI and ΔHHbMb 
superimposed with experimentally measured TOI and ΔHHbMb. For the TOI 
In subjects 2, 5, and 9 the breakpoint (i.e. deviation from linearity) in the 
model output matches the breakpoint in the experimental data closely. 
However, the overall fit of the model is poor. The breakpoint may represent 
sudden changes in the local balance between V̇O2 and Q̇, and these 
changes in the muscle oxygenation response profile may be reflected in 
whole body physiological responses. In healthy subjects, studies have 
shown the breakpoint in deoxygenated haemoglobin myoglobin to occur at 
75-90% of V̇O2,max. Given the intensity at which the breakpoint occurs, the 
breakpoint has been related to other physiological markers of exercise 
intensity such as the respiratory compensation point, maximal lactate steady 
state, and/ or critical power (Osawa et al., 2011; Bellotti et al., 2013; Murias 
et al., 2013; Racinais et al., 2014; Boone et al., 2015, 2016; Fontana et al., 
2015; Keir et al., 2015). However, it has been questioned whether these 
parameters are physiologically linked, due to the individual variance found 
between these parameters (Broxterman et al., 2015; Craig et al., 2015). As 
such, it remains to be determined whether the breakpoints and the 
physiological markers of exercise intensity are mechanistically linked (Boone 
et al., 2016). Nevertheless, the breakpoint in the ΔHHbMb response has 
been shown to be strongly correlated to V̇O2,peak (Boone et al., 2009; Murias 
et al., 2013) showing that, in those subjects with a higher V̇O2,peak, the 
breakpoint occurred later on in the ramp test. The mechanisms for this shift 
are yet to be elucidated. The model sensitivity analysis (see section 
ΔV̇O2/ΔWR below) showed that a 10% reduction in the V̇O2 gain (i.e. from 
0.1 to 0.09) caused a ~20% increase in the location of the normalised 
ΔHHbMb breakpoint (i.e. the breakpoint occurred later in the ramp 
simulation). This finding is consistent with experimental data where 
endurance trained athletes, tend to express a high V̇O2/WR slope (~11-12 
L/min/W) (Riley et al., 1996; Boone et al., 2008) compared to heart failure or 
vascular disease patients who often have a low V̇O2/WR slope of ~9-
11L/min/W (Hansen et al., 1987; Jones et al., 1998; Hsia et al., 2009). One 
possible explanation for the lower V̇O2/WR slope in HF patients may be as a 
consequence of a reduced blood flow to the periphery muscles, thereby, 
resulting in a greater contribution to energy transfer from anaerobic sources. 
However, this is not consistent with exercise below lactate threshold where 
contribution from anaerobic sources is minimal (Rossiter, 2011). Another 
possible explanation is that O2 utilisation in patients is less able to keep pace 
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with the demands of ramp exercise, this explanation is consistent with 
slowed V̇O2 kinetics in patients (Wasserman et al., 2011).  
The model predicted TOI responses show clear breakpoints in some 
subjects, whilst in others the TOI response follows a more fluid profile, 
making it harder to accurately determine the breakpoint in these subjects. 
From the TOI  responses of subjects 2, 5, and 9, the breakpoint can be 
clearly identified and the model predicts these breakpoints closely . In 
subjects 1 and 6 there is also a clear breakpoint in the data, however, the 
model predicted breakpoint is slightly delayed in subject 1 and slightly 
premature in subject 6. Except for subject 5, these subjects display a ‘typical’ 
sigmoidal response, which is why the model may be better at estimating TOI 
breakpoints in these subjects. In contrast, subject 7 and 10 had untypical 
responses (almost linear and exponential, respectively). In these subjects 
the model was unable to predict the TOI response profiles. This suggests 
that the model is more able to predict typical TOI responses, but is less able 
to predict TOI response profiles when the response does not follow a typical 
sigmoidal pattern. 
For the TOI data, in subjects 3, 4, 7 and 10 the model predicted NIRS 
responses are poorly predictive of the experimental data. For the HHbMb 
data the model predicted NIRS responses are poorly predictive of the 
experimental data in all subjects, as the model was optimised against TOI 
data. This variable and poor model fit to the experimental data suggests that 
the model in its current state is not an accurate representation of the NIRS 
oxygenation response and therefore needs more development and iterations 
before it can be utilised fully. This may need to include the addition of more 
complex systems such as a heterogenous fibre type compositions, more 
accurate measures of capillary, venous and arterial O2 concentrations (at 
rest and during exercise) and varying venous volume sizes. A sensitivity 
analysis was subsequently performed on the model however due to its poor 
accuracy in predicting the NIRS response any potential physiological 
mechanisms should be interpreted with extreme caution. 
To investigate the potential mechanistic determinants of the muscle 
oxygenation response, a sensitivity analysis was performed on the NIRS 
model for both step and ramp exercise. Table 10 shows model input 
parameters +/- 10% for the sensitivity analysis. Note that each parameter 
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was changed on an individual basis and therefore only one parameter was 
changed at a time for each simulation.  
Table 10: Experimentally derived (mean) model input parameters (middle 
column) with minus 10% (left) and plus 10% (right). 
Parameter Parameter value 
  Minus 10% Model input  Plus 10% 
CaO2 (L O2/ L blood) 0.18 0.20 0.22 
 
 
 
 
Venus volumes, litres    Muscle 0.63 0.70 0.77 
Body 0.09 0.10 0.11 
Mixed 2.07 2.30 2.53 
 
 
 
 
Baseline (unloaded pedalling) values   
V̇O2p, L/min 0.87 0.96 1.06 
Fraction from musclea 0.51 0.57 0.63 
Q̇tot, L/min 7.62 8.47 9.32 
Fraction to musclea 0.51 0.57 0.63 
 
 
 
 
Exercise V̇O2 and Q̇ 
parameters  
 
 
∆V̇O2m /∆WR, (L/min/W) 0.009 0.01 0.011 
∆Q̇ / ∆V̇O2m 4.89 5.43 5.97 
    
 
 
 
 
Muscle V̇O2 and blood flow kinetics 
  V̇O2m𝜏 (s) 23.90 26.56 29.21 
Q̇m𝜏 (s) 26.66 29.63 32.59 
Table parameters: Q̇ denotes blood flow. The subscripts ‘tot’ and ‘m’ denote total and muscle 
components, respectively. aThe remainder of the baseline V̇O2p (and Q̇tot) comes from (and goes to) 
the body compartment. CaO2 and venous volumes are taken from the experimental data described in 
methods protocol 1. All other values were measured experimentally as described in methods protocol 
2. Note that all values are means (standard deviations have been excluded for clarity).  
 
Sensitivity analysis results are shown in Table 11, Table 12 and Table 13. 
Table 11 shows model output values (phase 1 amplitude, phase 1 duration, 
and phase II τ) during step exercise simulations. Although NIRS was the 
primary interest in the sensitivity analysis, the model also gives information 
regarding V̇O2 dynamics. As such, V̇O2 outputs were also investigated for 
completeness, the results of which are shown in table 11. The parameters 
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that had the most impact on V̇O2 dynamics were baseline Q̇ and V̇O2 values 
and V̇O2 and Q̇ kinetics. Table 12 shows the tissue oxygenation index 
results for both step and ramp simulations. The parameter that caused the 
biggest change in TOI was the V̇O2/WR slope: where reducing the slope by 
10% caused a 31% change in delta TOI (compared to 7% delta for the 
original experimental input values). Table 13 shows model output values 
(V̇O2p mean response time) for ramp model simulations. These simulations 
revealed no significant change in V̇O2 mean response time when each 
parameter was changed by ± 10%.
98 
 
Table 11: Model output values (phase I amplitude, phase I duration and phase II time constant) for step exercise 
simulations for mean ± 10% 
 
 Minus 10% Plus 10% 
 
𝜽1 amplitude 𝜽1 duration 𝜽2 𝝉 𝜽1 amplitude 𝜽1 duration 𝜽𝟐 𝝉 
 
(%) (s) (s) (%) (s) (s) 
       Mean: 29.71 21.30 20.65 29.71 21.30 20.65 
       CaO2 29.62 20.90 20.58    
Venus volumes, litres   
Muscle 29.24 20.40 20.83 30.50 21.90 20.53 
Body 29.57 20.90 20.58 29.73 21.30 20.64 
Mixed 28.64 19.70 20.94 30.91 22.50 20.32 
Baseline (unloaded pedalling) values   
V̇O2 26.51 20.90 20.83 33.21 21.30 20.95 
Fraction from musclea 27.58 20.90 20.30 31.77 21.30 20.93 
Q̇tot 35.08 22.60 20.25 25.35 19.80 21.00 
Fraction to musclea 32.32 21.58 20.58 27.63 20.70 20.73 
Exercise V̇O2 and Q̇ parameters   
ΔV̇O2m / ΔWR 20.10 11.80 22.06 29.59 20.93 20.51 
V̇O2-Q̇ slope 27.07 21.20 20.46 32.73 20.90 20.81 
Muscle V̇O2 and blood flow kinetics   
Q̇m 𝜏 32.24 20.60 22.20 27.70 21.50 19.53 
V̇O2m 𝜏 29.24 20.90 16.81 30.03 21.30 24.51 
Table parameters: θ1 amplitude phase I amplitude; θ1 duration phase I duration; θ2 τ phase II time constant. Q̇ denotes blood flow. The subscripts ‘tot’ and ‘m’ 
denote total and muscle components, respectively. aThe remainder of the baseline V̇O2p (and Q̇tot) comes from (and goes to) the body compartment; 𝜏 time constant 
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Table 12: Model derived tissue oxygenation values for both step (left) and ramp (right) exercise 
 Tissue oxygenation index (%) 
 Step Ramp 
 
10% -10% 10% -10% 
 
Min Max Change Min Max Change Min Max Change Min Max Change 
             Mean: 64.8 71.8 7.0 64.8 71.8 7.0 59.2 71.9 12.7 59.2 71.9 12.7 
             CaO2    56.6 64.4 7.8    50.9 64.5 13.6 
Venus volumes, litres          
Muscle 64.7 71.8 7.1 64.5 71.8 7.3 59.2 71.9 12.7 59.2 71.9 12.7 
Body 64.7 71.8 7.1 64.5 71.8 7.3 59.2 71.9 12.7 59.2 71.9 12.7 
Mixed 64.7 71.8 7.1 64.4 71.9 7.5 59.2 71.9 12.7 59.2 71.9 12.7 
Baseline (unloaded pedalling) values          
V̇O2b 63.7 69.7 6.0 65.3 73.9 8.6 58.4 69.7 11.3 59.9 73.9 14.0 
Fraction from musclea 63.7 69.6 5.9 65.5 74.1 8.6 58.4 70.0 11.6 60.0 74.1 14.1 
Q̇tot 66.0 73.8 7.8 62.6 69.5 6.9 60.9 73.8 12.9 57.3 69.5 12.2 
Fraction to musclea 66.1 73.9 7.8 62.5 69.4 6.9 61.0 73.9 12.9 57.2 69.4 12.2 
Exercise V̇O2 and Q̇ parameters          
ΔV̇O2m /ΔWR 64.4 71.9 7.5 40.8 71.8 31.0 58.2 71.9 13.7 60.3 71.9 11.6 
V̇O2-Q̇ slope 66.2 71.9 5.7 63.0 71.9 8.9 60.6 71.9 11.3 57.9 71.9 14.0 
Q̇m τ 64.7 71.8 7.1 64.4 71.9 7.5 59.3 71.9 12.6 59.1 71.9 12.8 
V̇O2m τ 64.7 71.8 7.1 64.4 71.9 7.5 59.1 71.9 12.8 59.3 71.9 12.6 
 Table parameters: Q̇ denotes blood flow. The subscripts ‘tot’ and ‘m’ denote total and muscle components, respectively. aThe remainder of the baseline V̇O2p (and 
Q̇tot) comes from (and goes to) the body compartment; τ time constant.
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Table 13: Model output values for ramp incremental exercise simulations 
 Ramp model Mean response time (s) 
 
Parameter -10% Parameter +10% 
   Mean experimentally 
derived input value: 28.03 28.03 
   CaO2 28.03  
Venus volumes, litres 
Muscle 28.00 28.06 
Body 28.03 28.03 
Mixed 29.90 28.17 
Baseline (unloaded pedaling) values 
V̇O2A 28.28 27.76 
Fraction from musclea 28.09 27.97 
Q̇tot 27.71 28.30 
Fraction to musclea 27.94 28.10 
Exercise V̇O2 and Q̇ parameters 
ΔV̇O2m /ΔWR 28.23 27.85 
V̇O2-Q̇ slope 28.44 27.62 
Muscle V̇O2 and blood flow kinetics 
Q̇m τ 25.34 30.71 
V̇O2m τ 28.05 28.00 
Table parameters defined above 
Previous studies (Murgatroyd et al., 2011; Bowen et al., 2012) that have 
looked at the reproducibility of V̇O2 kinetics have produced 95% confidence 
intervals, and SD of 3.1 ± 0.9 s respectively in healthy individuals 
(Murgatroyd et al., 2011) and 5.0± 2.0 s respectively in heart failure patients 
(Bowen et al., 2012). Therefore, any changes greater than 3.0 s were taken 
as significant, as these changes are likely to be detectable, and 
reproducible, in a laboratory.  For muscle oxygenation indexes minimum, 
maximum, and the change in TOI were looked at, as well as the presence of 
any undershoots/overshoots in step protocol, and the breakpoint in HHbMb 
during the ramp protocol.  
Arterial O2 content 
Changing arterial O2 content did not have any significant effect on V̇O2 
kinetics during both step and ramp exercise. Furthermore, as CaO2 is 
relatively unchanged during exercise (Grassi et al., 1996) changing this 
parameter does not affect the kinetics of V̇O2p. The TOI profile during step 
101 
 
and ramp exercise was not altered with a 10% increase or decrease in CaO2 
however, the absolute TOI (i.e. the oxygenation level of the tissue) was 
shifted downwards (Figure 28) in both ramp and step exercise protocol.   
 
 
Figure 28: Top panel shows TOI response during a step exercise simulation 
with model mean (experimentally derived) values (left) and model mean 
values with a 10% reduction in arterial O2 content (right). TOI is shifted 
downwards by ~7%. Bottom panels show the same effect, for ramp exercise. 
 
In this scenario (i.e. where Q̇ is not limiting) a 7% reduction in muscle 
oxygenation availability does not cause a significant change in V̇O2 kinetics, 
and therefore would be unlikely to affect exercise tolerance. However, this 
may become a limiting factor in a heart failure patient with anaemia (Coats, 
2004).  
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Venous Volumes 
Increasing and/or decreasing the venous volume by 10% had no significant 
effect on V̇O2 kinetics, or the TOI profile, in both step and ramp exercise 
protocols. It has previously been shown that venous volume size influences 
limb-to-lung transit delay, which can alter the V̇O2 signal measured by breath 
by breath gas exchange however, it is likely that only a 10% change is too 
small to induce any detectable and/or physiologically significant changes in 
V̇O2 kinetics.  
Unloaded pedalling (baseline) parameters  
Baseline V̇O2: For step exercise, no significant changes in phase II V̇O2p 
kinetics were observed with a 10% increase or decrease in baseline V̇O2, 
although for ramp exercise there was a small change in phase I amplitude 
(3.5% increase) when V̇O2 baseline was increased by 10%, resulting in a 
0.5s speeding of the V̇O2 mean response time. 
Baseline cardiac output: When cardiac output was increased for step 
exercise (i.e. a higher baseline blood flow) this slowed phase II V̇O2p 
kinetics, and when it was decreased (i.e. a lower baseline blood flow), this 
reduced (i.e. made faster) phase II V̇O2p kinetics. Previous modelling studies 
have shown that increasing baseline cardiac output at unloaded pedalling 
reduces the reduction seen in venous O2 concentration and increases the 
steady state oxygenation level (i.e. a smaller reduction in oxygen extraction). 
Despite this it is accompanied by slightly slower phase II V̇O2p kinetics. This 
raises the possibility that solely raising the muscle perfusion during unloaded 
pedalling would result in phase II V̇O2p kinetics that were slowed to a small 
degree (Benson et al., 2013). Although this difference is small (less than half 
a second), somewhere along the O2 transport system, the increased blood 
flow is then manifested as a slowed phase II V̇O2p. Although a 10% change 
from mean values were not large enough to elicit a undershoot in TOI, a 
higher steady state value was seen when baseline cardiac output was 
increased compared to when it was decreased (66.0 % vs 62.6% 
respectively).  
Muscle V̇O2 and blood flow kinetics: The greatest effect on the phase II 
𝜏V̇O2p was seen by changing the time constant of 𝜏 V̇O2 at the muscle for 
step exercise. Faster 𝜏 V̇O2m values were manifested as a faster phase II 
𝜏V̇O2p. When V̇O2m kinetics are faster than muscle blood flow, the fall in 
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muscle oxygenation is accelerated. This could be a result of the poor 
matching of oxygen delivery and oxygen consumption, necessitating a 
higher fractional oxygen extraction to sustain a given metabolic rate. In this 
situation, muscle blood flow lags V̇O2m so that the V̇O2/ Q̇ ratio is altered. 
This causes an O2 delivery/utilisation mismatch: consequently, TOI 
transiently undershoots its steady state value (Figure 29). This profile has 
been demonstrated experimentally in heart failure patients previously 
(Sperandio et al., 2009; Bowen et al., 2012). These findings are in 
agreement with experimental data, and highlight the importance of the 
resting conditions on O2 extraction dynamics, and how changes in the 
Q̇m/V̇O2m relationship can alter the dynamics of the V̇O2 response (Ferreira 
et al., 2005; Benson et al., 2013). 
 
Figure 29: Tissue oxygenation response when muscle V̇O2 kinetics are 
faster relative to blood flow (Q) kinetics. In this simulation, when V̇O2m 
kinetics are speeded and Q̇ kinetics unchanged, tissue oxygenation 
transiently undershoots its steady state value.  
Although the undershoot observed computationally is relatively small, it is 
important to note that the change in V̇O2 kinetics that elicited the undershoot 
was also very small i.e. from 26.6s to 23.9s, meaning the mismatch between 
V̇O2 and Q̇ was just 5.7s (i.e. Q̇𝜏 = 29.6 and V̇O2𝜏 = 23.9s). The larger the 
discrepancy between V̇O2 and Q̇ kinetics was, the larger the undershoot in 
TOI was.  
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V̇O2/Q̇ slope 
Changing the V̇O2/Q̇ slope by 10% had only a very small effect on phase II 
V̇O2p kinetics (i.e. less than a second) for both an increase and decrease in 
V̇O2/Q̇ slope for step exercise. When the V̇O2/Q̇ slope was increased (i.e. for 
a given V̇O2 blood flow is higher) the change in TOI was decreased (from 
7% change to 5.7% change). Decreasing the V̇O2-Q̇ slope (i.e. less blood 
flow per 1 L change in V̇O2) caused a greater reduction in TOI (from 7% 
change to 8.9% change). This is likely because more blood flow per litre 
change in V̇O2 means more O2 rich blood being delivered to the muscles, 
whereas a reduced blood flow per 1 L change in V̇O2 would mean less O2 
delivery to the muscles, and therefore a greater reliance on O2 extraction.  
ΔV̇O2/ΔWR (V̇O2 gain) 
The parameter that had the most significant influence on step model TOI 
response was the ΔV̇O2m /ΔWR. Although mean (experimentally derived) 
values plus 10% produced no significant effects on TOI response, when 
simulating mean values -10%, the TOI response was altered, from a 7% 
total reduction in TOI during step exercise (model mean values) to a 30% 
total reduction in TOI during the same protocol (Figure 30). Note that all 
other parameters were kept the same as mean experimentally derived 
values.  
 
Figure 30: Simulated model outputs for step exercise for mean 
experimentally derived parameters (left) and mean parameters with a 
reduced ΔV̇O2 /ΔWR (from 10 L/min/W to 9 L/min/W). When ΔV̇O2/ΔWR was 
lower, TOI amplitude was increased from a 7% absolute change to a 30% 
absolute change.  
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V̇O2 gain is typically 10 mL/min/W during cycle ergometer exercise but can 
vary in-between individuals 9-12 mL/min/W (Hansen et al., 1988; Riley et al., 
1996; Boone et al., 2008). The model suggests that a small change in gain 
(i.e. from 0.01 L/min/W to 0.09 L/min/W) during step exercise can have a 
significant effect on tissue oxygenation index, and therefore O2 availability at 
the tissue. This was accompanied with a 9% reduction in phase I amplitude 
and a 10 s decrease in the phase I duration, but only a very small change in 
phase II kinetics (i.e. from 20.7 s to 22.1 s). A smaller and shorter phase I 
response would indicate less O2 being delivered, and therefore a larger 
reliance on O2 extraction. Despite this, reducing total blood flow in the step 
model by 10% did not cause a large change in TOI from model mean 
parameters, however it is possible that a 10% decrease in total blood flow 
(i.e. 8.47 to 7.63 L/min) was not large enough to cause any changes.  
For the ramp exercise simulations, changing ΔV̇O2/ΔWR also influenced the 
location at which the breakpoint in HHbMb occurred. For example, a 10% 
reduction in ΔV̇O2m /ΔWR from its mean values resulted in the breakpoint 
occurring at ~60% of normalised HHbMb, at roughly 400 seconds into the 
ramp. Whereas, a 10% increase in ΔV̇O2/ΔWR resulted in a breakpoint 
occurring at ~40% of normalised HHbMb, roughly 360 seconds into the 
ramp. As mentioned earlier, the breakpoint in HHbMb is strongly correlated 
to peak V̇O2, such that a higher breakpoint is associated with a higher 
V̇O2,peak and thus a better exercise tolerance, and a lower breakpoint  
 
Figure 31: Model simulations for ramp exercise with a reduced gain (left) 
and increased gain (right). When gain is lower the breakpoint in the HHbMb 
response occurs later on in the ramp and at a higher HHbMb. Conversely 
when gain is increased the breakpoint occurs 40s (~400 vs. 360 s) sooner in 
the ramp and at a lower HHbMb.  
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Other inferences from the model 
Of the parameters which elicited a change in the muscle oxygenation 
response (ΔV̇O2/ΔWR, baseline Q̇, arterial O2 content and V̇O2m𝜏), the slope 
of the HHbMb response was looked at during the ramp exercise simulations; 
Table 14 shows HHbMb slopes for each parameter. Each HHbMb response 
was divided into two sections and fit with a linear regression to determine the 
slope of the response. The initial portion of the response (slope a) 
corresponds to the onset of exercise until the breakpoint in HHbMb. The 
latter portion of the response (slope b) corresponds to first breakpoint in 
HHbMb until end exercise. 
 
Table 14: HHbMb slopes 
 
Slope a Slope b 
Mean  0.15 0.21 
   CaO2 
  -10% 0.15 0.21 
Baseline Q̇ 
  -10% 0.13 0.22 
+10% 0.15 0.20 
ΔV̇O2/ΔWR 
  -10% 0.15 0.22 
+10% 0.13 0.22 
V̇O2m 𝝉 
  -10% 0.14 0.21 
+10% 0.15 0.21 
There were no large changes in the slope of the HHbMb response of any of 
the parameters. Altering arterial O2 content shifted the absolute amount of 
tissue oxygenation downwards during step and ramp exercise simulations, 
but seemingly does not affect the slope of the response. Decreasing 
baseline cardiac output (baseline Q̇) resulted in a lower steady state TOI 
during step exercise. However, this was associated with only a 0.02 % 
decrease in the HHbMb slope. Decreasing ΔV̇O2/ΔWR by 10% caused a 
greater TOI amplitude during step exercise, however, only caused a 0.01% 
decrease in the HHbMb slope during the latter part of the ramp test. Finally, 
slightly speeding V̇O2m𝜏 (i.e. reducing mean values by 10%) caused an 
undershoot in TOI during step exercise however, only caused a 0.01% 
reduction the slope of the HHbMb response. It has been suggested that the 
107 
 
slope of the HHbMb response is related to the level of oxygen extraction in 
the exercising muscle (Barroco et al., 2017). In this regard, an undershoot in 
TOI during constant work rate exercise (representative of increased O2 
extraction at exercise onset due to V̇O2/Q̇ mismatch) would result in a 
corresponding increase in the HHbMb slope during incremental exercise. 
The NIRS model did not detect such changes. There are a few possible 
reasons for this i) due to the dynamic nature of ramp the body is more able 
to cope with small changes in these parameters and therefore, a 10% 
change is too small to detect changes in the HHbMb slope or ii) the NIRS 
model is not sensitive enough to detect these changes during ramp exercise. 
 
4.3.1  Model limitations, implications and confidence 
NIRS measurements can be influenced by several different factors including 
i) heterogeneity of blood flow and oxygen uptake, leading to non-uniform 
muscle oxygenation ii) capillary recruitment iii) adipose tissue thickness, and 
IV) relative contributions of haemoglobin and myoglobin to the NIRS signal.   
Heterogeneity of blood flow and muscle oxygenation 
As with the MCM Ramp incremental model (Chapter 3), it was assumed that 
the NIRS model contained a homogenous muscle compartment, such that, 
both blood flow and muscle V̇O2 were distributed uniformly throughout the 
muscle. However, the skeletal muscle is not a homogenous compartment. 
There is substantial heterogeneity in muscle blood flow (Laughlin and 
Armstrong, 1982; Piiper, 2000; Russell S. Richardson et al., 2001), and in 
muscle fibre types (with differing V̇O2/Q̇ ratios and different metabolic 
capacities (Crow and Kushmerick, 1982) distributed within bodily tissues, 
between exercising and non-exercising muscles (Ferreira, McDonough, et 
al., 2006), and within different locomotor muscles engaged in exercise 
(Armstrong and Laughlin, 1985; Piiper et al., 1985; McDonough et al., 2005; 
Koga et al., 2007, 2014; Laaksonen et al., 2010). It is therefore uncertain 
whether the NIRS model output provides an accurate assessment of the 
heterogenous blood flow and V̇O2 relationships within the muscle. The 
implications of this simplified approach to predicting NIRS responses is that 
the NIRS response will be different depending on the fibre type and 
distribution. Type I highly oxidative fibres have faster kinetics than type II 
fibres which are less oxidative thereby altering the oxygen extraction 
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response and in a muscle containing more type I fibres oxygen extraction 
will be higher (and faster) compared to a muscle type with a greater 
proportion of type II (less oxidative fibres). Therefore, in muscle with a more 
type I fibres the NIRS response may show a steeper HHbMb slope This 
simplification of the NIRS model may explain some of the discrepancies 
seen between model output and experimental data and may account for the 
models inability to detect subtleties in the NIRS response, such as the 
breakpoint and slope of the NIRS response. This may be even more 
important during ramp exercise where type II fibres are increasingly recruited 
as exercise intensity increases.  
Capillary recruitment 
During muscle contraction, intravascular volume increases by vasodilation, 
with recruitment of new microvascular vessels and/or increase of capillary 
surface area (Renkin et al., 1966; Baker and Davis, 1974). The model 
assumes that blood volume change occurs in the capillaries, and not in 
arterioles or venules which were kept constant. According to Poole and 
Mathieu-Costello (1989), capillaries contribute to >90% of the total blood 
volume in muscle and furthermore, they proposed that the storage of blood 
in veins would mainly occur externally to the muscle. As such, the vascular 
component of the NIRS signal would predominantly come from the 
capillaries, and so NIRS oxygenation changes are likely to mainly reflect 
changes in capillary and intracellular O2 levels. The model also assumes 
that any change in capillary blood flow is proportional to a change in cardiac 
output, however, as discussed above, blood flow to the exercising muscle is 
not homogenous and therefore, the model may not be an accurate 
representation of changes in oxygenation within different regions and across 
different muscles.  
Adipose tissue thickness 
NIR light must travel through the skin and subcutaneous fat layers to reach 
the underlying skeletal muscle, acting to “contaminate” the signal of interest 
(i.e. the signal coming from the skeletal muscle).  While algorithms have 
been developed for adipose tissue correction (Niwayama et al., 2000; 
Geraskin et al., 2007) these are not included in most commercial 
instruments (Ferrari et al., 2011). The NIRS model presented in this chapter 
is a simplified version of a NIRS device in that, it does not account for the 
effects of light scattering or absorption due to adipose tissue thickness. As 
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such, the NIRS model might not reliably replicate NIRS signals in 
populations with high adipose tissue thickness. One of the advantages of 
this, however, is it may potentially be able to provide important information of 
local muscle oxygenation, in patients who are excluded from NIRS studies 
due to obesity.  
Relative contributions of Hb and Mb to the NIRS signal 
Data examining the contribution of haemoglobin and myoglobin to the NIRS 
signal is conflicting. Some studies have reported that the contribution of 
myoglobin to the NIRS signal is minimal, around 10% with the remaining 
90% coming from haemoglobin (Seiyama et al., 1988; Mancini et al., 1994). 
Mancini et al. (1994) found using magnetic resonance spectroscopy that 
during submaximal exercise there was no desaturation of Mb, despite an 
increase NIRS desaturation. In addition, Seiyama et al. (1988) found the 
contribution of Myoglobin to the NIRS signal in hindlimb rats to be less than 
10%. However, as suggested by Davis and Barstow (2013), the type of 
muscle used in the study (rat white vastus hindlimb) contains only a small 
amount of myoglobin, therefore, this muscle may not be representative of 
NIRS myoglobin contribution in the human vastus muscle (Davis and 
Barstow, 2013). Other studies have shown myoglobin contribution to the 
NIRS signal to be much more significant (Tran et al., 1999; Richardson et 
al., 2001; Spires et al., 2011). Recently, Davis and Barstow (2013) 
determined the contribution of myoglobin to be greater than ≥50% in human 
muscles. In the model, one of the assumptions affecting the contribution of 
myoglobin to the NIRS signal is that myoglobin in the intercellular space is 
4.08g per litre of intracellular space (Duteil et al., 2005). This study utilised 
nuclear magnetic resonance imaging and was carried out in the human calf 
muscles of endurance trained and sprint trained athletes; a key finding from 
this study was that myoglobin concentration was increased in the endurance 
trained athletes (i.e. those with high oxidative capacity). With this in mind, 
the NIRS model may not be an accurate representation of NIRS signals in 
other muscles (i.e. that contain different fibre types and quantities), and also 
across untrained or diseased populations. Another assumption of the NIRS 
model is that intracellular partial pressure of oxygen remains constant 
throughout the exercise protocol and is ~17.3mmHg lower than the capillary 
partial pressure of O2. This assumption is based on a study by Hirai et al. 
(2018), which is the only study to date to measure partial pressure of oxygen 
across the interstitial space in the skeletal muscle microcirculation during 
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exercise contractions. This was achieved by utilising phosphorescence 
quenching in exposed male rat spinotrapezius muscle. As such, it is 
uncertain whether these assumptions hold true in human muscles.    
Other factors 
The NIRS HHbMb signal is normalised from baseline to peak exercise (0-
100%). Whilst baseline and peak HHbMb values were taken as 30s 
unloaded pedalling (baseline) and final HHbMb (peak) in order to retain the 
overall profile of the response (i.e. by taking the final HHbMb rather than the 
peak value throughout the ramp, the NIRS output will show any 
undershoot/overshoots relative to the final value) the slope of the response 
may be altered. This may partially explain why undershoots in the TOI 
response (in response to changing input parameter) were not associated 
with ‘reciprocal’ changes in the NIRS HHbMb response for ramp exercise. In 
addition, the NIRS model was only optimised against TOI data, so any 
inferences taken from the HHbMb data should be interpreted with caution.  
Model input parameters were derived from experimental data in healthy 
young individuals. Baseline cardiac output and cardiac output kinetics were 
measured by photoplethysmography, which utilises measures of finger blood 
pressure to estimate stroke volume, heart rate and cardiac output. While this 
method has been shown to correlate well with intra-arterial BP 
measurements (Gomides et al., 2010), it is less reliable during exercise 
transitions and higher exercise intensities (Waldron et al., 2017). During 
exercise testing in this current study, in some subjects at the onset of 
exercise or in the latter stages of ramp exercise calibration was lost. As 
such, absolute values were only used when derived during unloaded 
pedalling (i.e. low intensity steady state exercise), or to measure the change 
in cardiac output during moderate intensity exercise transitions. Additionally, 
data were discarded if calibration was lost during unloaded pedalling or the 
exercise transient. Cardiac output kinetics were determined using the same 
kinetic analysis technique as pulmonary V̇O2 data (see methods), however, 
determining V̇O2 kinetics from pulmonary V̇O2 data is done often, with 
vigorous procedures. This method of measuring cardiac output kinetics has 
not, however, gone through the same process. Given this, the cardiac output 
data (and V̇O2/Q̇ relationship data) inputted into the model may not be an 
accurate estimation of the actual cardiac output. Despite this, it is worth 
noting that the values obtained from this method lie within the ‘expected 
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normal’ range for healthy individuals (De Cort et al., 1991). Finally, V̇O2 
kinetics from step exercise were used as model inputs from ramp exercise. 
This may influence the model predictions as the V̇O2 response varies 
according to the exercise protocol so that kinetics measured from step 
exercise may not exactly match those measured from ramp exercise. 
4.4 Conclusion 
The model presented is the first, to our knowledge, to predict NIRS 
responses during ramp incremental and step exercise from knowledge of 
circulatory, respiratory, and oxygen uptake dynamic interactions. With 
respect to the muscle oxygenation dynamics, the model shows that 
alterations in the V̇O2/Q̇ relationship, including its kinetics, slope and 
absolute values, all affected the muscle oxygenation response. When V̇O2 
kinetics are faster relative to Q̇ kinetics TOI transiently undershoot its steady 
state value. Similarly, if baseline cardiac output becomes limiting to V̇O2, or 
there is a reduction in Q̇ per litre change in V̇O2, TOI will undershoot its 
steady state response. Additionally, the model suggests muscle oxygenation 
responses are also sensitive to changes in the ΔV̇O2m /ΔWR relationship. 
Specifically reducing this relationship caused a greater reliance on O2 
extraction.  The model, however, could not detect any changes in the slope 
of the HHbMb response during ramp exercise.  
The newly developed NIRS model, overall, was not able to accurately 
predict the muscle oxygenation response to ramp exercise. Despite no 
significant differences in the change in muscle oxygenation from the start to 
end of exercise, the model could not predict breakpoint in the data nor the 
slopes of the oxygenation responses. Therefore, further development and 
validation of the model is necessary before its clinical utility can be realised.  
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Chapter 5 Assessment of oxygen 
uptake kinetics measurements during 
ramp incremental exercise in heart failure 
patients 
 
5.1 Introduction 
The underlying principles of V̇O2 kinetics, and the V̇O2 response to exercise 
of different intensities, and of varying protocols (i.e. constant work rate [step] 
and incremental [ramp]) of have been described in Chapter 1. Briefly, the 
V̇O2 response to moderate intensity step exercise includes a three-phase 
response. Phase I reflects an increase in pulmonary blood flow, phase II 
represents an increase in V̇O2 at the exercising muscle and phase three 
indicates V̇O2 has reached a steady state. In heart failure, both phase I and 
phase II of the V̇O2 response may be impacted (Sietsema et al., 1986) 
indicating a failure to increase total blood flow (phase I), and muscle V̇O2 
(phase II). Accordingly, V̇O2 kinetics are impaired (slowed) in diseased 
states when compared with healthy individuals. This has been reported as 
early as 1927, when Meakins and Long, (1927) observed slower O2 kinetics 
in a patient with circulatory failure, compared with a healthy subject. Slower 
V̇O2 kinetics in heart failure are important to consider, as the demands of a 
given task in healthy versus heart failure patients do not differ, so for any 
given metabolic transition, the heart failure patient gains a higher O2 deficit. 
Given this, it is not surprising that V̇O2 kinetics are strongly correlated to 
exercise tolerance in heart failure (Sperandio et al., 2009), as well as highly 
predictive of morbidity and mortality (Schalcher et al., 2003). However, it 
remains unclear what underlying mechanisms are responsible for exercise 
intolerance in heart failure. Specifically, whether the underlying mechanisms 
for the reduction in exercise capacity and slowed V̇O2 kinetics is due to a 
limitation in convective O2 transport, and/or diffusive O2 transport is a topic 
of much debate. Resolving this issue may be useful  for the development of 
treatments and improved classification of these patients, allowing for more 
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appropriate treatment selection (Kemps et al., 2009). Moreover, as resting 
indices of cardiac function (Faggiano et al., 2001) and the level of perceived 
exercise tolerance (Wilson et al., 1995) poorly correlate with exercise 
capacity in heart failure patients, exercise testing with breath by breath gas 
exchange has become a pivotal tool in the evaluation and monitoring of HF 
patients. One of the limitations of breath-by-breath gas exchange 
measurements is that it represents a ‘whole body’ measurement and, as 
discussed by Poole et al. (2012), the scientific utility of breath by breath gas 
exchange measurements are dependent on rigorous demonstration that 
relate meaningfully to events occurring within the exercising muscle.  
A study by Sperandio et al. (2009) observed that during phase II of the V̇O2 
response, microvascular O2 flow was impaired in optimally treated HF 
patients compared to age matched controls at the onset of heavy intensity 
exercise. They observed a transient overshoot in the deoxygenated 
haemoglobin + myoglobin (qualitatively similar to the undershoot in capillary 
PO2) signal by near infrared spectroscopy, implying that estimated fractional 
O2 extraction increased above the steady state level because of impaired 
blood flow relative to V̇O2. This response is thought to be related to the 
transient lowering of capillary PO2 that appears large enough to reduce the 
diffusion gradient from capillary to mitochondria, causing impaired O2 flux 
and limiting the rate of increase in muscle V̇O2.  
Similar features have been observed in HF rats. Diederich et al. (2002), 
investigated the dynamics of PO2 in contracting skeletal muscle of rats with 
HF. In the control rats, at the onset of contractions PmO2 fell to a steady 
state value and there was no undershoot in PmO2 observed. Conversely, in 
rats with moderate Left Ventricular Systolic Dysfunction (LVSD), there was a 
more rapid fall in PmO2, which was associated with a transient undershoot 
below its steady state value. As PmO2 is representative of the relationship 
between Q̇m and V̇O2, these results are suggestive of a slowed 
microvascular blood flow response compared with that of V̇O2. Humans 
studies in support of this have demonstrated that the delay in V̇O2 kinetics at 
the onset of submaximal exercise in HF patients is correlated with a delay in 
cardiac output increase (Koike et al., 1994).  
Furthermore, Kemps et al. (2010) demonstrated that V̇O2 onset kinetics 
during exercise below LT, and recovery are prolonged in HF patients, and 
examined the physiological background of this delay in moderately impaired 
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HF patients by comparing the kinetics of cardiac output (Q̇) to V̇O2 (Kemps 
et al., 2010). They found there were no significant differences between the 
time constant of Q̇ to V̇O2 during exercise onset or recovery, indicating that 
O2 delivery was not in excess of metabolic demands in the HF patients. As 
studies with a similar approach in healthy individuals reported faster onset 
kinetics of Q̇ compared to V̇O2 (Lador et al., 2006), they postulated that the 
delayed O2 onset and recovery kinetics at submaximal exercise in 
moderately impaired HF patients are limited by an impairment in O2 delivery 
rather than O2 utilisation.  
Using a different approach Mezzani et al. (2013) found that light to moderate 
intensity aerobic exercise training in HF patients speeded pulmonary V̇O2 
kinetics and increased peak peripheral oxygen extraction, supporting the 
hypothesis that microcirculatory O2 delivery impairment is a key factor in 
determining exercise intolerance in HF patients.  
These data indicate that disturbances in cardio-circulatory (blood flow) 
responses  play a prominent role in limiting V̇O2p kinetics and tolerance to 
heavy intensity exercise. Nevertheless, it has been demonstrated that Q̇ 
kinetics adjust faster relative to V̇O2 kinetics, at least in health (Grassi et al., 
1996; MacDonald et al., 1998; Bangsbo et al., 2000). This is the first line of 
evidence that Q̇ is not limiting to V̇O2. Grassi et al. (1997) examined 
metabolic and cardiovascular adjustments in 82 heart transplant recipients 
(HTR), and the effects of different exercise protocols on metabolic and 
cardiovascular variables. They found that in heart transplant recipients a 
priming exercise bout, despite speeding O2 flow to the muscles, did not 
affect the V̇O2 on kinetics, implying that the slower V̇O2 on kinetics in heart 
transplant recipients  are attributable to peripheral factors (Grassi et al., 
1997). In addition, the V̇O2 recovery kinetics were slower in heart transplant 
recipients than in the control group, indicating a greater O2 deficit in heart 
transplant recipients and hence, a sluggish muscle V̇O2 adjustment.  
Grassi et al. (1998) was able to directly determine muscle O2 delivery and 
muscle V̇O2 kinetics by using isolated in situ dog gastrocnemius preparation. 
Despite eliminating any delay in O2 muscle delivery from rest to contraction 
(60-70% V̇O2,peak), there were no significant effect on V̇O2m kinetics, 
indicating that the V̇O2 on kinetics were not limited by O2 delivery to the 
muscle, but were presumably determined by the intracellular control of O2 
utilisation (Grassi et al., 1998).  
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In support of this hypothesis, Grassi et al. (1996) demonstrated in a unique 
study, via an adapted constant-infusion thermodilution technique (Andersen 
and Saltin, 1985), that at transition from light to moderate intensity exercise, 
the increase in the V̇O2 kinetics at the leg muscle was less marked when 
compared to the V̇O2 at the lungs. This finding indicates that the significant 
increase in O2 delivery to the leg muscle within this period, was largely offset 
by a reduction in O2 extraction, suggesting that V̇O2 at the leg muscle is not 
limited by bulk O2 delivery. These findings are important to consider because 
for those patients who are limited by O2 utilisation, interventions that are 
aimed to solely increase cardiac output (for example cardiac 
resynchronization therapy) may not be completely effective in patients with 
O2 utlilsation impairments.  
 
5.2 Assessment of oxygen uptake kinetics 
The assessment of oxygen uptake kinetics in healthy individuals is well 
established and has been described in detail in Chapter 1. Briefly, oxygen 
uptake kinetics are typically determined from breath-by-breath gas exchange 
measurements made during moderate intensity constant work-rate step 
exercise, where the phase II “fundamental phase” of the V̇O2p response is 
isolated and fit with an exponential function. However, this method of 
determining oxygen uptake kinetics has limitations when applied to 
determining oxygen uptake kinetics in heart failure patients. One such 
limitation is the poor accuracy of the exponential fit to the V̇O2 data, due to 
high signal to noise ratio. This is because a lower lactate threshold in heart 
failure patients results in a lower V̇O2 amplitude which, in turn, increases the 
signal-to-noise ratio thereby lessening the accuracy of the exponential fit to 
the V̇O2 data (Lamarra et al., 1987). Additionally, oscillations in oxygen 
uptake and CO2 production that are common in heart failure patients may 
worsen the accuracy of the exponential fit further (Francis et al., 1999). 
Furthermore, as phase I represents an increased blood flow, it is 
questionable whether sluggish cardiac function may prolong phase I, thereby 
confounding the accurate isolation of the fundamental phase. In Chapter 3, a 
sensitivity analysis of the MCMinc  model showed that a 10% reduction in 
total blood flow had the effect of prolonging phase I by 1.3 seconds, giving 
an indication that removing, up to, the first 20 seconds [as in health (Benson 
et al., 2017)] in order to isolate the fundamental phase may not always be 
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sufficient in heart failure patients, meaning the phase II response could be 
‘diluted’ by phase I. Although it is not known if this is enough to cause 
physiological alterations and is yet to be confirmed experimentally.  
Given the above limitations, some investigators have sought to characterise 
oxygen uptake kinetics by using the mean response time. There are several 
ways in which this can be done (Sietsema et al., 1986, 1994; Hepple et al., 
1999; Schalcher et al., 2003). One such way utilises an algebraic method 
where the cumulative sum of V̇O2, in excess of baseline (or resting) V̇O2 is 
subtracted from the theoretical V̇O2 requirement such that:  
t ∙ ∆V̇𝑂2 −  ΣV̇𝑂2 = oxygen deficit (58) 
where t is the test duration, ΔV̇O2 is the change in the steady state V̇O2, and 
ΣV̇O2 is the cumulative sum of V̇O2 in excess of baseline V̇O2. The mean 
response time is then calculated by dividing the oxygen deficit by the 
theoretical V̇O2 requirement such that:  
MRT = oxygen deficit / ΔV̇O2 (59) 
Whilst this method has been utilised in research settings (Sietsema et al., 
1994; Hepple et al., 1999; Schalcher et al., 2003; Bowen et al., 2012), due to 
the relatively complex nature of the data analysis process, it may not be 
easily applicable to clinical settings. In addition to this, constant work rate 
exercise bouts are not commonly used as standard care in clinic unlike ramp 
incremental tests. Furthermore, despite its inability to separate out total 
blood flow from changes in muscle oxygen uptake dynamics, it has been 
demonstrated to represent and even better predictor of mortality than 
V̇O2,peak in heart failure patients [Figure 32 (Schalcher et al., 2003)]. 
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Figure 32: Kaplan-Meier plots of cardiac survival (top,A), cardiac survival 
free of urgent transplantation (uTPL) [middle, B],and survival free of 
hospitalization (hosp) [bottom, C] for the following three categories of MRT: 
60s, 40 to 60 s, and 40 s. The table between top, A, and middle, B, denotes 
the number of patients in each category of MRT at baseline, and after 1, 2, 
3, and 4 years with respect to cardiac survival and cardiac survival free of 
urgent transplantation, respectively. The table below bottom, C, denotes the 
number of patients with respect to cardiac survival free of hospitalization. 
Taken from Schalcher et al. (2003).  
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The mean response time can also be obtained from ramp incremental 
exercise (which is often carried out as a part of standard care in clinical 
assessment of heart failure patients) and represents time taken for the V̇O2 
response to increase in a linear fashion. It is typically quantified as the time 
interval between the onset of the ramp exercise, and the intersection of the 
extrapolation of the baseline V̇O2 and the backwards extrapolation of the 
linear V̇O2/time relationship (Figure 33).  
 
 
Figure 33: A typical V̇O2 response to ramp incremental exercise of a 
representative normal subject. The mean response time (MRT) of the V̇O2 
response is calculated as the time from the onset of the ramp exercise to the 
point of the intersection of baseline V̇O2 and a linear back extrapolation of 
the V̇O2 vs time slope. Taken from Barstow et al. (2000).  
Until the development of the ramp protocol both a constant work rate step 
exercise test and a ramp test were required to obtain the four key 
parameters of exercise tolerance (i.e. V̇O2,max, lactate threshold, time 
constant for oxygen uptake kinetics and work efficiency). Whipp et al. 
(1981), showed that the ramp incremental test could be used as an 
alternative to two tests to accurately determine these parameters, based on 
the principle that V̇O2 operates with first-order linear dynamics. However, 
similar to constant work rate exercise, the mean response time derived from 
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ramp incremental exercise incorporates both phase I and phase II of the V̇O2 
response. Therefore, it is not clear if the MRT is a true representation of 
muscle oxygen uptake kinetics, especially in heart failure patients where 
impairments in the O2 transport system can derange these parameters. 
Therefore, the aims of this chapter were (i) to establish if pulmonary V̇O2 
kinetics measured during step exercise are an accurate reflection of muscle 
oxygen uptake kinetics in heart failure patients (i.e. V̇O2p𝜏 vs V̇O2m𝜏) and; (ii) 
if the mean response time measured from ramp incremental exercise is 
equal to muscle V̇O2 kinetics determined from step exercise in heart failure 
patients (i.e. V̇O2p,MRT vs V̇O2m𝜏). 
5.3 Methods 
Experimental data collection, measurements, exercise protocol and data 
analysis are described in the general methods section under sub-heading 
“Protocol 2” for healthy participants, and “Protocol 4” for heart failure 
patients. 
Model simulations 
The MCMinc and MCM step models were utilised and individualised on a 
patient-by-patient basis. Model input parameters (baseline V̇O2, V̇O2 gain, 
cardiac output kinetic, oxygen uptake kinetics and baseline cardiac output) 
were determined experimentally from ramp and step exercise tests. For 
each participant/patient, and each protocol (i.e step or ramp) muscle oxygen 
uptake kinetics were adjusted in the model until the model V̇O2p phase II 
output (for step exercise) or V̇O2p mean response time (for ramp exercise) 
matched the experimentally derived V̇O2 kinetics in a given individual, 
thereby providing model predicted (“muscle”) muscle V̇O2 kinetic and 
experimentally measured (“lung”) muscle V̇O2 kinetics. 
Previous studies (Murgatroyd et al., 2011; Bowen et al., 2012) that have 
examined the reproducibility of V̇O2 kinetics have produced 95% confidence 
intervals, and SD of 3.1 ± 0.9 s in healthy individuals (Murgatroyd et al., 
2011) and 5.0 ± 2.0 s in heart failure patients (Bowen et al., 2012). 
Therefore, any changes greater than 3.0 s for healthy participants and 5 
seconds for heart failure patients were taken to be physiologically significant, 
as these changes are likely to be detectable, and reproducible, in a 
laboratory. 
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Statistical analysis 
Model predicted, and experimentally measured, oxygen uptake kinetics were 
compared using paired t-tests. Significance was accepted as p < 0.05.  
 
5.4 Results and discussion 
Results are presented as mean ± standard deviation unless otherwise 
stated. Heart failure patients achieved a V̇O2,peak of 1.16 ± 0.46 L/min, which 
corresponded to a peak work rate of 81 ± 31 W. This was lower than healthy 
patients who achieved a V̇O2 peak of 3.57 ± 1.02 L/min and peak work rate 
of 290 ± 79 W. V̇O2 gain was lower in heart failure patients than healthy 
individuals (0.009 L/min/W vs 0.012 L/min/W respectively).  
Figure 34 shows V̇O2 responses to step and ramp incremental exercise in a 
representative HF patient and healthy individual. Oxygen uptake kinetics 
were significantly slower in heart failure patients than controls (step (V̇O2𝜏): 
24.0 s ± 7.2 s vs 50.4 s ± 17.8 s, p = 0.006 respectively; ramp (V̇O2,MRT): 
45.5 s ± 8.8 s vs 81.3 s ± 27.0 s, p = 0.01 respectively).  
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Figure 34: Oxygen uptake responses (V̇O2 L/min) plotted as a function of 
time during ramp incremental exercise (top panels) and constant work rate 
step exercise (bottom panels) in a representative heart failure patient (left 
panels) and healthy participant (right panels).  
Individual model input parameters are shown below in Table 15 (healthy 
participants) and Table 16 (heart failure patients). Model output parameters 
and experimentally derived muscle and pulmonary oxygen uptake kinetics 
are shown in tables 17-20. Figure 35 shows a summary of these findings.
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Table 15: Individual model input parameters from ramp and step exercise heart failure patient 
Subject 
V̇O2 baseline 
(L/min)  
Q̇ baseline 
(L/min) 
V̇O2p τ  
(s)  
Qτ 
(s) 
 Gain 
 (L/min/W) 
V̇O2 MRT 
 (ramp) 
ramp WR 
(W/min) 
ramp duration 
(s) 
1 0.24 3.52 47.7 54.0 0.007 48.00 4.00 579.00 
2 0.31 4.43 27.9 19.0 0.007 75.00 12.00 737.00 
3 0.29 4.14 83.9 113.0 0.010 144.00 5.00 437.00 
4 0.29 4.15 42.9 43.0 0.011 94.00 8.00 424.00 
5 0.24 3.47 57.2 46.0 0.010 67.00 4.00 829.00 
6 0.32 4.62 64.9 59.0 0.089 67.00 5.00 927.00 
7 0.38 5.45 26.1 55.0 0.013 86.00 5.00 609.00 
8 0.40 5.83 52.5 42.0 0.011 69.00 14.00 449.00 
Mean 0.31 4.45 50.39 54.00 0.009 81.25 7.13 623.88 
SD 0.06 0.84 19.06 26.88 0.002 28.84 3.87 190.66 
V̇O2 baseline was taken as final 60s UP during ramp test; Q̇ baseline = V̇O2 baseline x 14.5 (see methods); V̇O2p τ was measured from step exercise; Q̇τ was assumed from HR kinetics 
measured from step exercise, Gain was measured from ramp exercise; V̇O2 MRT was measured from ramp exercise. For more detail on data analysis see general methods 
section. 
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Table 16: Individual model input parameters from ramp and step exercise in healthy participants 
Subject 
V̇O2 baseline 
(L/min)  
Q̇ baseline 
(L/min) 
V̇O2p τ  
(s) 
Qτ 
(s) 
Gain 
(L/min/W) 
V̇O2 MRT 
 (ramp) 
Ramp rate 
(W/min) 
Ramp duration 
(s) 
1 1.05 6.19 26.25 22.20 0.013 39.00 33.00 732.00 
2 0.69 6.17 21.03 24.00 0.013 35.00 15.00 657.00 
3 0.78 8.70 19.97 11.32 0.012 43.00 20.00 718.00 
4 0.91 7.80 18.96 24.91 0.013 45.00 20.00 755.00 
5 1.11 11.55 20.08 41.77 0.012 60.00 30.00 636.00 
6 1.44 9.59 20.62 35.36 0.013 47.00 25.00 783.00 
7 0.70 8.40 17.82 14.95 0.013 31.00 25.00 552.00 
8 1.04 9.48 40.84 68.03 0.014 52.00 25.00 796.00 
9 0.95 8.55 30.63 29.01 0.011 54.00 15.00 608.00 
Mean 0.96 8.49 24.02 30.17 0.013 45.11 23.11 11.55 
SD 0.23 1.69 7.48 17.00 0.001 9.32 6.19 1.40 
V̇O2 baseline was taken as final 60s UP during ramp test; Q̇ baseline was measured experimentally during moderate intensity step exercise; V̇O2p τ was measured from step exercise; 
Q̇τ was measured from moderate intensity step exercise, Gain was measured from ramp exercise; V̇O2 MRT was measured from ramp exercise. For more detail on data analysis 
see general methods section. 
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Ramp exercise 
The experimentally measured pulmonary V̇O2 mean response time was 
significantly different from the predicted muscle V̇O2 kinetics in heart failure 
and health during ramp exercise (p = 0.0001; p = 0.002 respectively). It is 
worth noting that, although significantly different, the average MRT for the 
model predicted and mean experimentally derived values for healthy 
individuals, was only 1 second different (44s vs 45s, respectively). This one 
second difference is unlikely to be detectable when V̇O2 kinetics are 
measured experimentally in a laboratory (Murgatroyd et al., 2011). For HF 
patients, experimentally measured MRT was 9 seconds longer than model 
predicted V̇O2m. There was no correlation between MRT duration and 
baseline V̇O2 in healthy (r2 = -0.1; p >0.05) or in heart failure (r2 = 0.1; p > 
0.05), nor was there any correlation between mean response time and 
baseline V̇O2 in either the healthy or heart failure (r2 = -0.1; p >0.05; r2 = 0.5; 
p >0.05 respectively). 
 
Table 17: model predicted muscle V̇O2 kinetics and experimentally 
measured mean response time (MRT) in 8 heart failure patients for ramp 
exercise 
Subject MRT (s) experimental V̇O2mτ (s) model predicted 
1 48 33 
2 75 70 
3 133 122 
4 94 84 
5 67 57 
6 67 60 
7 86 76 
8 69 64 
Mean 80 71 
SD 25 26 
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Table 18: model predicted muscle V̇O2 kinetics and experimentally 
measured mean response time (MRT) in 9 healthy individuals for ramp 
exercise 
Subject MRT (s) experimental V̇O2mτ (s) model predicted 
1 39 39 
2 33 35 
3 42 43 
4 44 45 
5 59 60 
6 47 47 
7 30 31 
8 51 52 
9 52 54 
Mean 44 45 
SD 9 9 
Step exercise 
The experimentally measured muscle V̇O2 kinetics (i.e. phase II V̇O2p) and 
model predicted muscle V̇O2 kinetics from step exercise was significantly 
different in heart failure patients and in health (p = 0.001; p = 0.2 
respectively). Despite this statistically significant difference, the average 
difference between model predictions and experimental data was only 3 
seconds different in health (24s vs 27s) which as described above is unlikely 
to be physiologically detectable (Murgatroyd et al., 2011). In heart failure 
patients there was a 6 second difference between the two parameters (51s 
for experimental vs 57s for model predicted). which would be detectable in 
an exercise test (Bowen et al., 2012).  
Table 19: Model predicted muscle V̇O2 kinetics and experimentally 
measured pulmonary V̇O2 kinetics in 8 heart failure patients for step exercise 
Subject V̇O2pτ (s) experimental V̇O2mτ (s) model predicted 
1 48 55 
2 28 29 
3 84 95 
4 43 50 
5 57 62 
6 65 71 
7 26 36 
8 53 55 
Mean 51 57 
SD 19 21 
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Table 20: Model predicted muscle V̇O2 kinetics and experimentally 
measured pulmonary V̇O2 kinetics in 9 healthy individuals for step exercise 
Subject V̇O2pτ (s) experimental V̇O2mτ (s) model predicted 
1 26 26 
2 21 25 
3 20 18 
4 19 24 
5 20 26 
6 21 27 
7 18 19 
8 41 49 
9 31 32 
Mean 24 27 
SD 8 9 
Furthermore, despite some significant differences there were good 
correlations between experimentally measured V̇O2p MRT and model 
predicted V̇O2mτ in heart failure patients and healthy individuals (r2 = 0.98 
and 0.99 respectively)  and also between experimentally measured V̇O2pτ 
and model predicted V̇O2mτ (r2 = 0.97 and 0.88 respectively) in both heart 
failure patients and healthy individuals (Figure 36) suggesting that for the 
ramp protocol V̇O2p measured experimentally is similar to V̇O2m kinetics 
predicted by the model and that for step exercise V̇O2p kinetics measured 
experimentally are representative of V̇O2m kinetics predicted by the model.  
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Figure 35: Top panel: Mean response determined by breath-by-breath gas 
exchange measurements (“lung”) and model predictions (“muscle”) in heart 
failure patients (left) and healthy participants (right) during ramp incremental 
exercise. Bottom panel: Muscle oxygen uptake kinetics determined from 
breath-by-breath gas exchange measurements (“lung”) and model 
predictions (“muscle”) during constant work rate step exercise. In all 
conditions (i.e. step vs ramp, heart failure vs healthy) the oxygen uptake 
kinetics measured at the lung were significantly different from the predicted 
oxygen uptake at the muscle.  
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Figure 36: Top panel: correlations between experimentally measured V̇O2p 
MRT and model predicted V̇O2m𝛕 in heart failure patients (left) and healthy 
individuals (right). Bottom panel: correlations between experimentally 
measured V̇O2p𝛕 and model predicted V̇O2m𝛕.  
Mean response time: step vs ramp exercise  
Experimentally derived mean response time values determined from ramp 
incremental exercise and constant work rate step exercise are shown in 
Table 21. Mean response time was on average, 19 seconds longer when 
determined from ramp incremental exercise when compared to step 
exercise. However, the individual difference varied between patients. In 3/8 
patients MRT was slower when determined from ramp exercise whereas in 
the remaining 5 patients MRT was slower when determined from ramp 
exercise than step exercise.  
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Table 21: Experimentally derived mean response time (MRT) from ramp 
incremental and step exercise in heart failure patients 
Subject MRT (s) (Ramp) MRT (s) (Step) Difference (s) 
1 48 72 -24 
2 75 35 40 
3 144 100 44 
4 94 40 54 
5 67 72 -5 
6 67 75 -8 
7 86 44 42 
8 69 60 9 
Mean 81 62 19 
SD 27 21 7 
 
The experimental data and model simulations show good correlations 
between experimentally measured V̇O2p MRT and model predicted V̇O2mτ, 
and experimentally measured V̇O2pτ and model predicted V̇O2mτ in both 
heart failure patients and healthy individuals suggesting that pulmonary V̇O2 
kinetics measured during step exercise are an accurate reflection of muscle 
oxygen uptake kinetics in heart failure patients (i.e. V̇O2p𝜏 vs V̇O2m𝜏). 
However, when comparing methods of measuring MRT, when measured 
from ramp exercise, mean response time was on average 19 seconds faster 
when measured from step exercise suggesting that the mean response 
determined by different methods and from different protocols are not equal.  
 
In healthy individuals only a 1 second difference was found between 
experimentally measured MRT and predicted muscle V̇O2 kinetics whereas 
an average of a 9 second difference was observed in the heart failure group. 
Given that MRT is a summation of phase I and phase II of the V̇O2 
response, and phase I typically lasts ~15-20 seconds, it might be expected 
that MRT would be longer V̇O2p𝜏 in healthy individuals. One possible 
explanation for this could be because of the sensitivity of the mean response 
time to the paraments quantifying the V̇O2 response to exercise. For 
example, Boone et al. (2008) showed that MRT was influenced by the 
baseline that the ramp exercise was initiated from as well as the steepness 
of the ramp protocol. A lower baseline V̇O2 was associated with shorter MRT 
as were steeper ramp slopes. Because of this, it is recommended that 
baseline work rate should be 50 W or above however, this may not be 
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feasible in heart failure patients due to low exercise tolerance. For example, 
mean peak work rate during ramp exercise in this study was 81 W however, 
the lowest peak work rate achieved was 46 W. Additionally, starting the 
ramp exercise from a higher baseline may limit the number of data points 
obtained in a low-moderate intensity work rate. In this study, lower baselines 
were observed in the HF patients, as was steeper ramp slopes in health. 
Despite this there was no strong correlation between MRT and slope 
steepness or baseline V̇O2 in either group suggesting that MRT was not 
affected by these variables. 
A consistent finding was that oxygen uptake kinetics were significantly 
slower in heart failure patients than healthy individuals, regardless of the 
exercise protocol used, or the method of determining its kinetics. As oxygen 
uptake kinetics depend on the rate of tissue oxygenation (O2 delivery), and 
the ability to utilise O2, derangements of O2 delivery and/or O2 utilisation may 
be responsible for the prolongation of O2 kinetics in HF (Kemps et al., 2010). 
These derangements in O2 delivery and/or O2 utilisation are still not 
completely understood and furthermore, it is unclear which of the 
impairments (i.e. O2 delivery or O2 utilisation, or both) are the primary cause 
of exercise intolerance in heart failure.  
It is possible that the primary limiting factor (i.e O2 delivery or O2 utilisation) 
could vary between individuals. For example, Bowen et al. (2012) looked at 
V̇O2 kinetics and muscle oxygenation dynamics in heart failure patients 
before and after priming (i.e. to increase cardiac output) exercise. They 
found that the dynamics of microvascular O2 delivery-to-utilisation 
relationship in the skeletal muscles of HF patients to be impaired (this was 
manifested as an overshoot in muscle deoxygenation at exercise onset). 
However, they also observed that, although resting muscle oxygenation was 
increased and V̇O2 kinetics were speeded following priming exercise in all 
patients, in the patients with the slowest V̇O2 kinetics (and lower resting 
muscle oxygenation and worse symptoms), V̇O2 kinetics remained slow (>40 
s), and the rate of muscle deoxygenation actually declined after priming 
exercise. This suggests that the patients with slower V̇O2 kinetics were less 
able to ‘make use’ of the increase in oxygen delivery. This finding indicates 
that the patients in with slower V̇O2 kinetics (and more severe symptoms), 
may have been limited by some intracellular pathology, and the patients with 
less severe HF were able to gain more benefit from the increased Q̇m and 
therefore are not limited by O2 utilisation (Bowen et al., 2012).  
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Given that the severity of heart failure and prolongation of oxygen uptake 
kinetics at the skeletal muscle may be related to the locus of impairments in 
the O2 transport system (Bowen et al., 2012), it is of the upmost importance 
that determining V̇O2 kinetics at the skeletal muscle are done accurately, 
with care and precision. Although a ramp incremental test is more widely 
used in clinics, the results from this current study suggest that the pulmonary 
oxygen uptake kinetics gained from ramp incremental exercise cannot be 
reliably used to determine muscle oxygen uptake kinetics in heart failure 
patients alone as, according to the modelling predictions, they vary 
considerably depending on the chosen method of data collection and data 
analysis. Other non-invasive methods that can be applied more specifically 
at a skeletal muscle level (such as near infrared spectroscopy) may aid 
measurements in this context.  
It is also important to consider that, although the model has been validated 
against experimental V̇O2 data, it was not validated against ramp V̇O2 MRT 
(as these data were not available) and, therefore, it is not a given that the 
model is more accurate than the experimental data when comparing the two. 
Furthermore, there are limitations that should be considered with the model. 
One such limitation is that the venous volumes in the model remain constant 
between individuals and different exercise protocols/intensities, and are 
based on measurements made in healthy, amateur cyclists. This may affect 
model V̇O2 predictions as altering venous capacitances affects the amplitude 
and duration of phase I (i.e. the time delay) of the V̇O2 response. The 
influence of this time delay is that on reaching the lung, the muscular venous 
effluent incorporated into CVO2 is associated with a higher blood flow value 
than that which contributed to its determination (i.e. the instantaneous 
pulmonary blood flow is raised by a proportion related to the intervening 
transit time). Sluggish circulatory dynamics (e.g. in heart failure patients) 
may affect the venous volume during exercise and the exercise transient.to 
an even larger extent than in healthy individuals This may alter the time 
delay of the V̇O2 response and therefore subsequent kinetic coupling 
(Benson et al., 2013). Therefore, it is not known if these values are relevant 
in the heart failure population. 
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5.5  Conclusion 
In conclusion, the data and model simulations presented in this chapter 
show that, according to the model predictions, muscle oxygen uptake 
kinetics are strongly correlated to pulmonary oxygen uptake measurements 
in heart failure patients. However, the mean response time may differ within 
the same patient depending on the exercise protocol and method of data 
analysis used such that, the mean response time determined from step 
exercise is not equal to the mean response in the same patient when 
determined from ramp incremental exercise. Therefore, for ramp incremental 
exercise to be used to its full clinical utility, additional measurements may be 
needed alongside breath-by-breath measurements to identify patients in 
whom skeletal muscle dysfunction is a limiting factor in exercise tolerance.  
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Chapter 6 Characterising muscle 
oxygenation dynamics measured by near 
infrared spectroscopy in heart failure 
 
 
6.1 Non-invasive estimation of the matching of muscle O2 
delivery to O2 utilisation 
Direct measurement of the V̇O2m/Q̇m dynamics in humans is technically and 
practically challenging. As such, skeletal muscle O2 uptake (V̇O2m) is often 
estimated from measurements of pulmonary O2 uptake (V̇O2p) during 
cardiopulmonary exercise testing. However, it is known that pulmonary V̇O2 
kinetics dissociates from muscle V̇O2 kinetics during the exercise transient, 
partly due to intervening circulatory dynamics (Barstow et al., 1990; Lai et 
al., 2006; Benson et al., 2013). In addition, skeletal muscle blood flow has 
been estimated from measurements of cardiac output; however, these are 
complicated by variability of blood flow redistribution and vasodilatory 
capacity (Musch et al., 2004; Harper et al., 2008; Sperandio et al., 2012). 
Investigating muscle oxygenation dynamics provides an alternative 
approach to investigating V̇O2m-Q̇m dynamics. For example, modelling 
studies have shown that reducing V̇O2m relative to Q̇m slows and reduces the 
extent of the decrease in muscle oxygenation during exercise transients 
(Barstow et al., 1990) whereas reducing Q̇m relative to V̇O2m accelerates and 
increases transient decrease in muscle oxygenation. Moreover, a lower pre-
exercise Q̇m amplifies the latter response (Benson et al., 2013).  
Muscle oxygenation dynamics can be measured non-invasively in humans 
using NIRS. The principles of NIRS are discussed in detail in Chapter 1. 
Briefly, NIRS allows non-invasive and continuous measurement of local 
muscle oxidative metabolism at rest and during exercise, based on the 
principle that the NIR light absorption characteristics of haemoglobin (Hb) 
and myoglobin (Mb) depend on their oxygen saturation (Grassi et al., 2003). 
Of the NIRS derived parameters, relative changes in deoxygenated 
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haemoglobin and myoglobin (HHbMb) can be considered a proxy for the 
arterio-venous O2 difference (i.e. proportional to CaO2 – CvO2), and thus 
microvascular O2 extraction (DeLorey et al., 2003; Grassi et al., 2003).  
The use of NIRS in heart failure studies have predominantly been 
investigated during constant work rate exercise (DeLorey et al., 2003; Grassi 
et al., 2003; Sperandio et al., 2009; Bowen et al., 2012). A key finding from 
studying NIRS during constant work rate exercise is the presence of a 
transient overshoot in deoxygenated Hb and Mb (HHbMb), or a reciprocal 
undershoot in the tissue oxygenation index (TOI) signal by NIRS, implying 
that estimated fractional O2 extraction increases above the steady state level 
because of impaired O2 delivery relative to O2 requirements at the onset of 
exercise (Sperandio et al., 2009; Bowen et al., 2012).  However, during daily 
life humans hardly experience prolonged periods of metabolic steady state 
(Boone et al., 2016). As such, studying dynamics of V̇O2m-Q̇m during the 
non-steady state is highly relevant to understanding key aspects of 
metabolic and vascular control. The typical NIRS deoxygenated 
haemoglobin and myoglobin response to ramp exercise in healthy humans 
has been described in Chapter 1. In the context of this chapter, there is 
some uncertainty as to the most accurate and useful method of 
characterising and quantifying the HHbMb response profile. A linear 
relationship between Q̇m and V̇O2m would result in a hyperbolic oxygen 
extraction profile (Whipp et al., 1982; Ferreira et al., 2006).  However, so far 
the NIRS HHbMb response to incremental exercise has been best 
characterised with a sigmoidal function (Ferreira et al., 2007; Boone et al., 
2009, 2012; DiMenna et al., 2010; Chin et al., 2011) or more recently, a 
double linear function (Spencer et al., 2012). Figure 37 shows a schematic 
representation of both the sigmoid and double linear functions.  
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Figure 37: A schematic representation of a sigmoidal fit (left) and a double-
linear fit (right), the blue arrows indicate key parameters that each function 
generates. Data redrawn from (Ferreira et al., 2007).  
 
A sigmoidal response suggests that the dynamics of V̇O2m and Q̇m are not 
linear during ramp exercise but are exercise intensity dependent such that, 
at lower exercise intensities Q̇m kinetics are faster relative to V̇O2m kinetics, 
but as exercise intensity increases, Q̇m kinetics get progressively slower, 
until V̇O2m and Q̇m kinetics become well matched (Ferreira et al., 2007). 
Ferreira et al. (2007) demonstrated this by modelling the V̇O2m/Q̇m 
relationship from knowledge of deoxygenated haemoglobin and myoglobin 
response in a healthy subject (Figure 38). The linear portions of the 
V̇O2m/Q̇m relationship correspond to the flat areas of the arterio-venous O2 
content difference ([a-v]O2), indicating good matching between V̇O2m and Q̇m 
and therefore stable oxygen extraction. Whereas where Qm kinetics appear 
to be slow, and V̇O2m kinetics appear to be fast, (a-v)O2 difference increases 
steeply, indicating greater oxygen extraction. 
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Figure 38: Schematic representation of the relationship between 
arteriovenous O2 difference [a-vO2diff or (a-v)O2] and muscle V̇o2 (top) and 
blood flow and muscle V̇o2 (bottom). (a-v)O2 was estimated from the profile 
of the deoxygenated haemoglobin and myoglobin response. Taken from 
Ferreira et al. (2007).  
 
However, issues with the sigmoidal characterisation of the deoxygenated 
haemoglobin and myoglobin response arise from the lack of a physiological 
reasoning for the symmetrical upper and lower curves implied by a sigmoidal 
function (i.e. symmetrical upper and lower curves imply that the relationship 
is identical at exercise onset and at peak exercise). Furthermore, it has been 
argued that characterising the whole response may compromise the 
accuracy of the fit to other portions of the response (Spencer et al., 2012).  
The double-linear characterisation of the HHbMb response has been shown 
to provide a more accurate fit to the HHbMb response during ramp exercise 
when compared to the sigmoidal function. Similar to the sigmoid function, 
the double-linear function also suggests that the dynamic relationship 
between V̇O2m and Q̇m is exercise intensity dependent, where during 
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increasing exercise intensity, Q̇m kinetics increase slower relative to V̇O2m 
kinetics resulting in greater O2 extraction and thus an increase in HHbMb. 
This is until HHbMb reaches a ‘break-point’ where Q̇m and V̇O2m increase at 
a similar rate and the HHbMb signal plateaus. This approach of 
characterising the muscle deoxygenation response focuses on the location 
of the breakpoint of the NIRS HHbMb response however, it remains to be 
elucidated whether these breakpoints in the NIRS response are 
mechanistically linked to physiological markers of exercise intensity (Boone 
et al., 2016). Furthermore, the double-linear function disregards the initial 
portion of the HHbMb response at the onset of the ramp exercise (i.e. it fits 
from the point of systematic increase in HHbMb). It is questionable whether 
the advantages of a better fit to a portion of the data justifies the removal of 
the NIRS HHbMb response at the start of the ramp (which represents 
transitions in metabolic activity) and is arguably the area in which most day 
to day activities are performed; and therefore, where insights into the 
dynamic balance between V̇O2m and Q̇m at exercise onset may be obtained.  
More recently, Barroco et al. (2017) proposed a simplified method of 
characterising the muscle deoxygenation response to ramp exercise by 
NIRS, by comparing the slope of the HHbMb response in heart failure 
patients to aged match healthy controls. They showed that the slope of 
HHbMb was steeper in HF than healthy controls and that, towards peak 
exercise the HHbMb response increased in HF compared to a decreasing or 
flattening HHbMb in healthy controls. In addition, the slope of the HHbMb 
was significantly correlated to peak work rate in the HF group (i.e. a steeper 
slope was associated with a lower peak work rate). This simpler approach to 
characterising the HHbMb NIRS derived response may prove valuable in 
clinical settings, to quantify impairments in O2 delivery in HF patients.  The 
main limitation to this approach is that it disregards both the initial and final 
portion of the response. Therefore, as with the double linear function, 
disregarding portions of the response may mean important information 
regarding oxygen delivery and utilisation are essentially ignored.  
Resolving the issue of accurately and fully quantifying the HHbMb response 
to ramp incremental exercise has mechanistic implications for understanding 
the control of O2 delivery and utilisation. Furthermore, a simpler approach 
(i.e. one that does not require the need for complex mathematical sigmoidal 
functions) may aid the use of NIRS as an evaluative tool in a clinical setting. 
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The aims for this study were to: (i) use a simplified approach (by fitting the 
linear portion of the HHbMb response) to characterise the HHbMb NIRS 
derived response to ramp incremental exercise in HF patients; (ii) compare 
and determine which function (sigmoidal or double linear) fits the NIRS 
HHbMb data the best according to the Akaike Information Criterion  in a 
small subset of patients and; (iii) determine if NIRS deoxygenated 
haemoglobin + myoglobin responses can be utilised to identify the locus of 
exercise intolerance in heart failure patients. Aim iii is briefly addressed in 
this chapter by considering the profile of the NIRS HHbMb responses but is 
primarily addressed in the case study presented at the end of this chapter, 
by exploring the HHbMb and TOI responses in one patient prior to and post 
cardiac resynchronisation therapy.  
As NIRS measurements are indirect, there are some assumptions 
associated with this method (this will be discussed in more detail in the 
‘limitations’ section of this chapter). Briefly, it was assumed that (i) the 
∆HHbMb profile is a proxy for oxygen extraction in the tissue sampled by the 
NIRS probe, and; (ii) the relative contributions of haemoglobin and 
myoglobin to the deoxygenated ∆HHbMb signal is unknown, and that 
contributions from Mb do not affect the relationship between ∆HHbMb and 
(a-v)O2. These assumptions are inherent with the indirect NIRS technique 
however, due to the non-invasiveness of the technique, it can be applied 
relatively easily in clinical settings. With these assumptions in mind, NIRS 
∆HHbMb measurements can potentially provide unique non-invasive insights 
into control mechanisms governing the V̇O2m-Q̇m relationship.  
6.2  Methods 
Experimental data collection, measurements, exercise protocol and data 
analysis are described in the general methods section under sub-heading 
“Protocol 2” for healthy participants, and “Protocol 5” for heart failure 
patients. 
 
6.3 Results 
V̇O2 responses 
During incremental ramp exercise, V̇O2,peak was higher in healthy controls 
than heart failure patients (53.5 ± 14.8 mL/kg/min vs 15.8 ± 4.0 mL/kg/min 
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respectively). This was associated with higher peak work rates in healthy 
controls than heart failure patients (314 ± 70 W vs 95 ± 31 W respectively).   
NIRS responses 
Three distinct skeletal muscle deoxygenation (normalised HHbMb) 
responses to ramp incremental exercise were identified. These response 
types were identified by visual inspection only (Figure 39,Figure 40 and 
Figure 41). Response 1 is a sigmoidal type response, where at exercise 
onset O2 delivery is adequate to meet O2 utilisation demands. This is 
demonstrated by a flat or shallow initial deoxygenation response. Following 
this initial stage, as exercise intensity begins to increase, muscle oxygen 
delivery lags muscle oxygen demand, demonstrated by an increase in the 
deoxygenation response. Towards peak exercise, oxygen delivery “catches 
up” to oxygen utilisation demand and the deoxygenation response begins to 
plateau. This pattern of response was identified in 18 out of 31 HF patients, 
and all healthy controls. Response 2 is characterised by a slowing 
exponential-like muscle deoxygenation response. At exercise onset there is 
an immediate increase in muscle deoxygenation, indicating that muscle 
oxygen delivery is not adequate to meet oxygen utilisation demands, 
necessitating an increased reliance on oxygen extraction. As exercise 
continues, oxygen delivery and oxygen demand gradually become better 
matched, and muscle deoxygenation starts to plateau. This pattern was 
identified in 5 out of 31 patients. Response 3 can be characterised by a ‘two-
phase’ response. In this response, there is no slowing or plateauing of 
muscle deoxygenation at exercise onset or towards peak exercise. Instead 
muscle deoxygenation increases at exercise onset and continues to 
increase towards peak exercise. In patients manifesting this type of 
response, muscle oxygen delivery lags muscle oxygen demand throughout 
the exercise protocol, and towards peak exercise this oxygen delivery-
oxygen utilisation mismatch becomes worse. This pattern was identified in 8 
out of 31 patients. 
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Figure 39: RESPONSE  1 (n = 18) Similar to healthy individuals: at exercise 
onset O2 delivery is adequate to meet demands of O2 utilisation. As exercise 
intensity increases O2 delivery ’lags’ behind O2 utilisation, until HHbMb 
begins to plateau, indicating O2 delivery and utilisation are better matched. 
Open squares show patient data, red line was produced using a sigmoid 
function although its main purpose is to aid the reader by highlighting the 
response profile.   
 
 
 
Figure 40: RESPONSE 2 (n = 5) At exercise onset, an instantaneous rise in 
HHbMb, indicating O2 delivery is inadequate to meet demands of O2 
utilisation. As exercise intensity increases, O2 delivery ‘catches up’ and the 
HHbMb response begins to plateau, indicating improved matching of O2 
delivery to O2 utilisation. Open circles show patient data, red line was 
produced with an exponential function to illustrate the response pattern and 
aid the reader. 
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Figure 41: RESPONSE 3 (n = 8) Two phases, with no plateau or slowing of 
HHbMb at exercise onset or towards peak exercise, highlighting an 
immediate O2 delivery limitation, which is exacerbated as exercise intensity 
increases in these patients, indicating a progressive O2 delivery O2 utilisation 
mismatch. Open circles show patient HHbMb data, the red line was 
produced using a double-linear function and is there to aid the reader by 
highlighting the response pattern.  
 
Table 22 shows key parameters identified from the NIRS muscle 
deoxygenation responses during ramp exercise. Average V̇O2,peak was 
highest in response 2 (14.69 mL/kg/min), as was the slope of the 
deoxygenation response (1.83 %W). The lowest mean V̇O2,peak was in 
response 1 (14.69 mL/kg/min), but had the largest percentage change in 
muscle deoxygenation (23.88 %). Peak work rate was similar across each 
response (range 97-77 W). Response 3 had the lowest average 
deoxygenation slope (1.41 %W), but the highest average break point in 
muscle deoxygenation (point B; 82 W). Time to limit of tolerance was 654 s 
for response 1, 555 s for response 2, and 597 s for response 3. 
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Table 22: Key parameters derived from the NIRS deoxygenation response, 
separated by response profile in HF patients 
 
Response 1 Response 2 Response 3 
Point "A" (W) 23.76 18.00 23.38 
Point "B" (W) 75.65 68.00 82.13 
Point "C" (W) 96.59 99.00 98.63 
deoxy-HbMb slope (%W) 01.65 01.83 01.41 
delta deoxy-HbMb (%) 23.88 18.20 22.13 
V̇O2,peak (mL/kg/min) 14.69 18.53 15.03 
6.3.1 Characterising the data using a simplified approach 
Figure 42 shows the NIRS HHbMb response in a representative healthy 
control (top panel) and heart failure patient (bottom panel). Points A, B and 
C all occurred at lower work rates in heart failure patients than healthy 
controls. The mid-exercise HHbMb slope on average was steeper in heart 
failure than controls, and the HHbMb difference between points B and C was 
greater in heart failure than controls. These values are summarised below in 
Table 23. 
 
Table 23: Key variables of the NIRS HHbMb response in healthy controls 
and heart failure patients.  
Variables Healthy (n = 10) Heart failure (n = 31) 
Point "A" (W) 037 ± 10 23 ± 80 
Point "B" (W) 243 ± 56 75 ± 22 
Point "C" (W) 314 ± 75 97 ± 31 
HHbMb slope (%W) 0.56 ± 0 1.7 ± 1 
delta HHbMb (%) 003 ± 16 23 ± 11 
Table parameters: Point A, work rate at initial increase in HHbMb; point B, point as which HHbMb 
deviates from linearity; Point C, peak work rate; HHbMb slope, the linear portion of the muscle 
deoxygenation response; delta HHbMb, overall change in the muscle deoxygenation response from 
exercise onset until peak exercise. Data are reported as means ± SD. 
Steeper HHbMb- work rate slopes were significantly associated with lower 
peak work rates (r2 = -0.8, p < 0.05), and a lower V̇O2,peak (r2 = -0.7, p < 0.05) 
in patients (Figure 43). 
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Figure 42: Normalised deoxygenated haemoglobin-myoglobin (∆HHbMb %) 
response to ramp incremental exercise plotted as a function of increasing 
work rate (W) exercise in a representative healthy control (left) and heart 
failure patient (right). Point A corresponds to the point at which ∆HHbMb 
begins to systematically increase. Point B represents ∆HHbMb departure 
from linearity and point C corresponds to peak work rate. Note that data was 
normalised to the final HHbMb value (not the peak value) in order to 
maintain the profile of the response. Because of this, in some subjects 
(where the final HHbMb value was lower than the peak HHbMb value) 
normalised HHbMb exceeded 100%. 
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Figure 43: Correlation between ∆HHbMb-work rate slope and peak work 
rate (top), and V̇O2 peak (bottom) in patients.  
 
6.3.2 Comparing sigmoid and double linear functions 
For a small subset of patients, NIRS HHbMb responses were fit with both a 
sigmoidal and a double linear function and these fits were then compared. 
Individual and mean patient responses from the ramp incremental exercise 
test for these patients (n=8) are summarised in Table 24. In these patients, 
peak work rate was (mean ± SD) 106 ± 35 W, which yielded a V̇O2,peak of 
18.84 ± 5.65 mL/kg/min. Peak work rate was positively correlated with 
absolute V̇O2,peak (r2 = 0.89, p < 0.05), normalised V̇O2,peak (r2 = 0.86, p < 
0.05) and HR rise (r2 = 0.77, p < 0.05). However, there was no significant 
correlation between HR rise [a potential index of an increase in cardiac 
output; (Davies et al., 1972)] and V̇O2,peak when expressed as an absolute 
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value (L/min-1; r2 = 0.4, p > 0.05) or normalised to body mass (mL/min/kg; r2 
= 0.46, p > 0.05). Furthermore, there was no significant correlation between 
V̇O2,peak and the amplitude of the NIRS ∆HHbMb response (r2 = -0.46, p > 
0.05 and r2 = -0.47, p > 0.05 for absolute and normalised V̇O2,peak values, 
respectively).  
There was no significant correlation between the peak work rate and slope 1 
(double linear function), but there was a significant correlation between work 
rate peak and slope 2 (r2 = -0.56, p > 0.05 and r2 = -0.76, p < 0.05 
respectively). Similarly, for absolute V̇O2,peak (L/min), there was no significant 
correlation between slope 1, but there was a significant correlation between 
slope 2 and V̇O2,peak (r2 = -0.55, p  > 0.05 and r2 = -0.88, p < 0.05 
respectively).   
 
Table 24: Individual subject parameters from the ramp incremental exercise 
test 
Subject Peak WR  HR Rise V̇O2,peak  V̇O2,peak  
 
(watts) (bpm) (L/min) (mL/min/kg) 
1 136.00 135.00 1.79 20.46 
2 51.00 49.00 0.93 13.46 
3 98.00 95.00 1.59 17.89 
4 106.00 102.00 1.53 19.62 
5 93.00 88.00 1.20 12.66 
6 154.00 148.00 1.82 24.59 
7 74.00 33.00 1.02 13.60 
8 139.00 67.00 2.37 28.42 
Mean 106.00 90.00 1.53 18.84 
SD 35.00 40.00 0.48 5.65 
 
Figure 44 shows the second-by-second response of the change in 
deoxygenated haemoglobin and myoglobin (∆HHbMb), oxygenated 
haemoglobin and myoglobin (∆HbMbO2), and total haemoglobin and 
myoglobin (∆Hbtotal), and tissue oxygenation index (TOI%) from the onset of 
the ramp incremental exercise to the end of the ramp exercise in a 
representative subject. The sigmoidal and the double-linear function fits to 
deoxygenated haemoglobin and myoglobin for this representative subject 
are shown in Figure 45. This patient displayed a muscle deoxygenation 
profile of response 1 where HHbMb shows a brief period of relatively 
unchanging HHbMb, followed by progressive increase in the HHbMb signal, 
until, towards peak exercise, the slope of the HHbMb signal becomes 
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shallower, (although there is no pronounced plateau region in this patient). 
Out of the subset HF group (n = 8) 4 patients displayed this response profile 
(response 1), 2 patients showed slowing exponential-like responses 
(response 2), and the remaining 2 patients showed an immediate linear 
increase in HHbMb at the onset of the ramp until around 75% of peak work 
rate, where there was an upward inflection of HHbMb (response 3). This 
pattern was also preserved in the oxygenated haemoglobin profile, although 
appears to be more affected by changes in the ∆HbMbtotal signal (see Figure 
44). For example, in this representative subject, mid-way through the 
exercise there is a distinct sharp spike in ∆HbMbtotal which is associated with 
reciprocal changes in the oxygenated haemoglobin profile but is much less 
pronounced in the HHbMb response. 
Figure 44: Second-by-second responses of total haemoglobin and 
myoglobin (top left); oxygenated haemoglobin and myoglobin (top right); 
deoxygenated haemoglobin and myoglobin (bottom left) and tissue 
oxygenation index (bottom right) during ramp incremental cycling in a 
representative subject.  
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Figure 45: Sigmoidal fit (left) and double linear fit (right) of the deoxygenated 
haemoglobin and myoglobin response plotted as a function of normalised 
work rate in a representative subject.  
 
For the 8 patients, individual deoxygenated haemoglobin and myoglobin 
data was plotted as a function of normalised and absolute work rate and fit 
with both the sigmoidal and the double-linear functions. Group mean 
parameter estimates for both fitted functions are shown in  
Table 25. The breakpoint in the double-linear function occurred at 67 ± 24 W 
(absolute WR), and 57 ± 13 % (normalised WR). For the double linear 
function, in 6 out of 8 subjects, slope 1 was steeper than slope 2 (1.76 ± 0.7 
vs 1.14 ± 0.5 respectively; absolute WR) and (1.54 ± 0.5 vs 0.96 ± 0.3 
respectively; normalised WR), indicating a slowing of the muscle 
deoxygenation response towards peak exercise. Conversely, in 2 out of 8 
patients the slope 1 of the double-linear function was shallower than slope 2 
(0.62 ± 0.1 vs 1.90 ± 0.8 respectively; absolute WR) and (0.53 ± 0.2 vs 1.13 
± 0.8 respectively; normalised WR), indicating a speeding of muscle 
deoxygenation towards the end of exercise. Furthermore, in the patients 
displaying a markedly sharp increase in the ∆HHbMb towards the end of 
exercise (response 3) a robust fit of the sigmoid function was not possible. 
As such, these subjects were excluded from the sigmoidal model fitting 
averages. None of the patients displayed a distinct plateau towards the end 
of the ramp exercise, as is seen in healthy subjects (Ferreira et al., 2007). 
The 𝑐/𝑑 point (representing the x value at 50% of the total amplitude) was 
51.8 ± 19 W (absolute WR) and 44.3 ± 12 % (normalised WR). 
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Table 25: Group mean parameter estimates for the sigmoid and double-
linear model of the deoxygenated haemoglobin and myoglobin response 
profile (for all response types) plotted as a function of absolute work rate and 
normalised work rate. 
Sigmoid y0 A d xc c 
Absolute WR -7.69 128.21 0.08 64.8 3.63 
Normalised WR -7.69 128.2 0.07 53.22 2.89 
 
     
Double-linear BP (W) b1 m1 b2 m2 
Absolute WR 67.64 -28.66 1.48 -26.33 1.33 
Normalised WR 57.08 -13.89 1.29 -0.66 1.01 
Sigmoid model parameters: 𝑦0, baseline; A, amplitude; 𝑐 is a constant 
dependant on 𝑑, the slope of the sigmoid, where 𝑐/𝑑 gives the 𝑥 value 
corresponding to 50% of the total amplitude. Double linear 
parameters: BP, break point; b1, slope 1; m1, intercept 1; b2, slope 2, 
m2 intercept 2.   
 
Individual ∆AICC values for normalised ∆HHbMb are shown in Table 26. 
When plotted as a function of absolute work rate or normalised work rate, 
the double-linear model provided the best characterisation of the underlying 
HHbMb response in all subjects, indicated by a positive ∆AICC score. 100% 
of data points were considered for the sigmoid function, whereas a mean of 
90% (range 81 – 100 % amongst subjects) of data points were considered 
for the double-linear function (for both absolute work rate and normalised 
work rate). Based on a positive ∆AICC score, the results suggest that a 
double-linear function provides the best model fit of the ∆HHbMb response 
to ramp incremental exercise in heart failure patients, compared to the 
sigmoid function.  
Table 26: Individual ∆AICC values derived from comparisons between the 
double linear and sigmoid functions for normalised muscle deoxygenation 
(%∆HHbMb) plotted as a function of absolute and normalised WR. Positive 
scores favour the double-linear function. 
 ∆AICC values for %∆HHbMb 
Subject Absolute WR Normalised WR 
1 328.77 334.73 
2 315.07 315.08 
3 1221.68 1110.16 
4 878.06 878.05 
5 805.94 804.99 
6 198.75 198.75 
7 1519.43 606.24 
8 1043.99 1043.99 
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6.4 Discussion  
NIRS responses 
Three distinct responses from the NIRS deoxygenated haemoglobin and 
myoglobin signal were identified. Response 1 followed a sigmoidal-like 
response, which was demonstrated in 58% of HF patients. It is important to 
note that, although oxygen extraction slowed towards peak exercise, no 
patients showed a distinct plateau, similar to the response observed in 
healthy individuals (Figure 46). Overall, patients with response 1 had the 
lowest mean V̇O2,peak but the highest mean oxygen extraction. This is 
interesting to consider as, throughout this thesis, a higher oxygen extraction 
has been associated with a lower oxygen delivery. However, it is the profile 
of the oxygen extraction (rather than the overall amount) that may be the 
bigger determinant of exercise tolerance. For example, if a high amount of 
O2 is extracted in a very short space of time, this may drain the muscle of 
oxygen which, in turn, would transiently lower the microvascular partial 
pressure and inhibit O2 flux. However, if the oxygen is extracted in a stable 
but consistent manner over a prolonged period of time, O2 doesn’t become 
limiting (providing adequate O2 delivery is maintained), O2 flux is maintained, 
and exercise can be sustained for longer so that over the period of exercise, 
a larger amount of oxygen can be extracted and a higher V̇O2 achieved. 
Previous findings in healthy subjects have shown that a higher V̇O2,peak has 
been associated with higher oxygen extraction (Boone et al., 2009). 
However, in HF patients displaying this response, the (mean) higher oxygen 
extraction was not associated with the (mean) highest V̇O2. Furthermore, the 
highest (mean) V̇O2 was in patients who displayed response 2, which had 
the lowest overall O2 extraction. On average though, patients with response 
1 were able to exercise for longer than in those with responses 2 (654 vs 
555 s respectively). These findings are somewhat conflicting, as both 
V̇O2,peak and time to limit of tolerance are markers of exercise capacity, so it 
is logical to expect that the group who exercised longer would achieve a 
higher V̇O2,peak. However, this is not the case in the data presented in this 
chapter. From the data presented in this study, response 1 cannot provide 
any specific insights into the delivery vs utilisation limitation debate further 
than a sigmoidal response is typically seen in healthy individuals.  
 
150 
 
 
Figure 46: Response 1 in a representative HF patient (left) and healthy 
control (right). In HF patients displaying a sigmoidal-like response (response 
1) deoxygenated haemoglobin and myoglobin (ΔHHbMb %) did not show a 
distinct plateau in like that seen in healthy subjects, where ΔHHbMb % either 
plateaued or decreased slightly towards peak exercise.  
 
Response 2 followed a similar profile as response 1, with the exception that 
at the onset of exercise, HHbMb increased immediately (i.e. there was no 
flat or shallow HHbMb seen at exercise onset). This indicates that in these 
patients at the onset of exercise, there is an immediate increase in oxygen 
demand, that cannot be met with oxygen supply, causing an increased 
reliance on oxygen extraction. However, as exercise intensity increases, this 
mismatch between oxygen supply and demand decreases, and oxygen 
extraction follows a similar profile to response 1 until the end of exercise. In 
patients displaying this response, mean V̇O2,peak was higher than in the other 
two groups (i.e response 1 and 3), and % change in oxygen extraction was 
the lowest overall. Despite this, total ramp time was the shortest in this group 
[555 s vs 654 s (response 1) and 592 s (response 3)]. This may be because 
oxygen was depleted at a faster rate over a shorter period (represented by a 
steeper HHbMb slope) earlier on in exercise in those with response 2, 
thereby causing a greater reliance on anaerobic energy sources. A greater 
reliance on anaerobic energy sources contributes to an increased fatigue 
and therefore, earlier exercise termination. From the data presented in this 
study, the information gained from response 2 is that these patients are 
limited by oxygen delivery at exercise onset (i.e. they have a slow initial 
response) but are able to meet O2 delivery demands during exercise.  
Response 3 was characterised by an immediate increase in HHbMb at 
exercise onset (as with response 2), and an increasing HHbMb towards 
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peak exercise (instead of a decreasing increase in HHbMb towards peak 
exercise seen in responses 1 and 2). This indicates a progressive and 
increasing reliance on oxygen extraction in these patients. The mean 
V̇O2,peak in patients displaying response 3 was lower than those displaying 
response 2, but slightly higher than those with response 1. In addition, the % 
change in HHbMb was higher than response 2, and slightly lower than 
response 1. The response seen in these patients indicates that throughout 
the whole of the ramp exercise, oxygen delivery is lagging oxygen demand 
(due to the continuously increase HHbMb). Furthermore, in some patients 
this worsened towards peak exercise. Given this, it might be reasonable to 
expect these patients to have the lowest exercise capacity. However, 
patients in this group exercised on average for 43 seconds longer than those 
displaying response 2 (but 62 s less than response 1 group). These findings 
highlight the importance of considering the profile of the oxygen extraction 
(i.e. the steep at which oxygen is extracted) as well as the total amount of 
oxygen being extracted. The key information gained from response 3 is that 
patients with this response are primarily O2 delivery limited at exercise onset 
and throughout exercise. 
One possible reason for the inconsistency in the data could simply be a 
result of having different representative group sizes for each response. 
Especially considering that when the data was evaluated as a whole (i.e. not 
spilt into respective responses) there was a strong correlation found 
between these factors mentioned above (see next section below). However, 
more patients displaying responses 2 and 3 are needed to evaluate these 
responses reliably, and as separate entities. This part of this studies shows 
an alternative approach to characterising the NIRS HHbMb data as opposed 
to just fitting the data with a statistical function, as in previous studies. 
Although on its own it cannot provide definite conclusions regarding O2 
delivery vs O2 utilisation limitations, it may represent a useful additional tool 
in characterising the overall response type and deciding what function is 
more suitable to use when characterising the data. 
Simplified fit 
Heart failure vs healthy controls 
A simplified method of characterising the NIRS HHbMb data was applied to 
all heart failure patients and healthy controls, regardless of the profile of the 
response. Overall, heart failure patients demonstrated steeper 
deoxygenation-work rate slopes in addition to increasing (instead of stable or 
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decreasing) deoxygenation towards peak exercise. This finding is consistent 
with, and therefore, supports, the notion that impaired skeletal muscle 
perfusion causes V̇O2m/Q̇m mis-match and a greater reliance on oxygen 
extraction during steady state exercise transitions (Sperandio et al., 2009; 
Bowen et al., 2012) and incremental exercise (Wilson et al., 1989; Barroco 
et al., 2017) in heart failure patients.  
Healthy controls displayed a non-linear (sigmoidal) response to ramp 
exercise, consistent with previous studies investigating muscle 
deoxygenation dynamics during ramp exercise in healthy individuals, which 
is indicative of a non-linear V̇O2m/Q̇m relationship (Ferreira et al., 2007; 
Boone et al., 2009, 2012; DiMenna et al., 2010; Spencer et al., 2012; 
Barroco et al., 2017). There have been several mechanisms proposed for 
the s-shaped (i.e. non-linear V̇O2m-Q̇m relationship) muscle deoxygenation 
(∆HHbMb) response to ramp exercise in health. The initial unchanging or 
relatively flat response in ∆HHbMb at the start of the ramp (phase 1) has 
been attributed to the mechanical effects of muscle contraction at exercise 
onset (i.e. muscle pump and rapid vasodilation), that contribute to rapid Q̇m 
kinetics during light exercise, and which become progressively less 
important during higher work rates. In addition, parasympathetic withdrawal 
in the early stages of the ramp exercise results in an increase in cardiac 
output, which progressively slows as work rate increases (Stringer et al., 
2005; Ferreira et al., 2007). Following this initial slow response, ∆HHbMb 
increases more steeply (phase 2), indicating that fractional O2 extraction is 
greater than the increase in Q̇m during higher work rates. This may be 
related to changes in the parasympathetic-sympathetic balance (Ferreira et 
al., 2007), as well as muscle fibre type and recruitment. Muscle comprised of 
slow twitch fibres [which are preferentially recruited at the start of ramp 
incremental exercise (Koga et al., 2014)] demonstrate faster adjustments of 
Q̇m relative to V̇O2m, and better V̇O2m to Q̇m coupling when compared to fast 
twitch fibres [which are recruited later during the ramp (Jones et al., 2004)] 
(Behnke et al., 2003; McDonough et al., 2005). Ramp exercise is 
characterised by a shift from predominantly slow twitch fibres, to an increase 
in fast-twitch muscle fibre recruitment (Jones et al., 2004; Koga et al., 2014). 
As such, this may partially explain the slowing of Q̇m towards peak exercise 
(Ferreira et al., 2007; Boone et al., 2010). Additionally, Stringer et al. (2005) 
reported a non-linear increase in cardiac output during ramp exercise (i.e. a 
less pronounced increase in cardiac output at higher work rates). A non-
linear cardiac output response may also contribute to the non-linear V̇O2m-
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Q̇m relationship at the microvascular level. The plateau in ∆HHbMb towards 
the end of the ramp (phase 3) indicates a matching between the rate of 
increase in Q̇m relative to V̇O2m. It has been argued that the plateau 
indicates that fractional extraction has reached it upper limit (Boone et al., 
2016). In this context, in heart failure patients, steeper deoxygenation slopes 
were interpreted as an increased reliance on O2 extraction due to slower Q̇m 
relative to V̇O2m (i.e. impaired Q̇m), which gets progressively worse towards 
peak exercise, as indicated by an increasing (instead of stable or 
decreasing) ∆HHbMb slope.  Although this simplified method of 
characterising the muscle deoxygenation response excludes the initial and 
final portions of the ramp, evaluating the slope of the ramp can provide 
useful information. This is because a steeper ∆HHbMb-work rate slope was 
associated with a lower peak work rate and a lower V̇O2,peak in heart failure 
patients. This may be related to an increased reliance on oxygen extraction 
due to insufficient oxygen delivery, and/or greater recruitment of type II 
fibres, which are less oxidative and fatigue faster. In addition, by excluding 
the initial and latter stages, the slope of the deoxygenation response 
obtained is not influenced by the quality of the function fit to the rest of the 
data. For example, by measuring the slope of the deoxygenation response 
with a sigmoidal and/or double linear function, the fit to the linear portion of 
the response will be adjusted in order to get the best overall fit to the whole 
response (sigmoidal) or the middle and end portion (double-linear). Another 
advantage of using this simplified method is that it is avoids the need for 
applying complex functions, making it more accessible in clinical settings 
where access to, and knowledge of, statistical programs may be limited.  
 
Sigmoid function vs double linear function 
For sigmoid and double linear functions (in a sub-set of 8 patients) individual 
normalised muscle deoxygenation (%∆HHbMb) responses were fitted with 
either a sigmoid function (which considers the overall response) or a 
piecewise double-linear function (which considers the predominant increase 
in ∆HHb and the following plateau region). Based on a positive ∆AIC score, 
the double-linear function provided the best characterisation the %∆HHbMb 
response to ramp incremental exercise in all patients, relative to the sigmoid 
function. However, the AICc score is limited in that it is relative (i.e. it only 
compares one model fit to another), so although it demonstrates that the 
double-linear fit was better than the sigmoidal fit, it doesn’t give any 
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information regarding the physiological implications of this. Furthermore, it 
does not give information regarding the quality of the fit overall. For example 
both could be extremely poor fits but the AICc score would still provide an 
assessment of which of the two poor fits is the better out of the two. 
Physiological implications of the double-linear function: It is important to note 
that the %∆HHbMb response profile in all of the HF patients did not display a 
discernible plateau region as seen in healthy individuals (Spencer et al., 
2012), and in some patients the response became steeper at the end of the 
ramp incremental test. As the double-linear function is based on 
characterising (i) the slope of the HHbMb response and (ii) the plateau 
towards peak exercise, it is questionable whether the model, despite proving 
an overall better characterisation of the muscle deoxygenation response 
when compared to a sigmoidal function, has any physiological meaning. 
Nonetheless, in all patients there was a discernible breakpoint when fitting 
the double-linear function, indicating a relative change in the V̇O2m/Q̇m 
relationship. The break point in the HHbMb response, where the HHbMb 
response levels off, indicates a change in the V̇O2m/Q̇m relationship and 
possibly that microvascular O2 extraction has reached some upper limit 
(Boone et al., 2015). The underlying mechanisms for this breakpoint, 
however, are yet to be elucidated, but have been related to the critical 
power, maximum lactate steady state, and respiratory compensation point 
(Bellotti et al., 2013; Murias et al., 2013; Racinais et al., 2014; Keir et al., 
2015). This is based on the assumptions that (i) the critical power and the 
maximum lactate steady state demarcate the highest work rate that can be 
sustained for long periods of time and (ii) that the breakpoint in HHbMb may 
represent some upper limit of oxygen extraction. Therefore, these thresholds 
and the breakpoint in HHbMb may be related due to similar underlying 
physiology such that, they both reflect a common level of aerobic 
metabolism beyond which there is a progressive loss of homeostasis (Keir et 
al., 2015). In healthy individuals the break point in the HHbMb signal occurs 
between 75-90% of V̇O2,max (Boone et al., 2016); however, the breakpoint in 
the HF data occurred much lower (~60% of normalised work rate, which 
corresponded to a range of ~35-85% V̇O2,peak). Whether this is a true 
reflection of the underlying physiology or is simply caused by limitations in 
the fitting of the double-linear function is difficult to ascertain. Furthermore, 
the double-linear function is fit from the point of a systematic increase in 
∆HHbMb above baseline, observed during the middle portion of exercise 
onwards. This fit, however, excludes the initial phase 1 portion of the 
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∆HHbMb response, meaning information regarding the balance between O2 
delivery and O2 utilisation at the onset of exercise (possibly the intensity at 
which most activities of daily living are performed) is ignored (Boone et al., 
2016). This is a possible limitation of using this function to characterise 
muscle deoxygenation. Therefore, although the double linear function 
provided a superior fit to the data, according to the AICC score, it is important 
to consider whether the function is accurately describing the underlying 
physiological response Furthermore, it also important to consider whether a 
better fit that characterises a portion of the response is more desirable than 
a slightly worse fit that characterise the whole response.  
Physiological implications of the sigmoid function: The sigmoidal model 
indicates that, at very low work rates, Q̇m kinetics are faster than V̇O2m 
kinetics (that is, O2 is delivered to the muscle faster than it is utilised), 
resulting in a slower increase in fractional O2 extraction. Potential 
mechanisms for this response have been described above. 
In the heart failure patients, none displayed a pronounced plateau, and in 
some patients the muscle deoxygenation actually increased towards end-
exercise. This lack of a plateau in ∆HHbMb may have contributed to the less 
superior sigmoidal function fit (according to the AICC score); and may be 
indicative of a muscle blood flow limitation (i.e. when the ∆HHbMb response 
profile is flat, V̇O2m and Q̇m are well matched; however, an increasing 
∆HHbMb indicates that the increase in fractional O2 extraction is greater 
relative to the increase in Q̇m and therefore, that O2 delivery is not sufficient 
to meet the demands of O2 utilisation at that moment). This is especially 
evident in those patients in whom the slope of the ∆HHbMb response 
became steeper following the breakpoint in indicating that fractional O2 
extraction is greater than the increase in ∆HHbMb, suggesting that these 
patients are still heavily reliant on O2 extraction as exercise progresses 
towards peak exercise. This is unlike in healthy subjects (Spencer et al., 
2012), where most patients displayed a plateau, indicating that V̇O2m and Q̇m 
are well coupled (Spencer et al., 2012). Furthermore, the sigmoid function, in 
most cases, underestimated the reliance on O2 extraction in later exercise in 
this study. So, despite ∆HHbMb being normalised, the projected baseline 
and peak values either fell short (i.e. below 0%; in one subject the baseline 
value was consistently under -50% regardless of being expressed as a 
function of absolute work rate, or normalised work rate) or exceeded the 
100% peak value, which may result in the sigmoid function being unable to 
accurately identify baseline and end-exercise values. 
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Ferreira et al., (2007) proposed that the sigmoidal function could be used as 
a tool to detect changes in the V̇O2m/Q̇m relationship due to changes in 
microvascular function (i.e. a slow cardiac response necessitates a higher 
reliance on O2 extraction, causing the slope of the ∆HHbMb response to be 
steeper, and to increase at an earlier stage in exercise) and thus, predicted 
that disease-related changes in microvascular function may shift the sigmoid 
to the left, whereas exercise training and interventions to improve vascular 
function might shift the sigmoid to the right. Boone et al. (2009) 
demonstrated the latter by comparing the ∆HHb responses to cycle exercise 
in trained cyclists and physically active students and found a rightward 
shifting of the sigmoid in the trained group, suggesting that aerobic fitness 
status affects the V̇O2m/Q̇m relationship. In an effort to mimic disease related 
changes in microvascular function, DiMenna et al. (2010) investigated the 
influence of supine cycle ergometer exercise in comparison to upright cycle 
ergometer exercise on the ∆HHbMb response profile. The authors found that 
the slope of the ∆HHbMb profile was steeper during supine cycling when 
compared to upright cycling, consistent with the notion that the reduced 
muscle perfusion (due to the supine position) necessitates a higher fractional 
O2 extraction (Ferreira et al., 2007). However, the c/d point of the sigmoid 
(at which 50% of the total amplitude was reached) was not significantly 
altered [unlike in Boone et al. (2009)], suggesting that there was no leftward 
shifting of the sigmoid. This, however, could be a reflection of how much the 
supine position actually mimics disease related changes in microvascular 
function. In the present study, the c/d point occurred at a lower absolute 
work rate in heart failure patients than controls (52 W vs 136 W respectively) 
however, when work rate was normalised the c/d point was only 1% 
different between heart failure patients and healthy controls (44% vs 45% 
respectively), suggesting no leftward shift of the sigmoid in heart failure 
patients compared to young healthy controls in this study.  
 
6.5 Summary 
The double-linear function provided a better fit to the data compared to the 
sigmoid function according to the AICc score. Fitting the data with a double 
linear function provides us with a breakpoint, indicating a change in the 
V̇O2m/Q̇m relationship however, it is not clear if the breakpoint is 
physiologically significant, nor if it gives us useful information on what is 
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happening at the muscle during exercise. The double linear function also 
gives two slopes (slope 1 representing the linear portion of the response and 
slope 2 representing the plateau towards peak exercise), however the 
accuracy of these slopes may be compromised, by the function trying to get 
the best fit to both parts of the response. Slope 2 of the response is 
supposed to represent a plateau in muscle deoxygenation, although there 
were no distinct plateaus in HF patients seen in this study. Therefore, it is 
possible that this compromised the accuracy of the fit and as such, may 
have had an influence on the results. This may explain why there was no 
significant correlation between peak work rate and peak V̇O2 with slope 1 
(i.e. the linear portion of the response) with the double linear function.     
The sigmoid function characterises the whole of the muscle deoxygenation 
response, unlike the double linear function and simplified linear fit. This is 
advantageous in that information can be obtained regarding all stages of 
exercise. On the other hand, this may be partly why it provided a less 
superior fit to the data when compared to double linear function. 
Furthermore, in heart failure the responses were variable, and (unlike in 
healthy subjects) did not display a discernible plateau either at the beginning 
and/or at the end of exercise. Although the sigmoid function seems to 
describe the data well in health, the variable responses in heart failure 
patients may mean that the sigmoidal function does not always fit well to the 
data in HF, and therefore, the resultant information gained from this fit may 
not be accurate. For example, the c/d point (which is unique information that 
cannot be gained from the double linear of simplified linear functions), was 
not different between heart failure patients and healthy controls when 
muscle deoxygenation was plotted as a function of normalised work rate.  
Separating the NIRS derived deoxygenation into distinct responses may be 
useful to identify patients who are O2 delivery limited. However, more data is 
needed to reliably quantify the separate responses and their corresponding 
physiological meaning.  
The simplified linear fitting approach provides information on the slope of the 
response. Unlike the double linear function, the fitting of the linear regression 
is not dependent on any other portions of the response (as these are 
disregarded), meaning that the slope of the response is more likely to be a 
reliable representation of muscle deoxygenation. This may explain why the 
slope of the response using this approach was significantly correlated to 
peak work rate and peak V̇O2. In addition, using this method means there is 
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no need for complex functions. The major disadvantages of the simplified fit 
are that it disregards the initial and final portions of response of the muscle 
deoxygenation response, which are arguably, the most important areas of 
the test. Nevertheless, this simplified linear function provides important and 
useful information that is related to exercise tolerance. Given this, along with 
its ease of use and understanding may be the most useful tool to evaluate 
muscle deoxygenation dynamics in clinical setting.  
 
6.6 Study limitations 
As NIRS is an indirect measurement, there are inherent limitations that must 
be considered in this study. Two major assumptions of the study are that: (i) 
∆HHbMb responses reflect microvascular oxygen extraction in the portion of 
the muscle being investigated; and (ii) the contribution of myoglobin to the 
NIRS signal is unknown, therefore ∆HHbMb reflects both haemoglobin and 
myoglobin contributions, and this does not affect the relationship between 
∆HHbMb and oxygen extraction. Other important limitations inherent with all 
NIRS studies include: the effect of the relatively small (and superficial) 
sample of muscle tissue sampled on the NIRS signal, and the effect of 
changes in blood volume on the NIRS signal.  
HHbMb as a surrogate of oxygen extraction 
While this relationship is yet to be validated directly in humans (partly due to 
the difficulty in sampling venous blood from the exercise muscle without 
contamination from other muscles/tissue) studies in the dog gastrocnemius  
have found good, and very good, correlation between HHbMb and venous 
O2 saturation (Grassi et al., 2002; Goodwin et al., 2011; Wüst et al., 2014; 
Sun et al., 2016). Sun et al. (2016) found a highly linear correlation between 
NIRS derived HHbMb and CvO2 in the dog gastrocnemius muscle (r2 = 0.89 ± 0.06), indicating NIRS HHbMb accurately reflects mean venous O2 
saturation in the interrogated muscle tissue. Similarly, Wust et al. (2014) 
found a good correlation between venous O2 saturation and HHbMb in the 
dog gastrocnemius muscle in conditions of spontaneous blood flow (r2 = 
0.69 ± 0.12; p > 0.001) and a very good correlation during conditions of 
constant blood flow (r2 = 0.93 ± 0.06). Furthermore, indirect studies in 
exercising humans have demonstrated similar HHbMb kinetics to the (a-v)O2 
time course in human limb and isolated in situ dog muscle, intracellular PO2 
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in single amphibian muscle fibres and microvascular PO2 in rat muscle 
[(Grassi, 2005) Figure 47].   
 
Figure 47: Kinetics of different variables related to O2 extraction upon a step 
increase in metabolic demand, as determined in studies conducted by 
utilising different techniques and experimental models (Grassi et al., 1996, 
2002, 2003; Hogan, 2001; Behnke et al., 2002). Note that an increased O2 
extraction is reflected by an increased muscle deoxygenation by NIRS, by 
an increased C(a-v)O2, but by a decreased microvascular or intracellular 
PO2. The vertical broken lines (time = 0) indicate the time at which the 
metabolic demand was increased. All variables show a quite similar 
"biphasic" response, that is, an early phase lasting around 10 seconds in 
which no significant change vs the baseline value is observed, followed by 
the monoexponential increase (or decrease) to the asymptotic value. Taken 
from Grassi (2005).  
 
Contribution of Hb and Mb to the NIRS signal 
Due to similar absorption spectra, it is not possible to distinguish between 
haemoglobin and myoglobin. As such, the relative contributions of Hb and 
Mb to the NIRS signal are unknown. As discussed in detail earlier, there is a 
debate regarding the relative contributions of Hb and Mb to the NIRS signal, 
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and evidence is conflicting.  Some authors have suggested that the Mb 
contribution to the NIRS signal is small (Seiyama et al., 1988; Mancini et al., 
1994), although other studies has found the contribution much higher (Tran 
et al., 1999; Richardson et al., 2001; Spires et al., 2011). Davis and Barstow 
(2013) determined the contribution of myoglobin to be greater than ≥50% in 
human muscles. Regardless, the time course for the desaturation of Mb and 
Hb has been found to be similar (Davis & Barstow, 2013); therefore, a 
greater contribution of Mb to the NIRS signal would not invalidate the 
interpretation that changes in this signal reflect fractional O2 extraction 
(Grassi & Quaresima, 2016). For the purpose of this study it is recognised 
that the muscle deoxygenation signal by NIRS is derived from both Hb and 
Mb contributions.  
Small volume muscle tissue sampled by NIRS probe 
It is well known that adipose tissue thickness can have a confounding 
influence on NIRS measurements (van Beekvelt et al., 2001), as NIRS 
instruments can only interrogate a relatively small and superficial volume of 
skeletal muscle (Chance et al., 1988). To anticipate the possible influence of 
adipose tissue thickness, the ∆HHb signal was normalised to the amplitude 
of the response, and NIRS measurements were not collected in patients with 
large body mass. Furthermore, muscle activation, metabolism and blood 
flow are heterogeneously distributed; as such, the area of muscle under 
investigation may not be an accurate representation of the whole muscle 
(Grassi & Quaresima, 2016)  
Changes in blood volume 
While interpretation of the oxygenated NIRS signal (HbMbO2) is dependent 
on changes in muscle blood flow, the deoxygenated signal (HHbMb) 
appears to be less influenced by changes in blood volume, as it is primarily 
dependent on O2 extraction (Grassi et al., 2003; Goodwin et al., 2011; 
Grassi and Quaresima, 2016). As described above, there is an association 
between NIRS derived muscle deoxygenation and femoral O2 saturation, 
however, it has been shown that this is not the same for oxygenated 
haemoglobin and myoglobin. This has been demonstrated by Grassi et al. 
(2003) who observed the following relationships during cycle ergometry 
exercise: at the onset of exercise for ∼10 s all NIRS oxygenation variables 
remained constant (phase a in Figure 48) compared with the unloaded 
pedalling baseline. After this initial period, oxygenated haemoglobin and 
myoglobin (i.e. Δ[oxy(Hb + Mb)] in Figure 48) and deoxygenated 
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haemoglobin and myoglobin (Δ[deoxy(Hb + Mb)] in Figure 48) decreased 
and increased, respectively (phase b in Figure 48) and reached a steady-
state level in ∼60 s. As a consequence of the Δ[oxy(Hb + Mb)] and 
Δ[deoxy(Hb + Mb)] time courses during  phase b, the sum of the two 
variables, i.e., Δ[oxy(Hb + Mb) + deoxy(Hb + Mb)] (indicating the total Hb + 
Mb volume in the region of interest) remained substantially constant, 
whereas Δ[oxy(Hb + Mb) - deoxy(Hb + Mb)] decreased exponentially and 
reached a steady state in ∼60 s. After the initial 60 s, Δ[deoxy(Hb + Mb)] 
remained constant to the end of the exercise, whereas Δ[oxy(Hb + Mb)] 
increased (phase c in Figure 48). This increased muscle oxygenation during 
constant-load exercise was observed by MacDonald, (1999) and it did not 
correlate with the simultaneously determined oxygenated haemoglobin and 
myoglobin saturation in the vein draining from the exercising muscle. 
 
This observation is possibly due to an increased blood flow to the skin 
(Grassi et al., 2003). The deoxygenated Hb + Mb may not be affected by the 
increase in blood volume, since an enhanced blood flow is unlikely to be 
associated with an increase in gas exchange (Koga et al., 2015). In addition, 
the TOI% response is also less sensitive to changes in skin perfusion as it is 
presented as a ratio of (HbO2/Hbtotal). However, as it is still dependent on 
HbO2, may be more sensitive than ∆HHb.  
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Figure 48: (A) time courses of vastus lateralis Δ[oxy(Hb + Mb)], Δ[deoxy(Hb 
+ Mb)], Δ[oxy(Hb + Mb) + deoxy(Hb + Mb)], and Δ[oxy(Hb + Mb) - deoxy(Hb 
+ Mb)] in a typical subject during transition (at time 0, vertical dashed line) 
from unloaded pedaling to moderate intensity constant-load exercise. (B): 
same data shown in A, with abscissa expanded to allow a better 
appreciation of time courses of variables during the early phase of the 
transition. Different phases of the response are represented by a, b, and c. 
Taken from Grassi et al. (2003).  
 
 
6.7 Conclusions 
 
The present study demonstrates that in heart failure (NYHA II-III) patients 
the deoxygenated haemoglobin and myoglobin response to ramp 
incremental is variable between individuals but can be classified into three 
distinct responses according to the skeletal muscle O2 delivery dynamics 
during ramp incremental exercise. A simplified linear fit to the mid portion of 
the deoxygenation response gave valuable insights into the V̇O2m/Q̇m 
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relationship in heart failure patients. A steeper increase in muscle 
deoxygenation was related to lower peak work rates and a lower V̇O2,peak, 
indicating that patients with steeper deoxygenation slopes had a greater 
reliance on oxygen extraction due to limited oxygen delivery.  
In a small subset of patient’s muscle deoxygenation responses were 
characterised by a double linear function and a sigmoid function. According 
to the AICC score, the double-linear function provided a better fit to the data 
than a sigmoidal function. However, the lack of any discernible plateau in 
HHbMb towards the end of exercise causes a problem for both functions 
and, therefore, parameter estimates, and their physiological implications 
must be considered when judging model quality. As the data was highly 
variable between patients and given the three distinct response types shown 
fitting all or most of the response may not always be possible and/or 
appropriate with a ‘one fits all’ approach.  
As such, a simplified linear function that is fit to the just the linear portion of 
the HHbMb response may provide the most useful insights into the V̇O2m/Q̇m 
relationship, that can be applied across variable responses, and does not 
require complex mathematical functions.  
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6.8 Case study 
6.8.1 Introduction 
It has been shown that small increases in resting muscle blood flow have 
marked benefits for maintaining muscle O2 availability during exercise, 
predicting improved exercise tolerance. For example, Benson et al. (2013) 
showed that small increases in blood flow at rest not only increases the 
steady state (resting and exercising) muscle oxygenation values, but also 
reduces the characteristic undershoot in muscle oxygenation seen in heart 
failure patients (Sperandio et al., 2009), thereby giving a ‘double benefit’ 
effect. Furthermore, experimental data (Bowen et al., 2012) have shown that 
a priming exercise bout in heart failure patients (to increase baseline blood 
flow) also resulted in a reduction of the undershoot in muscle oxygenation 
seen at the onset of exercise in some patients. Based on this, it is 
reasonable to predict that increasing resting blood flow will have a profound 
effect on the dynamics of the muscle oxygenation response during a 
subsequent increase in work rate, thereby reducing the undershoot in 
muscle oxygenation. This is particularly pertinent for individuals with blood 
flow and O2 delivery problems, such as heart failure patients.  
 
The development of  cardiac resynchronisation therapy (CRT) has been a 
major breakthrough in the treatment of HF (Auricchio and Prinzen, 2011), in 
which the primary aim is to improve cardiac output by synchronsing the 
pumping action of the ventricles. This is achieved via implantation of a 
biventricular pacemaker, which has three leads that sit in the heart (one in 
the right atria, and a lead in each (the left and right) ventricle).  In some 
cases, CRT has been shown to improve quality of life, exercise tolerance, 
and left ventricular ejection fraction (LVEF) in HF patients (Birnie and Tang, 
2006; Tomczak et al., 2012).  Despite these advances, however, it has been 
reported that up to 30 % of patients that receive CRT therapy do not show 
any improvement in symptoms; these patients are often referred to as CRT 
‘non-responders’ (Saxon and Ellenbogen, 2003; Birnie and Tang, 2006). 
One hypothesis to explain CRT ‘non-responders’ is that the extra cardiac 
output generated from CTR isn’t being distributed to the exercising muscle 
and is instead being distributed elsewhere in the body, while a second 
hypothesis is that the extra cardiac output is being distributed to the 
exercising muscles but there is a problem with O2 utilisation at a skeletal 
muscle level (e.g. mitochondrial dysfunction) that means they are unable to 
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use the extra O2 being delivered (Bowen et al., 2012). As such, interventions 
aimed solely at improving cardiac output (i.e. CRT) might not be completely 
effective in patients who also have dysfunction at a skeletal muscle level. 
Additionally, when it comes to assessing the efficacy of CRT, important 
effects on the functional status of the patient are difficult to quantify 
objectively (i.e. by patients NYHA class and quality of life score), and very 
significant placebo effects can be seen with this type of intervention. 
Functional assessments therefore need to be performed in conjunction with 
less subjective measurements of ventricular performance and exercise 
capacity, pre- and post-CRT (Fox et al., 2005). With this in mind, non-
invasive methods of determining the primary locus of exercise intolerance in 
HF patients (i.e. impaired O2 delivery and/or impaired O2 utilisation) could 
prove useful in targeting individual therapeutic intervention (i.e. exercise 
training in patients with poor skeletal muscle function). As discussed in detail 
throughout this thesis, muscle oxygenation dynamics during exercise, 
measured noninvasively using near infrared spectroscopy, can provide 
insights into O2 delivery/utilisation matching. NIRS could therefore provide 
information on the locus (central/peripheral) of the exercise intolerance, 
which in turn may assist in guiding or quantifying the effectiveness of 
treatment. The aim of this case study was to measure muscle oxygenation 
dynamics non-invasively before and after CRT in a heart failure patient with 
reduced ejection fraction.  
6.8.2 Methods 
Participants and protocols 
One heart failure patient (age 76 years; BMI 24; LVEF 12 %; NYHA II) 
volunteered to take part in the study and provided informed written consent. 
The investigation was approved by the National Institute for Health 
Research, Leeds Clinical Facility research committee.  
The patient attended Leeds Clinical Research facility on two occasions. On 
both occasions, the patient performed a symptom limited ramp incremental 
exercise test to the limit of tolerance. Each test was preceded and followed 
with at least 4 minutes of unloaded pedalling at 10 W. Ramp rates (15 
W/min) was individually targeted to produce a test duration of 8-12 minutes 
and kept the same on both tests. The patient was instructed to keep the 
RPM between 70-80 on both tests. The test was terminated when the pedal 
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cadence could no longer be maintained above 50 rpm despite strong verbal 
encouragement. The first test took place prior to CRT implantation and the 
second test took place 6 weeks following CRT.  
Equipment and measurements 
Data was analysed in the same manner described in the general methods 
sections under sub-heading protocol 2.  
6.8.3 Results 
 
Results from the ramp incremental test are shown in Table 27. Peak work 
rate and time to limit of tolerance both improved by 9% and 17% respectively 
following CRT (185 to 202 W and 910 to 1060 s, respectively), despite a 
41% decrease in HHbMb. The tissue saturation index was significantly 
increased post CRT. V̇O2,peak on the first test before CRT was 1.34 
mL/min/kg however, due to a leak in the mask towards the end of the second 
exercise test it was not possible to obtain an accurate V̇O2,peak. 
 
Table 27: Key variables derived from ramp incremental exercise test 
Test Ramp rate (W/min) 
Ramp 
duration 
(s) 
V̇O2,peak 
(mL/min/kg) 
WR peak 
(W) 
HR rise 
(bpm) 
HHbMb 
amplitude 
(a.u.) 
Pre 15.0 910.0 1.34 185.0 40.0 20.1 
Post 15.0 1060.0 N/A 202.0 39.0 11.8 
       
 
Figure 49 shows the muscle deoxygenation (HHbMb) pre and 6 weeks post 
CRT (top) and tissue oxygenation index (bottom). In addition to the decrease 
in the change in muscle deoxygenation, the profile of the muscle 
deoxygenation also changed, such that, at the onset of exercise, muscle 
deoxygenation increased at a slower rate than before CRT. This is also 
reflected in the tissue oxygenation index profile.  
 
 
 
 
 
167 
 
 
  
 
 
Figure 49: NIRS deoxygenated haemoglobin and myoglobin (top) and tissue 
oxygenation index (bottom) response before and after cardiac 
resynchronisation therapy in a heart failure patient. 
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6.8.4 Discussion 
 
In the case study presented, exercise capacity (time to limit of tolerance and 
peak work rate) was improved in one patient following CRT. Additionally, the 
overall amount of muscle oxygen extraction (assessed by NIRS 
deoxygenated and haemoglobin and myoglobin, and tissue oxygenation 
index) was reduced, suggesting increased blood flow to the vastus lateralis 
muscle following CRT improved the matching between V̇O2m/Q̇m, and 
decreased the reliance on oxygen extraction during ramp incremental 
exercise in this heart failure patient. This is the first study to demonstrate this 
these changes following CRT by NIRS, although a larger subject number is 
needed to confirm this. Previous studies have shown that most patients will 
improve their exercise capacity by 1-2 mL/min/kg in V̇O2,max and 
improvements in exercise duration to be around 30-60 s (Saxon and 
Ellenbogen, 2003) following CRT. While the changes in V̇O2,max in this 
patient cannot be evaluated, exercise duration was increased by 57 s, in 
agreement with previous studies, and indicating that exercise capacity has 
been improved following CRT. This improvement can be attributed to 
improvements in cardiac structure and function (Cazeau et al., 2001; 
Auricchio et al., 2002). The mechanisms responsible for this are still not 
completely understood, but it is thought that the electrical resynchronisation 
of the heart can reduce the left bundle branch block-induced dyssynchrony 
between the left and right ventricle and the intraventricular dyssynchrony 
within the left ventricle (Abraham and Hayes, 2003). This acts to improve left 
ventricular filling time, decrease septal dyskinesis and reduce mitral 
regurgitation, improving central haemodynamics (Kass et al., 1999; 
Auricchio et al., 2002). Figure 50 shows changes in left ventricular ejection 
fraction following CRT from key clinical trials and studies (Auricchio et al., 
1999; Cleland et al., 2001; Linde et al., 2002, 2008; Higgins et al., 2003; 
Young et al., 2003; Abraham et al., 2004; Bristow et al., 2004; Moss et al., 
2005).  
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Figure 50: Change in left ventricular ejection fraction (LVEF) after cardiac 
resynchronisation therapy (CRT) in heart failure patients with different 
functional classes (New York Heart Association; NYHA), in comparison to 
LVEF before CRT (blue bars), and 3-6 months CRT (red bars), or 12-24 
months (green bars). Taken from Auricchio and Prinzen (2011).  
 
Despite this improvement in cardiac haemodynamics, there is still a portion 
of patients (around 30%) classed as CRT “non-responders”. Non-responders 
can be classed as: those who do not see an improvement in symptoms, but 
continue to live as an effect of therapy; and those who experience relief from 
symptoms but have poor outcomes (Auricchio and Prinzen, 2011). Possible 
central explanations for the variability in response to CRT include variability 
in the patterns of mechanical dyssynchrony, the site of LV stimulation, and 
the etiology of heart failure (Birnie and Tang, 2006). However, as mentioned 
earlier, indices of cardiac function do not relate well to exercise tolerance. As 
such, it is pertinent to consider what is happening peripherally. One 
possibility is that the extra cardiac output generated from CRT does not 
reach the exercising muscle but is diverted elsewhere (i.e. a blood flow 
redistribution problem), while another is that the extra cardiac output is 
reaching the exercising muscle, but some patients are unable to utilise the 
extra cardiac output (and therefore oxygen) being delivered. This may be 
attributed to a plethora of skeletal muscle adaptations that have been 
observed in heart failure patients (Figure 51) including a shift in fibre type 
from type I oxidative fibres, to type II glycolytic fibres; a reduction in 
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mitochondrial density and mitochondrial volumes; muscle wasting and 
muscle fibre atrophy; and increases apoptosis. Accordingly, several studies 
have observed a significant relationship between skeletal muscle 
abnormalities (such as those listed above and in Figure 51), and exercise 
tolerance (Wiener et al., 1986; Mancini et al., 1989, 1992; Sullivan et al., 
1990; Minotti et al., 1991; Drexler et al., 1992; Clark et al., 1996; Massie et 
al., 1996; Nagai et al., 2004; Middlekauff, 2010).  
 
 
Figure 51: Effects of heart failure on the skeletal muscle. Taken from Poole 
et al. (2011). 
 
Wilson et al. (1984), demonstrated the presence of skeletal muscle 
dysfunction by (invasively) simultaneously measuring cardiac 
haemodynamics and peripheral blood flow in 11 heart failure patients, with 
and without dobutamine infusion. Without dobutamine, patients were limited 
by fatigue and had reduced oxygen uptake, as well as markedly elevated leg 
muscle oxygen extraction at peak exercise, consistent with a blood flow 
limitation. With dobutamine infusion, cardiac output was significantly 
increased, as was leg blood flow. Despite this, there was no significant 
change in maximal exercise duration or peak V̇O2. Whereas, leg muscle 
oxygen extraction significantly decreased (85 ± 2 % to 80 ±  2%, p < 0.01), 
suggesting that even with increased oxygen delivery, the skeletal muscle 
may not extract the extra oxygen being delivered.  
The results from the present case study are similar to those found by Wilson 
et al. (1984), in that following intervention (to improve cardiac output), 
171 
 
muscle blood flow appeared to be increased but muscle oxygen extraction 
was decreased. This supports the conclusion that an increased blood flow 
reduced the reliance on O2 extraction, presumably by improving the 
matching of the V̇O2m/Q̇m ratio. Unlike in Wilson et al. (1984), in the current 
case study, exercise duration and peak work rate was improved, indicating 
that CRT may result in some improvement in exercise tolerance (although as 
this case study is only in one patient it is unclear whether this result would 
be seen in other HF patients). Unfortunately, the patient was not followed up 
in the present study, therefore, it is not known if the patient presented in this 
case study was deemed a responder or non-responder.  
The slight improvement in exercise capacity would suggest a response to 
therapy. However, this patient did not their increase oxygen extraction which 
is more indicative of a non-responder. It is logical to think that if oxygen 
delivery to the exercising muscle is improved, then oxygen extraction rates 
would be increased in order to “take advantage” of the increased oxygen 
delivery in order to facilitate an improvement exercise capacity however, 
oxygen extraction was decreased in this patient. It is therefore possible to 
interpret these results such that, prior to CRT the patient was primarily 
limited by oxygen delivery however following CRT this primary limitation 
appears to have moved towards an oxygen utilisation limitation. This raises 
several questions: (i) has this patient improved tolerance to exercise 
following CRT (and therefore is a “responder”) despite skeletal muscle 
abnormalities, and does this depend on the degree of the improvement in 
oxygen delivery (i.e. is it enough to override a poor oxygen utilisation 
response? (ii) Did muscle oxygen extraction not increase in an attempt to 
keep the V̇O2m/Q̇m relationship stable, such that O2 delivery is well matched 
to O2 utilisation (i.e. would an even larger increase oxygen delivery be met 
with a larger increase in oxygen extraction? These questions highlight one of 
the limitations in using NIRS in this way i.e. it is only possible to assess the 
balance between oxygen delivery and oxygen utilisation such that it is not 
always possible to distinguish if changes in the NIRS oxygenation response 
are a result of a change in oxygen delivery and/or a change in oxygen 
utilisation. One possible way to overcome this limitation is to eliminate the 
influence of one of these factors (i.e. the influence of oxygen delivery). This 
concept is addressed in the next chapter.  
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6.8.5 Conclusion 
This data presented in this case study suggests that NIRS may be a useful 
and objective way to assess CRT effectiveness, by demonstrating 
improvement in skeletal muscle oxygen delivery. Furthermore, NIRS may 
have the potential to identify the locus of the O2 delivery/utilisation limitation 
underlying exercise tolerance in a given heart failure patient, so that those 
who are likely to be CRT non-responders may be identified before 
undergoing invasive surgery (see future considerations section for 
discussion).   
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Chapter 7 Assessing the 
reproducibility of muscle oxidative 
capacity measured by near infrared 
spectroscopy in healthy humans 
 
7.1 Introduction 
A major symptom of heart failure is poor exercise tolerance. Although 
exercise intolerance does not correlate to the degree of cardiovascular 
dysfunction (Witte et al., 2004), it represents one of the best predictors of 
mortality (Clark et al., 1996). Abnormal skeletal muscle metabolism in HF 
may, in part, account for this dissociation between cardiac function and 
exercise intolerance (Massie et al., 1987; Mancini et al., 1994; Clark et al., 
1996; Bowen et al., 2012). In the skeletal muscle, three energy pathways are 
responsible for ATP regeneration: the breakdown of phosphocreatine (PCr), 
which results in the formation of inorganic phosphate (Pi); 
glycolysis/glycogenolysis, which produces lactate and H+; and oxidative 
phosphorylation, by the coupling of oxygen use to the phosphorylation of 
adenosine diphosphate (ADP) in the mitochondria (Baker et al., 2010). The 
mitochondria generate most of the ATP required to support muscle 
contraction. As such, mitochondrial functioning and/or density is related to 
exercise capacity (Holloszy, 1967; Holloszy et al., 1970; Gollnick et al., 
1973). Accordingly, impairments in the mitochondria, such as reductions in 
mitochondrial function and/or density, are associated with ageing (Conley et 
al., 2000) and diseases including diabetes (Joseph et al., 2012) and heart 
failure (Clark et al., 1996).  
During recovery from exercise, NIRS measurements during repeated arterial 
occlusions have been utilised in order to determine the kinetics of the 
recovery of muscle oxygen consumption (mV̇O2). The purpose of the 
occlusions is to achieve brief periods of ischemia, such that mV̇O2 is isolated 
from the influence of circulatory and pulmonary interactions (i.e. in the 
absence of blood flow, muscle deoxygenation occurs solely by O2 
consumption). The time-course of the mV̇O2 recovery follows an exponential 
time-course and is directly related to oxidative capacity [in single frog muscle 
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fibres (Wüst et al., 2013)]. The mV̇O2 recovery rate constant (k) is therefore 
considered to be an index of mitochondrial function (Motobe et al., 2004; 
Ryan et al., 2012, 2013, 2014; Brizendine et al., 2013; Adami et al., 2017). In 
humans the recovery kinetics of mV̇O2 determined by NIRS have been 
shown to be closely correlated with the kinetics of PCr recovery determined 
by 31PMRS following exercise (Ryan et al., 2013) and by muscle biopsy 
(Ryan et al., 2014).  
This NIRS method for assessing oxidative capacity relies on two competing 
assumptions: i) that exercise is sufficiently intense enough to activate 
mitochondrial oxidative enzymes and elicit a sufficient increase in mV̇O2; 
and ii) that O2 availability is not limiting to k (Haseler et al., 2004; Adami and 
Rossiter, 2017). In addition, there should be no change in blood volume 
(represented by changes in total haemoglobin + myoglobin in the NIRS 
signal) during occlusions for this method to be valid, as changes in blood 
volume could confound the slope of the recovery mV̇O2 (Ryan et al., 2012). 
The latter issue has been addressed by Ryan et al. (2012) who developed a 
method for correcting for blood volume changes. Meeting the other two 
conditions is largely dependent on the researcher correctly carrying out the 
test and have been addressed in detail in the discussion section.  
The principles of NIRS have been described in detail in Chapter 1. In the 
context of this chapter, the rate of decrease in tissue oxygenation index 
(TOI) or oxygenated haemoglobin and myoglobin (HbMbO2; or, conversely, 
the rate of increase in deoxygenated haemoglobin and myoglobin, HHbMb) 
during the intermittent arterial occlusions is considered an estimate of 
muscle oxygen consumption. The relatively low cost of NIRS and ease of 
application on human participants have made NIRS an attractive tool to use 
in both research and clinical settings (Wolf et al., 2007). Despite this there 
are few published studies reporting the reproducibility of the oxidative 
capacity assessment (Ryan et al., 2012; Southern et al., 2013; Adami et al., 
2017). Furthermore, of these reports, the techniques used to elicit a rise in 
mV̇O2 have varied from electrical stimulation (Ryan et al., 2012), pneumatic 
ergometer (Southern et al., 2013), resistance bands (Southern et al., 2013) 
and running (Buchheit et al., 2011) in healthy populations, and manually 
applied (hand) resistance (Adami et al., 2017) in chronic obstructive 
pulmonary disease (COPD) patients. It is worth noting, however, that in the 
few studies that have been published good reproducibility was reported 
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regardless of the method used for exercise (i.e. coefficient of variance of 
~10%).  
Throughout this thesis, the importance of utilising non-invasive methods of 
assessing skeletal muscle function (i.e. O2 uptake/consumption at the 
skeletal muscle) has been discussed. In chapters 3 and 4 computational 
approaches were used to investigate muscle V̇O2 dynamics, and in chapter 
5, 6 and 7 experimental approaches (i.e. gas exchange and NIRS) were 
utilised to investigate the same. The experimental NIRS measurements 
made so far in this thesis have been reflective of both oxygen delivery and 
oxygen utilisation, thereby giving important insights into the balance between 
oxygen delivery and oxygen utilisation. This chapter will focus on a novel 
technique developed to investigate muscle oxygen consumption at the 
exercising muscle solely by NIRS (Hamaoka et al., 1996; Motobe et al., 
2004). This technique may present a non-invasive method of detecting 
skeletal muscle abnormalities, without the confounding effects of O2 delivery. 
If this technique is reproducible it may represent a useful tool to identify 
individuals who have an oxygen utilisation limitation at the skeletal muscle 
level regardless of their blood flow status. The aim of this study was to test 
the reproducibility (assessed by coefficient of variance and intraclass 
correlation) of this oxidative capacity assessment technique (see methods) 
in young healthy individuals, to include tests conducted on the same day, 
and tests conducted across on two different days. Manual resistance was 
applied for the exercise portion of the test (see methods) in order to keep the 
test simple and inexpensive, so that it in future studies it could be applied in 
heart failure patients in a clinical setting. 
7.2 Methods 
Methods are described in the general methods section under sub-heading 
“Protocol 5”. 
7.3 Results 
 
Participants 
 
All participants tolerated the sustained and intermittent arterial occlusions 
well and completed the whole protocol. In two subjects mV̇O2 k or τ could 
not be confidently resolved for all four oxidative capacity assessments, and 
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in one subject, mV̇O2 k or τ could not be confidently resolved in two 
oxidative capacity assessments (see discussion section for possible 
explanations). In these subjects the data did not fall in an exponential 
manner, rather, the data was highly variable such that fitting an exponential 
function was either not possible, or fitting an exponential function returned 
unphysiological results (e.g. τ of 430 s). As such, these tests were excluded 
from further analysis.  
 
Physiological normalisation  
 
Physiological normalisation revealed the maximum physiological range 
calculated from the minimum and maximum NIRS signal values during and 
after the sustained arterial occlusion. Values ranged from a minimum TOI of 
(mean ± SD) 45 ± 11% (day 1) and 42 ± 8% (day 2) to a maximum TOI of 73 
± 2% (day 1) to 72 ± 3% (day 2), giving a mean range of 28 ± 10% (day 1) 
and 30 ± 7% (day 2). There were no significant differences between 
minimum or maximum TOI between either same day bouts or different day 
bouts (p > 0.05).  
 
Muscle oxidative capacity 
 
Subject test-retest reliability variables are presented in Table 28. A total of 
44 mV̇O2 recovery kinetics assessments were performed for the study. 
Individual test re-rest reliability of 𝜏 within the same day was CV = 6.7, ICC = 
0.92 (day 1) and CV = 12.6, ICC = 0.08 (day 2). Individual test re-rest 
reliability of rate constant k within the same day was CV = 10.3, ICC = 0.98 
(day 1) and CV = 12.47, ICC = 0.26 (day 2). Figure 52 shows the NIRS 
signal during the oxidative capacity assessment and the resultant mV̇O2 
kinetics in a representative subject. Figure 53 shows comparisons of k and τ 
across bouts 1 and 2 on days 1 and 2. Bland-Altman limit of agreement 
analysis revealed 95% confidence intervals of (-1.2, 0.7 k day 1; -0.5, 0.9 k 
day 2; -6.1, 1.8 τ day 1; -8.6, 9.5 τ day 2), and no order effect was detected.  
Figure 54 shows Bland Altman limit of agreement plots for repeated k and τ 
measurements between same day bouts.  
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Table 28: Test-retest reproducibility and coefficient of variant (CV) of 
gastrocnemius muscle oxidative capacity assessed by near infrared 
spectroscopy in young healthy participants 
  τ (s) k (min-1) 
 
Bout 1 Bout 2 CV ICC Bout 1 Bout 2 CV ICC 
Day 1 26.4 ± 8 28.6 ± 11 6.70 0.92 
2.7 ± 
1.5 2.9 ± 2.5 10.32 
0.9
8 
Day 2 28.3 ± 9 27.8 ± 7 
12.6
0 0.08 
2.4 ± 
0.9 2.2 ± 0.2 12.47 
0.2
6 
Data are presented as mean ± SD. k = proportional to muscle oxidative 
capacity; CV = coefficient of variation; ICC Intraclass correlation coefficient 
 
Table 29 shows the test-retest reproducibility and coefficient of variance of 
oxidative capacity assessment where tests were performed on separate 
days.   
Table 29: Test-retest reproducibility and coefficient of variance (CV) of 
gastrocnemius muscle oxidative capacity assessed by near infrared 
spectroscopy in young healthy participants on separate days    
 
day 1 day 2 CV ICC 
𝝉 (s) 25.7 ± 11 28.0 ± 2 14.0 0.55 
k (min-1) 2.8 ± 2 2.15 ± 0.1 7.1 0.28 
Data are presented as mean ± SD. k = proportional to muscle oxidative 
capacity; CV = coefficient of variation; ICC Intraclass correlation coefficient 
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Figure 52: HbMbO2 changes during the oxidative capacity protocol for a 
representative subject on day 1. The left panels show the HbMbO2 
(corrected for changes in blood volume) during dynamic exercise (grey 
shaded area) and intermittent arterial occlusion during recovery. Right 
panels show calculated muscle V̇O2 recovery profile k mV̇O2 (red line). The 
letters (a-h) are given to illustrate how corresponding mV̇O2 values are 
derived from the negative linear HbMbO2c slopes during intermittent 
occlusions. τ (s) is the mV̇O2 time constant determined by non-linear least 
squares regression analysis. k, is the rate constant, which is linearly related 
to muscle oxidative capacity (k = (1 / τ)∙60, min-1).  
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Figure 53: Muscle oxidative capacity and k (top panels) τ (bottom panels) 
test-retest analysis on day 1 and day 2. Red line shows linear regression, 
dotted line show line of identity (x = y) 
 
 
Figure 54: Bland-Altman plots of agreements between repeated 
measurements of muscle V̇O2 τ (left) and recovery rate constant (k, right). 
Dashed lines show 95% limits of agreement.  
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7.4 Discussion 
This study found that the mV̇O2 recovery rate constant k (an index of 
mitochondrial function), and time constant τ measured by NIRS is 
reproducible in healthy subjects. The within subject variability in this study 
(mean CV for τ = 9% and for k = 11%) was consistent with the results of 
other studies using similar techniques (CV 10-11%; Southern et al., 2014), 
(CV 9.4%; Buchheit et al., 2011), (CV 10.6%; Ryan et al., 2012), and (CV 
9.8%; Adami et al., 2017). Furthermore, the time constants reported in this 
study (mean τ 25.7 s day 1; 28.0 s day 2) were similar to those reported in 
similar populations (Ryan et al., 2012), and also to those measured in the 
same participants, by pulmonary oxygen uptake measurements which were 
reported in chapter two (mean τ  24.4 s).  In addition, time constants were 
also similar to the recovery time constant of PCr kinetics measured by MRS 
in the gastrocnemius muscle (Yoshida and Watari, 1993; McCully et al., 
1994; Larson-Meyer et al., 2000; van den Broek et al., 2007). The finding 
from the present study supports the use of NIRS assessment in determining 
mitochondrial oxidative capacity in healthy subjects.     
Factors influencing variability and reproducibility of the NIRS muscle 
oxidative test 
The two major conditions of the oxidative capacity test are i) that exercise is 
sufficient to activate mitochondrial oxidative enzymes and an increase in 
mV̇O2 and ii) that oxygen is not limiting to k. Care needs to be taken during 
the oxidative capacity tests that both these conditions are met. For example, 
experiments on isolated single muscle fibers have shown that maximal 
activation of mitochondrial enzymes might not be achieved when contraction 
frequency is too low (Wüst et al., 2013).  However, higher order PCr 
recovery kinetics have been reported during recovery from very high 
intensity exercise performed in vivo (Forbes et al., 2009). In addition, strong 
activation of muscle fibers may limit O2 availability and slow PCr recovery 
kinetics (Haseler et al., 2004). However, the point at which to stop exercise 
during the oxidative capacity test has varied between different researchers. 
In some studies, physiological normalisation was completed after the 
oxidative capacity assessment, so the level of O2 desaturation was not 
measured and scaled to the maximum physiological range during the 
exercise (Ryan et al., 2012, 2013, 2014). Others have used a percentage of 
maximal work intensity determined from prior exercise tests. For example, 
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Motobe et al. (2004) measured mV̇O2 recovery in the forearm following 60 s 
dynamic handgrip exercise at 40% of participants’ maximal voluntary 
contraction, and Buchheit et al. (2011) measured mV̇O2 following running at 
40% and 60% of (pre-determined) maximal running speeds. Recently, 
Adami et al. (2017) used a modified version of the protocol proposed by 
Ryan et al. (2012), by completing the physiological normalisation maneuver 
prior to the oxidative capacity assessment. This allowed determination of the 
maximal physiological range of each subject (in older adults and chronic 
obstructive pulmonary disease patients) prior to the oxidative capacity 
assessment, to avoid reaching a critical low intramuscular PO2 level induced 
by the exercise. In addition to good reproducibility Adami et al. (2017), 
showed that exercise stimuli that resulted in a small increase in mV̇O2 and 
small reduction in saturation was associated with poor test-retest 
reproducibility. Consequently, it was suggested that the risk to NIRS test 
validity of under stimulating the muscle during dynamic exercise was greater 
than the risk of O2 limiting deoxygenation caused by contractions that are 
too intense or sustained. The authors therefore recommended that exercise 
desaturation should reach a value in 30-50% of the physiological 
normalization range in order to ensure test quality (Adami et al., 2017). 
In this current study, the mean 30-50% physiological normalisation range 
was 64% (for 30% desaturation) and 58% (for 50% desaturation). The mean 
actual desaturation for all 11 participants was 57%. Excluding the two 
participants in which it was not possible to confidently estimate kinetic 
parameters changed this by only 1% (i.e. a mean of 58%). As such, 
participants in this current study were at the maximum (50%) range of 
desaturation on average of that suggested by Adami et al. (2017). This is of 
interest, as in all but two tests, the mV̇O2 recovery did not follow a strictly 
exponential profile. Rather, after an initial ‘slowed’ mV̇O2 response, the 
response profile then fell exponentially. This suggests that in this group of 
healthy participants, a target of 50% PN is too high (i.e. O2 was desaturated 
to an extent in which O2 availability became limiting to mV̇O2). This is 
demonstrated in Figure 55. In this individual, minimum TOI was 36% and 
maximum TOI was 74%, therefore the 50% PN muscle desaturation target is 
74 - [(74-36)/2] = 55%. As can be seen, exercise was stopped at a level of 
59%, which was 4% above the 50% target value (this equates to ~40% of 
PN range). Despite this, the first 4 mV̇O2 recovery slopes were 
uncharacteristically slow, before they began to fall exponentially. This slow 
initial response is suggestive of O2 delivery being limited (Adami et al., 
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2017). This pattern (i.e. initial slow mV̇O2 recovery slopes) was observed in 
all but two oxidative capacity assessments. Consequently, the exponential 
was fitted to the data from the point at which the data points began to fall in 
an exponential manner (determined by visual inspection). Estimating the 
parameters in this way may have influenced curve fitting (i.e. because the 
point at which to start the fitting is subjective to the person conducting the 
analysis). Therefore, this may explain some of the variability in 
measurements. In addition, removing these first data points from analysis 
means that the initial mechanisms of the muscle recovery phase are 
essentially ignored. This raises the possibility that by removing the first few 
data points means missing out on quantifying some physiological 
mechanism. 
 
 
 
 
Figure 55: NIRS traces from a representative subject during a single visit. 
Left: The PN manoeuvre identifies the maximal physiological range (blue 
line), determined from the minimum TOI (TOI min) at the end of the 
sustained arterial occlusion, and the maximum TOI (TOI max) at the end of 
the reactive hyperaemia. Middle: the start of the oxidative capacity 
assessment. Grey shaded area indicates brief plantar flexion exercise. The 
red dotted line shows where plantar flexion exercise was stopped (~59%). 
Target desaturation determined by the PN was 55% (i.e. 4% lower than were 
exercise was stopped, equating to ~40% PN range). Right: resulting mV̇O2 
recovery response profile. Circles show slope of HbMbO2 recovery. Red line 
is non-linear regression fit to estimate rate constant k and 𝜏. 
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Southern et al. (2013) tested the reproducibility of the oxidative capacity test 
during different exercise modalities in healthy individuals. In this study PN 
was performed before the oxidative capacity test. In both exercise protocols 
(resistance band vs ergometer) muscle desaturation for the oxidative 
capacity test was capped at 30% of the PN range. The authors reported no 
deviations from an exponential response in the mV̇O2 recovery and 
concluded mV̇O2 time constants were reproducible in both exercise 
modalities. As the study by Adami et al. (2017) was in older and chronic 
obstructive pulmonary disease patients, it is possible that a higher level of 
exercise was needed to activate oxidative enzymes and produce a sufficient 
mV̇O2 response (which may be due to a smaller muscle mass and lower 
muscle respiratory capacity) compared to healthy populations (Coggan et 
al., 1993; Maltais et al., 2000).  
 
Additionally, in two of the subjects, it was not possible confidently determine 
time constants from the mV̇O2 recovery slopes (which were erroneously 
low). Consequently, possible explanations for this were explored. Figure 56 
shows the physiological normalisation maneuver (top panels) and the 
corresponding first bout of exercise (bottom panels) in the two participants 
where kinetics parameters could not be confidently estimated. As can be 
seen, in both participants the muscle was desaturated beyond the 50% PN 
target. As such, in these participants it is likely that O2 became limiting to k 
and therefore confounded the slopes of the mV̇O2 recovery.  
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Figure 56: TOI profiles during PN manoeuvre (top panels) and oxidative 
capacity assessment (bottom panels) in the two subjects in whom recovery 
kinetics could not be confidently estimated. For subject x (left panels) TOI 
min was 34%, and TOI max was 80%. Target muscle desaturation therefore 
is 80 – ((80 – 34)/2) = 57%. The solid red line shows where exercise should 
have been stopped (i.e. 57%) and the dotted red lie shows where exercise 
was actually stopped (i.e. 49%). For subject y (right panels) TOI min was 
52.5%, and TOI max was 72.5%. Target muscle desaturation therefore is 
72.5 – ((72.5 – 52.5)/2) = 62.5%. The solid red line shows where exercise 
should have been stopped (i.e. 62.5%) and the dotted red lie shows where 
exercise was actually stopped (i.e. 53%). 
 
It is also important to consider the possible consequences of completing the 
physiological normalisation manoeuvre before the oxidative assessment, as 
this essentially creates an ischemic preconditioning effect (Crisafulli et al., 
2011), which could influence the assumptions inherent with the oxidative 
capacity technique (i.e. sufficient oxygen availability). The effects of this on 
mitochondrial functioning and the resultant k rate constant remain largely 
unknown (Adami et al., 2017). However, it has been argued that due to a 
strong correlation between NIRS derived oxidative capacity and high-
resolution respirometry, O2 availability is not problematic when measuring 
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oxidative capacity with NIRS in healthy individuals (Chung et al., 2018). On 
average, in the current study, the muscle was depleted to 50% of the 
physiological normalisation range. Despite overall reproducible results, as 
described above, there was an initial lag before mV̇O2 recovery fell 
exponentially, suggesting a cut-off point of 30% of physiological 
normalisation might be a more suitable value in healthy participants to 
minimise errors and disparities in curve fitting, and supporting the notion that 
O2 availability is important to consider when performing the oxidative 
capacity assessment.    
 
Changes in blood flow 
In order for the oxidative capacity test to be valid, there should be no change 
in blood volume (represented in the NIRS signal as tHbMb) such that there 
should be symmetrical changes in HbMbO2 and HHbMb (Ryan et al., 2012). 
However, it has been suggested that during occlusions there is a blood 
volume change that can mask changes in the NIRS signals due to oxygen 
consumption (Ryan et al., 2013) and consequently, may act to confound the 
slope measurements for oxygen consumption (De Blasi et al., 1997; Van 
Beekvelt et al., 2001). The cause of the blood volume change during arterial 
occlusion has been attributed to the movement of haem concentrations from 
larger vessels undetectable by NIRS, to microvascular beds detected by 
NIRS, which is caused by residual pressure gradients (Ryan et al., 2013). To 
overcome this, a blood volume correction algorithm was applied, and fitted 
the linear regression analysis to the corrected NIRS signals. This method of 
correcting for blood volume has been shown to provide good reliability of 
mV̇O2 recovery (CV = 10%) and produced similar coefficients of variance to 
PCr recovery kinetics (Ryan et al., 2012).  
 
Influence of adipose tissue thickness (ATT) 
 
Near infrared light must cross the skin and subcutaneous fat in order to 
reach the underlying skeletal muscle tissue, Therefore, the amount of 
adipose tissue can influence the NIRS signal (i.e. high ATT values act to 
dampen the NIRS signal). This is important to consider when testing obese 
populations. In this study participants were young, healthy and relatively 
lean, so it is anticipated that the effects of ATT to be lessened. Furthermore, 
the NIRS device used (continuous wave spectrometer) is unable to calculate 
the path length of near infrared light and therefore absolute concentrations of 
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O2 consumption are not possible. In order to account for this, the data was 
scaled to the maximal physiological calibration (ischemic calibration). This 
method allows for comparisons between individuals with varying amounts of 
ATT overlying the muscle of interest. Whilst time domain and frequency 
domain devices estimate path length and better estimate absolute values, 
these devices are still influenced by ATT (Koga et al., 2011). As such, this 
additional information will not influence the calculation of the rate constant k 
for the recovery of mV̇O2 (Ryan et al., 2013). Therefore, compared to 
previous studies, the results from this study suggest that the physiological 
normalisation range may vary depending on the population being studied 
and therefore needs to be considered when determining methods and that, 
in young healthy individuals the PN range may be smaller, and target 
desaturation be lower (i.e. closer to the 30% mark rather than 50%). 
 
Finally, other factors such as variability in NIRS placement, NIRS movement 
artifact, and day-to-day variability in participants could contribute to the 
overall variability in this study.   
 
7.5 Conclusion 
 
The NIRS oxidative capacity assessment test-retest reliability was found to 
be reproducible within the same day, and between different days. However, 
the mV̇O2 recovery response profile did not follow a strictly exponential 
response possible influencing curve fitting and the resultant mV̇O2 recovery 
kinetics. With this in mind, it is important that the person administering the 
test has a thorough understanding of the methodological limitations and 
constraints of the test, as well as the ability to respond to the results ‘on 
screen’ during the test, in order to satisfy the main assumptions of the test. 
Consequently, strict and specific guidelines that could be adopted and 
adhered to in clinical practice would be essential if the test was to become a 
mainstream clinical tool. Furthermore, the NIRS oxidative capacity test may 
be useful to identify the presence of skeletal muscle dysfunction, 
independent of blood flow. This is important as, in patients with skeletal 
muscle dysfunction, improving blood flow and oxygen delivery to the muscle 
may not give way to any improvements in symptoms or exercise tolerance, 
as the skeletal muscle can’t ‘make use’ of the extra oxygen being delivered. 
This is pertinent in patients that meet the current criteria for cardiac 
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resynchronisation therapy (which does not include any measure of skeletal 
muscle function). If a heart failure patient is identified to have skeletal 
muscle dysfunction, interventions such as exercise training can be 
implemented to improve to efficacy of cardiac resynchronisation therapy. 
Therefore, despite its inherent limitations, NIRS represent an important 
technique that is valuable and practical in research and clinical settings.  
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Chapter 8 Conclusions and future 
considerations 
 
There were two major aims of this thesis: (i) to develop and validate a  
computational model of circulatory and oxygen uptake dynamics, that is able 
to predict oxygen uptake measurements that are experimentally measured 
at the lungs (i.e. pulmonary oxygen uptake), and at the skeletal muscle (i.e. 
muscle oxygen uptake) for ramp incremental exercise and; (ii)  to test the 
clinical utility of using near infrared spectroscopy as a non-invasive tool to 
determine the locus of exercise intolerance in heart failure patients. 
To fulfil the first aim, a model of circulatory and oxygen uptake and dynamics 
for ramp incremental exercise was developed and validated. The new 
components of the ramp incremental model included adding a muscle fibre 
recruitment component in which individual muscle fibres, with their own V̇O2 
gain, can be gradually recruited throughout the exercise. Other additions to 
the model included modelling to V̇O2 and Q̇ responses to rise with an initial 
short exponential phase followed by a linear phase for the rest of the ramp in 
order to mimic the V̇O2 response to ramp exercise.  This is the first model to 
predict the pulmonary V̇O2 response (typically measured by gas exchange 
measurements) to ramp exercise which has been validated against V̇O2 and 
Q̇ measurements measured directly (Fick method) in healthy humans. The 
model was developed specifically for ramp incremental exercise so that it is 
transferable into clinical settings. This is because the standard exercise test 
heart failure patients undergo is an incremental exercise test. However, to 
date, much of the research undertaken has focused on constant work rate 
exercise, where the oxygen uptake response is different. The model was 
developed even further in Chapter 4 to include a NIRS output (specifically 
oxygenated haemoglobin and myoglobin, deoxygenated haemoglobin and 
myoglobin, tissue oxygenation index and total haemoglobin and myoglobin). 
This involved the addition of a NIRS compartment, within the muscle 
compartment that takes simulated arterial and venous O2 concentrations 
from the validated O2 transport model (described in Chapter 3) as inputs and 
calculates the corresponding muscle NIRS signals. The development of a 
muscle oxygenation response was motivated by the need for a deeper 
understanding of the relationship between oxygen delivery and oxygen 
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utilisation in heart failure patients. The new ramp model and NIRS model 
were able to simulate experimental data to provide insights into muscle 
oxygen utilisation dynamics to ramp exercise. Based on the model 
simulations the following conclusions can be drawn: (i) breath-by-breath gas 
exchange measurements, on their own, are not a reliable estimate of muscle 
oxygen uptake kinetics and (ii) alterations in the oxygen delivery-to-oxygen 
utilisation relationship, including its kinetics, the slope of the oxygenation 
response and its baseline absolute values, all have an influence on the 
muscle oxygenation response. Specifically, when V̇O2 kinetics are faster 
relative to Q̇ kinetics the tissue oxygenation index transiently undershoots its 
steady state value. Similarly, if baseline cardiac output becomes limiting to 
V̇O2, or there is a reduction in Q̇ per litre change in V̇O2, tissue oxygenation 
will undershoot its steady state response. Additionally, a novel finding from 
the model simulations is muscle oxygenation responses are sensitive to 
changes in the oxygen uptake-to-work rate relationship. Specifically, 
reducing this relationship by 10% caused a greater reliance on O2 extraction 
as demonstrated by a steeper HHbMb slope. 
The model presented in chapter 4 is the first of its kind to predict muscle 
oxygenation responses by near infrared spectroscopy during ramp 
incremental and step exercise from knowledge of circulatory, respiratory, 
and oxygen uptake dynamic interactions. However, the newly developed 
NIRS model, overall, could not accurately predict the muscle oxygenation 
response (tissue oxygenation index and deoxygenated haemoglobin and 
myoglobin) to ramp exercise. There were no significant differences in the 
change (delta) in the muscle tissue oxygenation index from the start to end 
of exercise, however, the model could not predict breakpoint in the data nor 
the slopes of the oxygenation responses. Given the poor fits to the data, 
further development and validation of the model is necessary before its 
clinical utility can be realised, and before inferences can be made regarding 
mechanisms of exercise intolerance.  
For the second aim, a variety experimental approaches were utilised. 
Chapter 5 aimed to determine whether breath-by-breath pulmonary gas 
exchange measurements from ramp exercise alone can provide a reliable 
estimation of skeletal muscle oxygen uptake kinetics in heart failure patients. 
This was based on the need for a method of determining muscle V̇O2 
kinetics more easily in a clinical setting. The model simulations and 
experimental data presented in this chapter show that, according to the 
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model predictions, muscle oxygen uptake kinetics were strongly correlated 
to pulmonary oxygen uptake measurements in heart failure patients during 
ramp exercise. However, the pulmonary mean response time (that 
encompasses both phase I and phase II of the V̇O2 response) may differ 
within the same patient depending on the exercise protocol (i.e. ramp vs 
step) and method of data analysis used such that, the mean response time 
determined from step exercise is not equal to the mean response in the 
same patient when determined from ramp incremental exercise. Although 
these findings are based on modelling predictions, they highlight the 
importance of carefully considering methodological strategies when making 
non-invasive measurements in heart failure patients. Given these findings, 
for ramp incremental exercise to be used to its full clinical utility, additional 
measurements may be needed alongside breath-by-breath measurements 
to identify patients in whom skeletal muscle dysfunction is a limiting factor in 
exercise tolerance. As such, for the next chapter near-infrared spectroscopy 
was implemented during a range of exercise protocols and conditions. The 
aim of Chapter 6, was to characterise the NIRS deoxygenated haemoglobin 
and myoglobin response to ramp incremental exercise in heart failure 
patients. A simplified approach to doing so proved the most useful in regard 
to the information gained from the test, as well as the method that could be 
most easily transferred into a clinical setting. Using this simplified method, 
the following conclusions were derived: (i) in heart failure patients, the 
deoxygenated haemoglobin and myoglobin response to ramp incremental is 
variable between individuals but can be classified into three distinct 
responses according to the skeletal muscle O2 delivery dynamics during 
ramp incremental exercise and; (ii) a simplified linear fit to the mid portion of 
the deoxygenation response gave valuable insights into the V̇O2m/Q̇m 
relationship in heart failure patients. Specifically, a steeper increase in 
muscle deoxygenation was related to lower peak work rates and a lower 
V̇O2,peak, indicating that patients with steeper deoxygenation slopes had a 
greater reliance on oxygen extraction due to limited oxygen delivery. This is 
the first study to date, to directly compare the different methodological 
approaches to characterising NIRS data from ramp incremental exercise in 
heart failure patients. It is also the first use the response type profile (i.e. in 
this study three distinct profiles were identified) to characterise NIRS 
responses. These responses may be useful in future studies to assist 
characterising the NIRS response and identify patients who are limited by 
skeletal muscle O2 delivery based on their response type.    
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Furthermore, the near infrared spectroscopy and oxygen uptake data 
presented in the short case study presented at the end of the chapter 
suggests that NIRS may be a useful and objective way to assess the 
effectiveness of cardiac resynchronisation therapy. In the case study, 
following intervention to increase cardiac output, muscle blood flow 
appeared to be increased (indicated by a higher baseline TOI) however 
overall muscle oxygen extraction was decreased (indicated by a smaller 
delta) indicating that an increased blood flow reduces the reliance on O2 
extraction, presumably by improving the matching of the V̇O2m/Q̇m ratio. This 
shows the potential utility of NIRS for future studies, in distinguishing 
between patients in whom exercise tolerance is mediated primarily by 
oxygen delivery and in those whom it is mediated primarily by limitations in 
oxygen utilisation (i.e. in the presence skeletal muscle dysfunction), so that 
those who are likely to be cardiac resynchronisation therapy non-responders 
may be identified before undergoing invasive surgery. With the right exercise 
protocol, it would be possible to use NIRS to determine changes to these 
factors described above. (0or example, by utilising a RISE protocol ) with 
measurements of breath-by-breath gas exchange and near infrared 
spectroscopy, performed at various stages of their treatment plan (i.e. before 
and at intervals following CRT) the following outcomes could be 
demonstrated: (i) exercise tests that include NIRS can distinguish between 
patients in whom exercise intolerance is mediated primarily by oxygen 
delivery, and those in whom this is mediated primarily by limitations in 
oxygen utilisation (i.e. skeletal muscle dysfunction) (ii) CRT increases both 
central cardiac output and skeletal muscle blood flow, and describe the time 
course of these changes. This can be demonstrated by performing 
echocardiography measurements (for central haemodynamics) and by 
assessing baseline blood flow by utilising near infrared spectroscopy 
measurement from the warm up and step portions of the RISE test (iii) in 
those in whom the exercise test results suggest exercise intolerance is 
primarily a consequence of a limitation in oxygen utilisation, there is a 
reduction in the magnitude of improvement in CHF symptoms following CRT 
(this could be assessed by subjective questions, such as ‘ratings of 
perceived exertion’ charts as well as their clinical response to the therapy 
(IV) describe the time course of any increase in exercise tolerance following 
CRT, and gain insight into the mechanisms of any improvement (further 
insights could also be gained from developing and utilising the NIRS model) 
and finally (V) if the tests are repeated at intervals following CRT (i.e. 1 
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week, 6 weeks, and 6 months) these data could be used to describe the time 
course of any increase in exercise tolerance following CRT. The advantage 
of this test is that, echocardiography measurements and a ramp incremental 
exercise test are standard clinical assessments for CRT patients as such, 
the addition of NIRS and an extension of the standard ramp test to include a 
short constant work rate bout following the ramp are relatively simple and 
non-invasive additions. The study would, however, require more visits to the 
research lab for the patients.  
The technique presented in Chapter 7 demonstrates another method for 
determining the presence of skeletal muscle dysfunction. Although it is yet to 
be validated in heart failure patients it represents a promising non-invasive 
method of identifying, by NIRS, skeletal muscle dysfunction (if present) 
without the influence of blood flow. The advantages of this technique are that 
it does not require maximal, or even a high amount of, effort on behalf of the 
individual completing the test. The disadvantages of this test are it requires 
the person administering the test to have a thorough understanding of the 
methodological limitations and constraints of the test, as well as the ability to 
respond to the results ‘on screen’ during the test, in order to satisfy the main 
assumptions of the test. Regardless, it was found that the NIRS oxidative 
capacity assessment test-retest reliability was reproducible within the same 
day, and between different days in young healthy individuals. Furthermore, 
the results from this study contribute to other studies in determining what the 
physiological normalisation range should be. Other studies have suggested 
30-50% however this study showed that in some cases, 50% was too large 
of a decrease in muscle oxygenation and a value closer to 30% may be 
more appropriate in young healthy individuals. Future studies testing the 
reproducibility and validity of this technique in heart failure patients is the 
logical next step in determining a non-invasive way to detect skeletal muscle 
dysfunction in heart failure patients.  
To conclude, computational models are simplifications of complex systems, 
nevertheless, they can provide useful insights into the normal and 
physiological functioning of such complex systems that cannot be gained 
through experimental work, either due to technical limitations or ethical 
issues. A sufficiently detailed model, which has been validated under a wide 
range of physiological and pathological conditions, may be able to relate 
skeletal muscle oxygenation dynamics to exercise intolerance mechanisms 
in heart failure. Consequently, the models presented in this thesis could 
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assist in tailoring interventional treatments and in assessing the efficacy of 
such treatments. As such, their continued development and verification are 
an important direction for future research. In addition, although the 
applications of near infrared spectroscopy presented in this thesis have 
several limitations, this is inherent with all non-invasive investigations, and 
has the advantage of being relatively easily to apply in clinical settings. 
Therefore, despite its inherent limitations, near infrared spectroscopy 
represents an important technique that is valuable and practical in research 
and clinical settings.  
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